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Abstract 
Background: The mucous
 
membrane of the oral cavity is the site of many neoplasms, 
reactive processes, infections and manifestation of systemic diseases. Lesions in the 
oral mucosa may be the primary clinical feature or the only sign of muco-cutaneous 
diseases. Some conditions can result in considerable morbidity and mortality if not 
properly treated. Patients with such conditions may often consult a dermatology 
clinic. Information on the diversity, magnitude and burden of these conditions in 
general is rare in Africa and specifically in Sudan. To plan for effective oral health 
services, correct diagnosis based on proper investigations and epidemiological studies 
are essential.  
Objective: This study aimed to explore the diversity of pathological and non-
pathological conditions of the oral mucous membrane in patients with skin lesions 
attending the outpatient facility of Khartoum Teaching Hospital (KTH) - Dermatology 
Clinic, Sudan. The study also had the following specific objectives: to estimate the 
frequency and socio-behavioural distribution of oral mucosal lesions (OML) in 
patients with skin diseases; to assess the impact of these conditions on patients’ daily 
life activities using the Arabic version of the Oral Impact on Daily Performances 
(OIDP) inventory in patients with and without OML; and, to describe clinical features 
of oral pemphigus in persons attending the outpatient clinic.  
Methods: From October 2008 to January 2009, all outpatients aged above 18 years 
attending the dermatology clinic of KTH were invited to participate in a cross-
sectional hospital-based study. Data were collected by face-to-face interviews using 
structured questionnaires followed by clinical examinations of the skin and the oral 
cavity. Oral cavity clinical examinations, diagnosis of OML and decayed, missing and 
filled teeth (DMFT) registration were performed following the World Health 
Organization (WHO) criteria. Biopsies, smears and immunohistochemistry (IHC) 
were used as adjuvant techniques for confirmation. An Arabic version of the OIDP 
inventory was used to assess oral health related quality of life. 
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 Results: In Paper 1, OML were registered in 315 out of 544 (57.9%) patients with 
confirmed skin diseases. Tongue lesions were the most frequently diagnosed OML 
(23.3%), followed in descending order by white lesions (19.1%), red and blue lesions 
(11%) and vesiculobullous diseases (6%). Presence of OML in patients with skin 
disease was most common in older age groups (p<0.05), in males (p<0.05), patients 
who reported systemic disease (p<0.05) and among current users of smokeless 
tobacco (toombak) (p<0.00). 
In Paper II, at least one oral impact (OIDP > 0) was reported by 190 patients (35.6%). 
The prevalence of any oral impact was 30.5%, 36.7% and 44.1 % in patients with no 
OML, one type of OML and more than one type of OML, respectively. The number 
of types of OML and the number and types of oral symptoms were consistently 
associated with the OIDP scores. Patients who reported bad oral health, ≥ 1 dental 
attendance, > 1 type of OML, or ≥ 1 type of oral symptom were more likely than their 
counterparts in the opposite groups to report any OIDP. The odds ratios (OR) were 
respectively; 2.9 (95% CI 1.9-4.5), 2.3 (95% CI 1.5-3.5), 1.8 (95% CI 1.1-3.2) and 6.7 
(95% CI 2.6-17.5). Vesiculobullous and ulcerative lesions of OML disease groups 
were statistically significantly associated with OIDP.  
In Paper III, nineteen of 21 patients with PV had oral lesions (mean age 43.0, range 
20 – 72 yrs.). Of 18 patients who had experienced both skin and oral lesion during 
their lifetime, 50% reported that oral lesions preceded skin lesions. More than 68% 
(13/19) of these patients were < 50 years of age, with female: male ratio of 1.1:1. The 
palatal and buccal mucosae were the most common locations followed by tongue and 
lower lip. The Oral Lesion Activity Score (OLAS) was higher in those who reported 
living outside of Khartoum, were outdoor workers, had lower education and belonged 
to central and Western tribes, compared with their counterparts. The histopathological 
pictures of all specimens were in agreement with the IHC findings. 
Conclusions: OML were frequently diagnosed in patients with skin disease and 
varied with age, gender, systemic condition and use of toombak. OIDP occurred more 
frequently among patients with skin disease with OML, compared with patients with 
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skin disease without OML. The Arabic version of the OIDP inventory used in this 
study showed acceptable and reliable psychometric properties. The majority of PV 
patients had oral lesions. The socio-demographic, clinical and histological pictures of 
oral PV are in accordance with the literature. The IHC on formalin-fixed tissue 
samples may be an alternative test to confirm the diagnosis of PV. The results of this 
study shed light on the higher prevalence of OML in patients with dermatologic 
diseases and thus emphasize the importance of routine examination of the oral 
mucosa in these patients. Collaboration efforts between dermatologists and dentists 
would provide better treatment and avoid serious morbidity and mortality.  
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1. Introduction 
1.1 Oral mucosal lesions - definitions and public health 
aspects 
The term mucous membrane is defined as the moist lining of the oral cavity, 
gastrointestinal tract, nasal passages, and other body cavities that connect with the 
exterior. In the oral cavity, this lining is called the oral mucous membrane or oral 
mucosa. At the lips, the oral mucosa is continuous with the skin and in the pharynx it 
is continuous with the moist mucosa lining the rest of the gut [1]. Oral mucosal 
lesions (OML) in the present thesis have been defined as any abnormal change or any 
swelling in the oral mucosal surface. It is known that the oral cavity, including the 
oral mucosa, is the host of neoplasms, reactive processes, infections, and 
manifestations of many systemic body physiological and pathological changes [2, 3]. 
In this respect, the oral mucosa mirrors the patient’s general health [4]. It is 
noteworthy that oral health workers face a tremendous variety of lesions ranging from 
uncommon to common conditions and traversing from life-threating diseases to the 
most innocent and hereditary ones. More than 200 mucosal conditions have been 
documented [5]. Andreasen et al. [6] reviewed the epidemiology of some common 
oral disorders, other than dental caries and periodontal disease, which affect the oral 
and maxillofacial structures. The review revealed that 25% to 50% of the populations 
examined had oral mucosal diseases, which comprised a tremendous variety of lesions 
including malignant ones. In 2003, the World Health Organization (WHO) described 
OML as one of the major public health problems worldwide [7, 8].  
Globally, OML have been studied from different points of view; clinical aspects, 
histology, pathogenesis, etiology, and treatment modalities. Only a few 
epidemiological studies have focused on OML at the global level [8]. From a public 
health point of view, Pindborg stated: “The diseases with the highest priority would 
be those which are the most dangerous, and those which are the most prevalent 
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provided the latter present a therapeutic problem. Also of interest would be such oral 
mucosal diseases, which, although rare, are of great nuisance to the patients. In this 
connection, it should be emphasized that numerous OML are expressions, often the 
first, of systemic diseases”[9]. In that connection, the 1960s and 1970s witnessed 
interest of the WHO in OML and listed the most prime diseases of interest to be; oral 
carcinoma, leukoplakia, erythroplakia, leukokeratosis nicotina palati, lichen planus, 
submucous fibrosis, herpetic gingivostomatitis, acute necrotizing gingivitis, cancrum 
oris, candidiasis, and aphthous ulcerations [9].  
Another public health threat, the acquired immunodeficiency syndrome (AIDS), has 
been recognized as the leading cause of death in Sub-Saharan Africa and the fourth-
leading cause of mortality world-wide [10]. Between 60% and 90% of the people with 
human immunodeficiency virus (HIV) infection will have at least one oral lesion at a 
period of time during the development of the disease [11]. Pseudomembranous 
candidiasis, hairy leukoplakia, Kaposi sarcoma, periodontal diseases and non-
Hodgkin’s lymphoma are considered to have strong associations with HIV/AIDS. 
Moreover, hyperpigmentation, necrotizing stomatitis, salivary gland diseases, and 
bacterial and viral infections have moderate associations with the disease. Since the 
onset of the HIV pandemic, oral lesions have been well recognized as early indicators 
of HIV infection and as predictors of HIV disease progression [11].  
Although some diseases only affect the oral cavity in many occasions, the mouth is a 
mirror of associated skin diseases or underlying systemic conditions [4]. The 
epithelium of the oral cavity and skin originates from the same embryonic ectoderm, 
while the posterior third of the tongue originates from endoderm. Thus, the skin and 
oral mucosa share some properties, and diseases may manifest themselves both in oral 
mucosa and skin [1, 3, 12]. The most important skin diseases with oral manifestations 
are listed in Table 1. These diseases have been described in a number of review 
papers [13-17]. Of particular concern in this study is oral pemphigus vulgaris.  
Table 1: Skin Diseases With Oral Manifestations [18] 
Genetic-related 
diseases  
Oral manifestation  Immune-related 
diseases 
Oral manifestation 
Ectodermal 
dysplasia 
Xerostomia, hypodontia, anodontia, dental 
deformity  
Pemphigus Bullae, erosion, ulcers 
White sponge nevus  Thick white, corrugated or velvety, diffuse 
plaques affect the buccal mucosa, bilaterally 
in most instances  
Paraneoplastic 
pemphigus 
Bullae, erosion, ulcers, hemorrhagic crusted lips 
Hereditary benign 
intraepithelial 
dyskeratosis 
Thick white corrugated plaques (buccal and 
labial mucosa in most instances)  
Mucous membrane 
pemphigoid    
Bullae, erosion, ulcers 
Pachyonychia 
congenita 
Thick white plaques (lateral margins and 
dorsal surface of the tongue) 
 Linear IgA 
dermatosis  
Bullae, erosion, ulcers 
Dyskeratosis 
congenita  
Bullae followed by erosion and eventually 
hyperkeratosis (tongue, buccal mucosa), 
progressive periodontal diseases. Leukoplakic 
lesions considered premalignant lesions 
Angina bullosa 
hemorrhagica 
Blood-filled vesicles or bullae 
Xeroderma 
pigmentosum  
OSCC of the lower lip and the tip of the 
tongue 
Epidermolysis 
bullosa acquisita 
Bullae, erosion, ulcers, constricted oral orifice, 
hypoplastic teeth 
Hereditary 
mucoepithelial 
dysplasia  
Asymptomatic demarcating fiery-red erythema 
of the hard palate 
Less involvement (attached gingivae, tongue 
mucosa) 
Bullous 
pemphigoid 
Bullae, erosion, ulcers 
Incontinentia 
pigmenti  
Hypodontia (oligodontia), dental hypoplasia, 
delayed eruption 
Erythema 
multiforme  
Erosion, ulcers, hemorrhagic crusted lips 
Darier’s disease  Multiple, normal-coloured or white, flat-
topped papules 
(Hard palate, alveolar mucosa) 
Reactive arthritis 
(Reiter’s 
syndrome) 
Erythematous papules, shallow ulcers, geographic 
tongue 
Warty dyskeratoma Pink or white umbilicated papule (keratinized Lichen planus Interlacing white lines bilaterally on the posterior 
17 
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(isolated Darier’s 
disease) 
mucosa) buccal mucosa (Wickham’s striae), atrophic 
erythematous area with central ulceration, white 
plaques replacing normal papillary surface of the 
tongue 
Peutz-Jeghers 
syndrome 
Brown to blue-gray macules freckle-like 
lesion (primary vermilion zone) 
Graft-versus-host 
disease 
Resemble oral lichen planus, pinpoint white 
papules, ulcers 
Heretidary 
hemorrhagic 
telangiectasia  
Red papules blanched on diascopy Psoriasis  White plaque, red plague, ulcers, erythema migrans 
(not confirmed) 
Ehlers-Danlos 
syndromes  
Marked elasticity of the tongue (an ability to 
touch tip of the nose with the tongue (Gorlin’s 
sign)), friability of oral mucosa, hypermobility 
of TMJ, dental abnormality  
Lupus 
erythematosus  
Ulcers, erythema, hyperkeratosis, xerostomia 
Tuberous sclerosis  Enamel pitting on the facial aspect of the 
anterior permanent dentition. 
Multiple fibrous papules, diffuse fibrous 
gingival enlargement (angiofibroma) 
Systemic sclerosis  Microstomia, loss of attached gingival mucosa, 
gingival recession, xerostomia  
Multiple hamartoma 
syndrome  
Multiple papules affecting gingivae, dorsum 
of tongue and buccal mucosa. High arched 
palate, periodontitis, extensive dental caries  
CREST syndrome  Telangiectasias  
Epidermolysis 
bullosa  
Ulcers, microstomia, ankyloglossia, dental 
deformity, severe caries. 
Acanthosis 
nigricans  
Fine papillary area of mucosal alteration 
Palmoplantar 
keratoderma 
White lesions (leukokeratosis)   
1.2 Prevalence of OML globally 
Epidemiological investigations of OML may be grouped into three categories: studies 
on oral cancer, studies on specific lesions other than cancer, such as recurrent 
aphthous ulcers (RAU) and recurrent herpes labialis, and studies of the prevalence of 
OML as a group. Current published studies in the last two categories are few 
compared with studies of oral cancer, dental caries and periodontal diseases [8, 19].  
The prevalence of a disease is the proportion of people in a population that has the 
disease at a given point in time [20]. Population-based studies are the optimal choice 
to estimate the prevalence of OML but population-based studies are expensive and 
time consuming [21]. A large comprehensive population-based study conducted by 
Axéll, revealed that 75% of the documented lesions were relatively rare with a 
prevalence of 0.01-3.8% [22]. To investigate rare conditions adequately, most 
publications considering OML are based on population subgroups like the elderly or 
school children and on special groups like patients from outpatient clinics and patients 
with specific diseases [23-31]. Focus on the special groups may ensure that patients 
with rare diseases will be included in the sample. 
According to the WHO, oral cancer and precancerous lesions are the most important 
OML that have been studied [9]. Oral cancer is considered the eighth most common 
cancer worldwide and the third most common cancer in south-central Asia. About 
2.6% of all cancers worldwide is oral cancer [32] and oral squamous cell carcinomas 
(OSCC) constitute more than 90% of these cancers [33]. Precancerous lesions such as 
leukoplakia, erythroplakia and oral submucous fibrosis entail a high risk of malignant 
transformation, reported to be in the range of 30-80% [34]. Thus, identifying these 
lesions at an early stage is important to initiate proper treatment. The prevalence of 
oral leukoplakia has been reported to vary from 0.1% among 27.443 adults in 
Minnesota, USA to 10.6% among 803 individuals aged 15 years and above in Kenya, 
indicating that leukoplakia varies across geographical locations. Most of the studies 
on precancerous lesions have been conducted in Southeast Asia [7, 35, 36]. National 
19 
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oral health survey conducted in Sri Lanka, reported a prevalence of erythroplakia 
between 0.05-0.2% [37]. The prevalence of oral submucous fibrosis, mostly reported 
from Indian subcontinent, was up to 0.5% [38, 39]. Oral lichen planus as a 
premalignant lesion showed an annual malignant transformation rate of 0.36% [40]. 
Among 20,333 Swedish people aged 15 years and above, oral lichen planus was 
found in 1.9% [41].  
Table 2 shows the prevalence of the ten top OML in studies conducted among 
individuals aged 15 years and above from the general population as well as among 
dental attendees. In these studies, the types of OML that have been included had great 
influence on the prevalence reported. For instance, when different types of tongue 
lesion were taken into account, a higher prevalence of OML was generally reported 
[22, 27, 42]. The same observation was noted when non-pathologic morphologic 
alterations such as Fordyce’s granules, geographic and fissured tongue were 
considered [22, 24, 42]. In these studies, white lesions (frictional lesions, leukoplakia, 
lichen planus and leukoedema) account for a considerable proportion of OML and 
were observed in more than 6 studies. Data may also differ if they are collected from 
case history, rather than from lesions observed at time of examination. This has been 
shown in RAU and recurrent herpes simplex [22]. Also, several studies have shown 
that the overall OML prevalence was linked to risk habits, sex and age. Tobacco and 
use of a denture were significantly linked with the occurrence of leukoplakia, 
frictional lesions and denture stomatitis [22, 23, 27, 42-45]. An increase in overall 
OML prevalence was observed with increased age [43, 46]. Nevertheless, these 
studies have shown that OML such as frictional lesions, leukoplakia, cheek bite, 
denture stomatitis, lichen planus, fissure tongue, RAU, traumatic lesion, leukoedema, 
geographic tongue and melanin pigmentation are the ten most observed OML among 
the studies. The least common OML observed were papilloma and scar.  
Table 2 shows that substantial variation exists between the studies in terms of sample 
size, age, and time allocated for data collection, sampling methods, diagnostic criteria, 
training and calibration. The absence of consensus among these elements creates 
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difficulties in comparing results across the various studies [47]. For example, the 
standardized WHO criteria are valid for most of the OML that were investigated in 
the studies presented in Table 2, but only 9 out of 17 studies used those criteria. In 
addition, training and calibration of examiners to achieve accurate diagnosis and a 
high level of agreement were missing in some studies. Among the studies that 
reported training and calibration, only a few explained the technique used in details 
[22, 43] while the majority gave no further information. Using natural or artificial 
light in a steady manner throughout the data collection would also decrease variation 
in the prevalence of OML reported. Such information was lacking in the majority of 
the studies. This means that variation in methodological considerations among OML 
prevalence studies is a real problem, making comparison among different studies a 
difficult task [47, 48].  
There is a lack of information about the prevalence of OML in Sudan. In 1992, a 
population-based study conducted in Northern Sudan revealed that the prevalence of 
snuff dipper’s lesions was 5.1% (281) among 5500 adults over the age of 20 years 
[49]. Abbas et al. [50, 51] reported two cases of mucosal leishmaniasis with oral 
manifestations. Visceral, cutaneous and mucosal leishmaniasis are endemic in Sudan, 
with mucosal leishmaniasis being the least common one.  
 
 
 
 
 
 
 
Table 2: An overview of studies published considering the prevalence of OML between 1976 and 2011 (the ten top OML per each 
study) 
Year 
Country  
Sample 
size  
(Duration)  
Age in 
years 
Population 
frame 
Sampling 
method  
Diagnostic 
criteria 
Examiners’ 
training and 
calibration,  
Number (n) 
OML 
% 
OML and prevalence (%)  
[22] 1976 
Sweden 
 
20333 
 
+15 County residents Axéll  Reported 
 n >1 
61.6 Fordyce’s granules 82.0, leukoedema 48, denture 
stomatitis 16.0, excessive melanin 9.0, geographic 
tongue 8.4 , amalgam tattoo 8.2, snuff dipper’s lesion 
8.0, fissured tongue 6.4, preleukoplakia 6.3, frictional 
lesion 5.4  
[52] 1986 
USA 
 
23616 
(16 years) 
 
+35 Oral cancer 
screening data 
base 
Retrospective 
study   
Not 
reported 
Reported 
 n >1 
21.0 number per 1000: leukoplakia 28.9, snuff dipper’s 
lesion 1.6 , cheek bite 1.2, lichen planus 1.1, smoker’s 
palate 0.7, leukoedema 0.3 
[44] 1988 
USA 
17.235 
(6 years) 
+17 NHANES III 
data base  
Retrospective 
study   
WHO  Reported 
n >1 
27.9 denture stomatitis 3.6, amalgam tattoo 3.3, cheek bite 
3.0, frictional lesion 2.6, nevus 2.0, geographic tongue 
1.8, herpes labialis 1.6, scar 1.4, denture hyperplasia 
1.1, RAU 0.8 
[53] 1995 
Cambodia 
1319 
(27 days) 
+15 County residents 
Invitation 
WHO Reported 
 n =1  
4.9 lichen planus 1.8, candidiasis 1.4, leukoplakia 1.1, 
submucous fibrosis 0.2, cancer 0.1, cheek bite 0.2, 
glossitis unspecified 0.2, angular chelitis 0.5, papilloma 
0.1 
[36] 1995 
Kenya 
 
803 
(not 
reported) 
+15 County residents  
Random 
sampling 
WHO 
Others  
Reported  
n =1 
48.6 leukoedema 26.0, melanin pigmentation 12.7, 
leukoplakia 10.6, palatal keratosis 6.4, frictional lesion 
5.5, preleukoplakia 4.1, borderline leukoplakia 2.4, 
cheek and lip bite 1.3, snuff dipper’s lesion 0.4 
[54] 1997 
Malaysia 
11697 
(5 months) 
+25 County residents  
Random 
sampling 
WHO 
 Axéll  
Others 
Reported 
n >1 
9.7 number per 1000; denture stomatitis 33.5, other lesions 
25.8, betel chewer’s mucosa 16.0, leukoplakia 9.6, 
smoker’s palate 4.9, angular chelitis 3.9, lichen planus 
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3.8, median rhomboid glossitis 3.3, submucous fibrosis 
0.6, cancer 0.4 
[42] 2000 
Slovenia 
  
555 
(not 
reported) 
15, 25, 
35, 45, 
55, 65 
County residents 
 Random 
sampling 
WHO  
Axéll  
Others 
Not reported 
n =1 
61.6 Fordyce’s granules 49.7, fissured tongue 21.1, varices 
16.2,  
denture stomatitis 4.3, leukoplakia 3.1, cheek bite 2.7, 
lichen planus 2.3, frictional lesion 2.2, geographic and 
fissured tongue 1.1, mucocele 0.9  
[23] 2001 
Spain 
337 
(a year) 
≥30 Dental clinic 
attendees 
Census  
WHO 
Others 
Not reported 
n >1 
58.7 melanin pigmentation 24.6, frictional lesion 11.5, linea 
alba 10.1, cheek biting 6.8, fissured tongue 5.0, 
traumatic lesion 4.7, hemangioma 3.2, denture 
stomatitis 2.6, herpes labialis 2.3, RAU 2.3 
[27] 2002 
Span 
 
308 
(6 months) 
+30 County residents  
Random 
sampling 
WHO  
Others 
Not reported 
n >1 
51.1 varices 21.0, frictional lesion 7.5, traumatic lesion 7.1, 
denture stomatitis 6.5, excessive melanin 5.8, denture 
hyperplasia 5.2, fissured tongue 3.9, lichen planus 3.2, 
cheek bite 2.9, angular chelitis 2.9, coated tongue 2.9 
[46] 2007 
Germany 
4210 
(4 years) 
≥21  County residents  
Random 
sampling 
Not 
reported 
 
Not reported 
n >1 
11.83 leukoplakia simplex 2.8, leukoplakia verrucosa 0.05, 
leukoplakia erosive 0.02, erythroplakia 0.02, lichen 
planus 0.4, ulcer 0.7, exophytic neoplasia 3.0, 
herpetiform/aphthous ulcers 1.6, other lesions 2.9 
[55] 2007 
Mexico  
23785 
(21 years) 
+15 Dental attendees 
data base 
Retrospective 
study 
Others Not reported 
n >1 
 number per 1000; leukoedema 105.3, traumatic lesion 
40.2, frictional lesion 32.1, traumatic erythema 28.5, 
morsicatio buccarium (cheek bite) 21.6, chronic 
atrophic candidiasis (denture stomatitis) 20.1, 
inflammatory fibrous hyperplasia (denture hyperplasia) 
15.8, RAU 8.5, herpes labialis7.9, geographic tongue 
7.6   
[43] 2008 
Italy 
 
4098 
(8 years) 
 
≥19 Cancer screening 
data base 
Retrospective 
study  
WHO  
Axéll 
Reported  
n >1 
25.0 traumatic lesion 2.9, cheek bite 2.2, denture stomatitis 
1.9, fibroma/fibrous hyperplasia 1.7, vascular lesions 
1.7, frictional lesion 1.7, RAU 1.7, lichen planus 1.4, 
candidiasis 1.4, leukoplakia 1.1 
[25] 2009 
Saudi 
Arabia 
2552 
(42 
months) 
+15 Dental clinic 
attendees 
Census  
Not 
reported 
 
Not reported 
n =1 
15.0 Fordyce’s granules 3.8, leukoedema 3.3, traumatic 
lesion 1.8, fissured tongue 1.4, torus platinus 1.3, 
frictional lesion 0.9, tongue tie 0.5, melanin 
pigmentation 0.5, hairy tongue 0.5, geographic tongue 
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0.5, smoker's palate 0.5, RAU 0.3, varices 0.3  
[24] 2009 
Iran 
598 
(a year) 
≥19 Dental clinic 
attendees  
Census 
Not 
reported 
 
Not reported 
n =1 
49.3 Fordyce’s granules 27.9, fissured tongue 12.9, 
leukoedema 12.5, hairy tongue 8.9 
[56] 2009 
Turkey  
5000 
(16 month) 
≥17 Dental clinic 
attendees  
Census 
WHO  
Others 
Reported 
n >1 
 
15.5 Absolute numbers: RAU 116, coated tongue 107, 
secondary herpes (herpes labialis) 102, fissured tongue 
48, traumatic lesion 46, morsicatio buccarium (cheek 
bite) 36, frictional lesion 29, fibro-epithelial hyperplasia 
29, tongue atrophic papillae 25, melanin pigmentation 
24  
[57] 2009 
USA 
3.182 
(3 weeks) 
adult Dental clinics 
attendees  
Census 
Others Reported 
n >1 
 
26.7 frictional lesion 7.6, amalgam tattoo 3.7, traumatic 
lesion 3.4, fissured tongue 2.5, fibroma/fibrous 
hyperplasia 2.4, smoker's palate 1.3, geographic tongue 
1.2, burns 1.0, snuff dippers lesion 0.8, leukoplakia 0.7 
[45] 2011 
Sangli, 
India 
24.422 
(18 
months) 
Not 
reported 
Dental clinic 
attendees  
Census 
Not 
reported 
Not reported  2.5  RAU 0.7, submucous fibrosis 0.6, cancer 0.3, 
leukoplakia 0.3, lichen planus 0.1, fibroma/fibrous 
hyperplasia 0.1, denture stomatitis 0.09, pyogenic 
granuloma 0.07, submucous fibrosis + leukoplakia 0.05 
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1.3 Biological, socio-demographic and behavioural factors 
associated with OML 
Risk has been defined as “a probability of an adverse outcome, or a factor that raises 
this probability” [58]. By definition, a risk factor must clearly establish that the 
exposure has occurred before the outcome [59]. Thus, longitudinal studies are essential 
to launch risk factors, whereas cross-sectional studies can only provide evidence of 
risk indicators.  
The oral cavity of healthy individuals harbors hundreds of bacterial, viral, and fungal 
species, many of which are commensal ones. Pathogenic ones, which could constitute 
biological risk factor for OML, colonize and overgrow in response to changes in the 
host immunity, micro-environment or other triggers in the oral cavity such as food or 
dental material. In addition to the above mentioned biological risk factors, OML are 
strongly related to behavioral and socio-economic status.  Thus, the OML are 
multifactorial diseases which may have a number of various risk factors rather than a 
single cause. Table 3 lists some of the factors affecting the oral mucosal tissues. 
Generally, lifestyle related factors have a great influence on oral diseases [8]. 
Evidently, tobacco either in smoke - or smokeless form constitutes an important risk 
factor for many oral diseases, including OML [60, 61]. Studies have demonstrated a 
dose-response relationship between tobacco usage and OML. These diseases can be 
listed as; smoker’s palate (stomatitis nicotina) [62], smoker’s melanosis [43], palatal 
keratosis (associated with reverse smoking), frictional keratosis [43], coated /hairy 
tongue [63], oral candidiasis, median rhomboid glossitis [64] , snuff-dipper’s lesion 
[65], leukoplakia [66], erythroplakia [67] and OSCC. A number of review papers have 
described these diseases in general [61, 68-71]. Tobacco use in various forms has been 
estimated to account for over 90% of cancers in the oral cavity, with increased risks 
when tobacco use is combined with alcohol [72, 73]. In South and South-East Asia, 
90% of oral cancer are attributed to tobacco use combined with areca nut ⁄ betel quid 
chewing, heavy alcohol drinking and dietary micronutrient deficiency[74]. In Sudan, 
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the role of toombak (smokeless tobacco) has been stated to be of major importance in 
the aetiology of oral squamous cell carcinoma [75]. Idris et al. [75] studied 1.916 cases 
of oral neoplasms registered in Sudan Cancer Registry from 1970 to 1985, and found 
that 66.5% of oral malignancy was OSCC, followed by tumors of the salivary gland, 
neoplasms of non-odontogenic and non-epithelial origin and odontogenic neoplasm . 
Men had a higher frequency than women, and the lesions were more prevalent in older 
age. The betel quid chewing was found to be a significant etiological factor of 
submucous fibrosis in a case-control study in Sri Lanka [76].  
With connection to lifestyle related factors, about 21% of Waimiri-Atroani Indians in 
Brazil, showed focal epithelial hyperplasia, an infectious condition that have been 
connected with close living conditions, dietary insufficiency and poverty in many 
ethnic and racial groups [77, 78]. The role of denture use as a risk factor for stomatitis 
has been extensively studied and reviewed, reporting prevalence of denture stomatitis 
ranging from 17% to 71% among denture wearers [79-84]. 
 A cross sectional study from India conducted among 1187 employees of Mysore city 
found that the prevalence of oral pre-malignant and malignant lesions was higher in 
individuals with lower compared to individuals with higher socio-economic status 
[85]. Similar results have been obtained by a case-control study using data from the 
baseline screening of a randomized oral cancer screening trial in Kerala, India [86]. In 
a study of 202 agricultural workers in Brazil, the prevalence of actinic cheilitis was 
39.6%, where formal education and more than four years education were found to 
decrease the risk for actinic cheilitis [87]. A total of 362 beach workers from Brazil 
exhibited 15.5% of actinic cheilitis. The study found that beach workers with lower 
education (up to 6 years of schooling) were 1.7 times more likely to have actinic 
cheilitis than those with more than 6 years of education [88].  
A number of studies have revealed that outdoor workers who are exposed to higher 
solar radiation time have a higher probability of developing actinic cheilitis. The 
prevalence of actinic cheilitis have been reported to vary between 15% and 43% 
among outdoor workers [87-89], while in the general population the prevalence has 
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varied between 0.4 and 2.4% [88]. Another study from Brazil revealed 16.7% of 
actinic cheilitis among 240 farmers [89].  
Some investigators have reported that the prevalence of OML increases with 
increasing age, and being a male. In a study done on 598 referred Iranian patients, the 
prevalence of patients with OML increased significantly with age from 25.8% in the 
youngest age group (<19 years) to 74.3% in the oldest group (≥ 60 years). The study 
also found that OML occurred more frequently in men (62.4%) than in women (37.6%) 
(P<0.004) [24]. Similar results were found in the NHANES III data, showing that 
individuals aged ≥ 70 years almost twice the odds of having OML as compared with 
the youngest age group (17 - 29 years). The same study showed that males had 
significantly larger odds of having OML than females [44]. In general, older people are 
more susceptible for systemic diseases and have been exposed to risk factors 
throughout their life course, such as for instance tobacco, alcohol and multiple 
medications. Besides, males and females often have differing degrees of exposure to 
some of the lifestyle and environmental risk factors. One of the main significant risk 
factors for OML associated with autoimmune dysfunction is ethnicity and being 
females [90]. Genetic factors are suggested to play a role in ethnic disparities [91]. 
Other risk factors for OML include physical trauma, physical chronic irritation and 
chemical irritation. 
In conclusion, the risk factors responsible for OML are numerous, and previous studies 
have put more emphasis on behavioral risk factors rather than socio-economic factors 
in relation to OML. Control of OML depends on the availability and accessibility of 
the oral health systems, but risk reduction is only possible if services are focused on 
primary health care and prevention. 
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Table 3: Factors affecting oral mucosal lesions. Table adapted from Kleinman et al. 
[19] 
Lifestyle  Tobacco  
 Alcohol  
 Diet  
 Stress  
 Hygiene  
Environmental  Ultraviolet radiation 
 Occupation  
Infectious Agents  Bacterial  
 Viruses  
 Parasites  
 Fungal  
Host Factors  Genetic predisposition  
 Immune status  
 Congenital anomalies  
Therapeutic  Biologics 
 Medications  
 Chemotherapy  
 Radiation therapy  
 Prosthetic devices 
 Dental restorations 
Trauma  Burns  
 Lacerations  
 Poisons  
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1.4 Oral pemphigus vulgaris 
Pemphigus encompasses a group of a life-threatening autoimmune diseases that is 
characterized by circulating IgG antibodies targeting several types of keratinocyte 
antigens [92]. The term pemphigus is derived from the Greek word Pemphix, meaning 
bubble or blister, introduced by Hippocrates (460–370 BC), who described a 
pemphigoid fever as “pemphigodes pyertoi”, a disease that was not having blisters and 
accordingly perhaps did not signify pemphigus. The term pemphigus was originally 
given by Wichmann in 1791, who classified the disease as a chronic bullous disease. 
Pemphigus vulgaris (PV) was recognized as a separate entity by Lever in 1953, based 
on its clinical aspects, natural course and histopathology [93]. In 1964, using indirect 
immunofluorescence (IIF), Beutner and Jordon discovered that the sera of patients 
with PV had immunoglobulin IgG autoantibodies against the cell surface of 
keratinocytes [94]. Later in 1990, Amagai et al. [95, 96] identified the intercellular 
antigen as desmosomal cadherin, desmogleins (Dsg)-3 130-kDa adhesion molecules.  
1.4.1 Desmosomes 
Oral epithelium is a complex structure consisting mainly of keratinocytes anchoring to 
one other by desmosomes, and to the underlying basement membrane via 
hemidesmosomes. Desmosomes are glycoproteins of the cadherin supergene family 
that serve as adhesive complex as well as a cell-surface attachment site for the keratin 
intermediate filaments of the cytoskeleton. They comprise series of proteins, mainly 
Dsg and desmocollins that link to cytokeratins by desmoplakins and plakoglobin [97]. 
Each protein consists of an extracellular domain, a transmembrane domain, and an 
intracellular domin. Desmosomes are crucial for intercellular adhesion of oral and skin 
keratinocytes. However, some differences do exist; Dsg3 is expressed all over the oral 
epithelium, while it is only expressed in the basal and immediate suprabasal layer of 
the epidermis. On the other hand, Dsg1is expressed all over the epidermis and oral 
epithelium, more in the superficial layers and less in the deeper layers of both 
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epidermis and oral epithelium [98]. When both desmosomes coexist, damage to any 
one of them wouldn’t affect the integrity of the epithelium.  
1.4.2 Pathogenesis and aetiology 
Pathogenesis of PV is not yet completely understood. Acantholysis is the histologic 
hallmark of PV, and describes separation of keratinocytes from each other. There are 
several hypotheses about acantholysis in PV that each may contribute partially to 
explaining its mechanism. In 1999, Amagai et al. [99] proposed the Dsg compensatory 
mechanism theory, which clarified the basic pathophysiology of pemphigus and the 
classification of the clinical features. In 2001, Grando et al. [100] hypothesized that 
anti-Dsg autoantibodies do not act alone to cause pemphigus. Rather, other 
autoantibodies which accompany antibodies directed against Dsg1 and 3, play essential 
roles in the development of the disease. In 2004, Wang et al. [101] suggested that 
apoptosis may play a significant role in the mechanism of acantholysis. In 2006, 
Claude et al. [102] proposed the basal cell shrinkage hypothesis. It was based on 
existing sharp differences in the cytoskeleton composition of basal and suprabasal 
keratinocytes, as well as differences in surface receptors. Accordingly, there are 
differences in their rigidity and signaling events that are triggered by PV antibodies. 
Recently, Grando et al. [103] proposed a new term, apoptolysis, which is suggested to 
be the link between suprabasal acantholysis and cell-death pathways to basal cell 
shrinkage. 
Although the PV autoantibodies are pathogenic, the role of cellular immunity system in 
the acantholysis is unclear. Studies have shown that autoreactive T-cell responses to 
Dsg3 may be crucial in the pathogenesis of PV, since antibody production generally 
required T-cell help. In addition, a strong association was found between specific HLA 
class II alleles and recognition of Dsg3 by T lymphocytes [104]. 
Although pemphigus has been reported in all races and ethnic groups, a significantly 
increased prevalence of PV has been observed in certain ethnic groups such as 
Ashkenazian Jews, Mediterranean descendants and persons from South Asia [105-
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107]. Rare familial cases of PV have been reported [108]. A genetic susceptibility to 
pemphigus was first proposed by the finding of an increased frequency of major 
histocompatibility complex class II genes HLA -A10 haplotype in patients with 
pemphigus [109]. There is also an association with HLA class II allele; (HLA-DR4 
(DRB1*0402) in Ashkenazi Jews, DRw14 (DRB1*1041) and DQB1*0503) in 
Europeans and Asians [110, 111].  
In addition, a wide variety of drugs and dietary factors has been implicated in the onset 
of pemphigus. These may be categorized according to their chemical structure in thiol 
and non-thiol compounds [112-114]. The role of estrogens [115], radiotherapy [116] 
cosmetics [117] and viruses (herpes viruses, human herpes virus 8, cytomegalovirus, 
Epstein Barr virus, HIV) in the etiology of PV is reviewed elsewhere [118]. No 
infectious pathogen has been proven to date to have an etiological role in pemphigus. 
PV may occasionally be associated with other autoimmune disorders such as 
rheumatoid arthritis, myasthenia gravis, lupus erythematosus and pernicious anaemia 
[119].  
1.4.3 Oral lesions 
Clinically, pemphigus manifests itself with cutaneous or mucosal blisters and erosions 
that are distributed according to regional variation of the pemphigus antigen, 
depending on the kind of epithelial antigen targeted [120]. Thus axilla, scalp, buccal 
mucosa and face are the principal locations, followed by neck and shoulder, leg, upper 
back, chest and abdomen, groin, low to mid back, in descending order of frequency. It 
was originally thought that clinical phenotype of pemphigus is defined by the anti-
desmoglein autoantibody profile [121] (Table 4). Recently, it has been demonstrated 
that Dsg1 and Dsg 3 cannot differentiate between various morphologic subtypes of PV 
[122] and that pemphigus sera contain autoantibodies to over 50 types of antigens to 
desmosomal and non-desmosomal adhesion molecules other than Dsgs, not all being 
pathogenic [123].  
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Table 4: Main types of pemphigus involving the oral mucosa. Table adapted from 
Scully & Mignogna [124]. 
Variant  Oral 
lesions 
Antigens localisation  Target Antigens Antibody 
Class  
Mucosal PV  Common  Desmosomes  Dsg3  IgG 
Muco-cutaneous 
PV 
Common Desmosomes Dsg3 & Dsg1 IgG 
IgA pemphigus Common  Desmosomes Dsg3 
Desmocollin1 
Desmocollin 2 
IgA 
Paraneoplastic 
pemphigus  
Common Desmosomes or 
Hemidesmosomes 
Desmoplakin 1  
Desmoplakin2  
Periplakin 
BP 230  
IgG or IgA  
Pemphigus 
foliaceus 
Uncommon  Desmosomes Dsg1 IgG 
 
PV is the main and the most prevalent and aggressive type of pemphigus, 
corresponding to about 70% of cases and the one that usually affects the oral mucosa 
[124, 125] (Appendix 10.5 depicts clinical manifestations in patients with oral PV in 
our study). Ninety percent of patients with PV will develop oral lesions during the 
course of their disease, while a small group of patients never develops skin lesions. 
Despite the frequency of oral involvement and the fact that oral mucosa could be the 
primary site of involvement in 75% of cases [126], few studies have investigated the 
oral manifestations of PV (Table 5). The damage to Dsg3 can be compensated for by 
Dsg1, which would maintain the integrity of the skin, but not the oral mucosa, 
particularly in the early stages. This may explain why oral lesions in most cases 
preceded skin lesions (Dsg compensatory theory) [99].   
The clinical manifestations of pemphigus have been quantified and translated to 
objective outcome measures to assess the disease activity. Such measures are used 
alongside subjective assessment of disease severity. Accordingly, several clinical 
outcome measures have been developed to assess the clinical disease activity and 
disease progression over time and to evaluate therapeutic intervention [127, 128]. The 
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only validated ones are the autoimmune bullous skin disorder intensity score (ABSIS) 
and the pemphigus disease area index (PDAI) [129]. Many authors have found that the 
clinical severity of pemphigus has a parallel relationship with the level of Dsg1 and 
Dsg3 antibodies in the patient’s serum [130-132], a result that has great impact in 
treatment plan and patients follow up, but conflicting results do exist [131, 133]. 
 34 
Table 5: Summary of studies that have investigated more than three patients with oral lesions of pemphigus vulgaris  
Year/ 
Country 
Type of study, place 
of study 
Mean age 
(range 
years) 
No. of 
patients 
Female/Male  Oral mucosal sites in  
descending order  
Patients with non-oral 
mucosal sites N (%) 
[134] 1997 
USA 
Retrospective  
Dental clinic 
42 (3-66) 12 9/3 Gingiva, buccal, tongue, palate, 
floor of mouth, labial, 
oropharynx 
8 (66.6%) 
[135] 1999 
 UK 
Retrospective  
Dental clinic 
All patients over the 
previous decade  
1997 
50.2 (16-83) 55 33/22 Buccal, palate, tongue, lip, 
gingiva, floor of mouth  
13 (24%)  
[136] 2000  
USA 
Retrospective 
Dental clinic  
56.1 (27-68) 42 30/12 Buccal, gingiva, palate, tongue Not recorded 
[137] 2001  
USA 
Retrospective  
Dental clinic 
(biopsies)  
1974-1996 
56.5 (27-79) 33 25/8 Buccal, mandibular vestibules, 
entire mucosa, tongue, palate 
1 at examination 
1 history of skin lesion 
[138] 2005  
Spain 
Retrospective  
Dental clinic  
1981-2001 
44.7 (21-87) 14 10/4 Cheek, lip, gum, palate 6 (42.8%) 
[139] 2006 
Thailand 
Retrospective 
Dental clinics 
1991-2004 
37.7 (18-55) 18 12/6 Gingiva, buccal, palate, 
retromolar area, tongue, lip, 
floor of mouth 
Not reported 
[140] 2007 
 India 
Retrospective 
Dental clinic  
2004-2006 
42.3 (20-69) 20 12/8 Buccal, palate, lip, tongue, floor 
of mouth, tonsil, gingiva 
Not reported 
[106] 2007 
Greece  
 
Retrospective  
Dental and 
dermatology clinic  
6th decade of 
life 
 (30-83) 
129 88/41 Not recorded  18 (13.9%) 
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1985-2004 
[141] 2008  
India 
Retrospective  
Dental and 
dermatology clinic  
2001-2007 
42.7 (15-70) 71 45/26 Buccal, palate, lip, tongue, floor 
of mouth, gingiva 
33 (46.4%) 
[142] 2008  
Brazil 
Retrospective 
Dental clinic 
1974-2000 
4th decade of 
life 
4 2/2 Buccal, alveolar, soft palate, 
tongue, lip  
Not reported 
[143] 2008 
Croatia 
Retrospective  
Dermatology clinic  
2000-2006 
(20-95) 15  10/5 Buccal, palate, gingiva, tongue, 
lip 
15 (100%) 
[144] 2009  
Brazil 
Cross-sectional 
Dermatology clinic 
 2007-2008  
 (5-88) 6 3/3 Buccal, palate 6 (100%) 
[145] 2011  
Brazil 
Retrospective 
(biopsies) 
1988-2009 
3rd-5th 
decades of 
life 
22 17/5 Buccal, palate, lip, retromolar 
area 
Not reported 
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1.4.4 Microscopic appearance 
Histologically, the oral lesions of pemphigus show a pattern analogous to that studied 
in skin lesions. The early alteration in the lesion is intercellular edema within the lower 
epithelium, followed by detachment of epithelial cells (acantholysis) due to loss of 
intercellular bridges, which is typical in pemphigus, but may also be seen in viral 
diseases, Darier’s diseases and others [93, 119, 146]. Consequently, a horizontal cleft 
develops above the basal cell layer, where basal cells stay attached to the basement 
membrane and are separated from one another (tombstone). The acantholytic cell 
(Tzanck cells) are detected after attachment loss within the cleft and show 
degenerative changes characterized by large, swollen, hyperchromatic nuclei and little 
cytoplasm [147]. Polymorphonuclear leukocytes may also be present within the cleft. 
In the early stage of the disease, eosinophils may be detected in the lower epithelium, a 
finding referred to as eosinophilic spongiosis [148]. Slight perivascular mixed 
inflammatory cell infiltrate found in the underlying connective tissue, often including 
eosinophils. 
For diagnostic confirmation, the histopathology alone may not be enough, so the 
immunofluorescence technique is important. Since 1964, IIF of serum has been used to 
identify circulating autoantibodies and to quantify the autoantibody concentration by 
using different substrates, such as human skin or monkey esophagus [94]. In some 
patients, pemphigus antibodies are not detected due to interference by other antibodies, 
the presence of immune complexes, early stages of disease or when the disease is 
inactive. In such cases, direct immunofluorescence (DIF) is the most reliable test for 
pemphigus. It is performed on fresh tissue and demonstrates the presence of 
intercellular IgG and C3 along the cell surface membrane. A more sensitive test than 
IIF, enzyme-linked immunosorbent assay (ELISA), is also used to detect circulating 
autoantibodies to Dsg1 and Dsg3 [130]. These methods require fresh tissue or serum. 
Several studies have used formalin-fixed paraffin embedded tissue as an alternative to 
frozen tissue, and have reported the possibility of detecting pemphigus autoantibodies 
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intercellularly when using DIF[149], immunoperoxidase staining technique [150] and 
when using IHC [151].  
1.4.5 Treatment 
Before the introduction of steroid therapy in the late 1940s, PV was always fatal, with 
dehydration and secondary systemic infections as the main causes of death [152-154]. 
Based on global literature published in the past 12 years, the PV mortality rate was 
8.2% (range 0-20%) with an annual rate of mortality of 0.6% [123]. The mortality rate 
was much lower when the disease was confined to the mouth, but high doses and 
prolonged administration of steroids can result in numerous adverse effects, many of 
which are serious or even life threatening [155].  
The current therapeutic regimen is based on systemic corticosteroids along with other 
adjuvant therapy, such as immunosuppressive drugs (azathioprine, cyclophosphamide, 
cyclosporine, mycophenolate mofetil, chlorambucil, and methotrexate). Anti-
inflammatory drugs and immunomodulation therapy have also been introduced in 
unresponsive cases. Recently, a biological therapy named rituximab has been 
introduced and proven to be highly effective in the treatment of severe and recalcitrant 
pemphigus since earliest report [156]. Rituximab is a human/murine chimeric 
monoclonal antibody directed against CD20 of B-cells. It reduces circulating B-cell 
and prevents their maturation into antibody-producing plasma cells.  
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1.5 Psycho social impacts of OML  
In 1947, the WHO declared a new definition of health in terms of a state of complete 
physical, mental, and social wellbeing and not only the absence of disease and 
infirmity [157]. This new health concept acknowledged that objective measures of 
diseases in terms of clinical indicators alone should be extended to encompass 
individuals’ subjectively perceived oral health status. Quality of life (QoL), a concept 
that has been recognized to be part of a broader health concept, has been defined as 
“individuals’ perception of their position in life in the context of culture and value 
systems in which they live, and in relation to their goals, expectations, standards, and 
concerns” [158]. QoL is now recognized to be an important adjunct to the traditional 
clinical measures of health, including oral health [158] . In an effort to make QoL more 
useful for health researchers, health related quality of life was borne as a new concept 
in the 1960s. Bowling [159] stated that “health-related quality of life (HRQoL), is a 
major concept in relation to the experience of illness and the outcome of health 
services”. The notion of oral health-related quality of life (OHRQoL) appeared in the 
1980s without any strict definition and thus should be based on the same reasoning as 
the HRQoL. Nevertheless, a fluid definition has been accepted in terms of “cyclical 
and self-renewing interaction between the relevance and impact of oral health in 
everyday life” [160]. OHRQoL is not only about individuals’ self-perceived oral health 
in terms of social, psychological and functional consequences of oral diseases, but also 
about their perception on how important those consequences are. The most important 
aspect of OHRQoL is to bring the individual rather than only the teeth/mouth 
perspective into focus in the research field of oral health [161]. 
1.5.1 Measures of oral health related quality of life 
A number of OHRQoL measures have been developed and used in different clinical 
settings, oral health surveys and clinical trials [162]. Principally, there are three 
categories of OHRQoL measure; societal indicators, global self-ratings of OHRQoL 
(single-item ratings) and multiple item inventories OHRQoL [161]. These measures 
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were suggested to be used as supplements to the traditional clinical oral health 
indicators, to expand communication between patients and their health workers and to 
offer meaningful information of the psychosocial consequences of oral diseases [163]. 
Table 6 depicts some of the OHRQoL instruments developed for use in adults, their 
original reference, abbreviations and the number of items included. 
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Table 6: Oral health related quality of life instruments for use in adults, their original reference, abbreviations, and number of 
items included 
Original Reference Instrument  Abbreviation  No. of items Type  
[164] Bergner et al. (1981) The Sickness Impact Profile SIP 73 Generic  
[165] Cushing et al. (1986) The Social Impacts of Dental Diseases SIDD 14 Generic  
[166] Atchison & Dolan (1990) Geriatric (General) Oral Health Assessment Index GOHAI 12 Generic  
[167] Dolan et al. (1991) Rand Dental Health Index - 3 Generic  
[168] Strauss & Hunt (1993) Dental Impact Profile DIP 25 Generic  
[169] Slade & Spencer (1994) Oral Health Impact Profile  OHIP-49 49 Generic  
[170] Locker & Miller (1994) Subjective Oral Health Status Indicators SOHSI  42 Generic  
[171] Leao & Sheiham (1996) Dental Impact on Daily Living DIDL 36 Generic  
[172] Kressin et al. (1996) Oral Health Related Quality of Life Measure  OHQOL 3 Generic  
[173] Cornell J et al. (1997) Oral Health Quality of Life Inventory OH-QoL 56 Generic 
[174] Slade (1997) Oral Health Impact Profile-14 OHIP-14 14 Generic  
[175] Adulyanon & Sheiham (1997) Oral Impact on Daily Performance  OIDP 9 (8) Generic  
[176] Cunningham et al. (2000) Orthodontic Quality of Life Questionnaire OQLQ 22 Specific 
[177] McGrath & Bedi  (2001) UK Oral Health Related Quality of Life Measure OHQoL-UK 16 Generic  
[178] Allen & Locker (2002) Oral Health Impact Profile (OHIP-EDENT) OHIP-20 20 Generic  
[179] Ni Riordain et al. (2011) Chronic Oral Mucosal Diseases Questionnaire COMDQ 26 Specific  
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The different OHRQoL measures vary in terms of dimensions measured, format and 
number of questions, subscales, response format and approaches of acquisition scores. 
They were imposed to be efficient, easy to complete, and handle, reliable, valid, 
discriminative, evaluative instruments and supported by a relevant conceptual model 
[180] . A number of them have been systematically tested to assess their psychometric 
properties such as reliability, validity and responsiveness [180]. Nevertheless, no single 
instrument can be viewed as a gold standard set of questions or concepts [181]. The 
majority of these measures has been constructed in the English language and is planned 
for use in English speaking countries. Evidence shows that cultural groups vary with 
respect to OHRQoL, in disease expression and in their use of health care system across 
countries [182, 183]. Therefore, a systematic approach to translation and cross-cultural 
adaptation is a first step to choosing an appropriate measure.  
The OHRQoL measurements can be divided into generic and disease specific 
measures. The generic ones evaluate total impact of various oral conditions and are 
used when comparing OHRQoL across populations, such as Oral Impact on Daily 
Performance (OIDP) [175]. The disease specific ones, as Orthognathic Quality of Life 
Questionnaire (OQLQ) [176], focus on unique aspects of the disease being studied and 
are more responsive to small clinical changes that may occur over time. It has been 
suggested that both measurements should be used when assessing quality of life [176, 
184].  
OHRQoL measures principally focus on dental diseases, hyposalivation, dentofacial 
deformity and temporomandibular disorders [185-188], but few studies have 
documented the effect of OML upon quality of life [189-193]. Table 7 gives an 
overview of studies that have focused on the impact of OML on OHRQoL in adults 
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Table 7: An overview of studies published globally, focusing on the impact of OML on QoL in adults 
Reference (year)  OML  Study type  Quality of life measure 
used 
[194] (2002)  Oral lichen planus Questionnaire OHQOL-UK
©
, OHIP-14 
[195] (2002)  Oral lichen planus Treatment OHQoL, OHIP 
[196] (2002)  Oral lichen planus Treatment OHIP-14 
[190] (2003) Stomatological diseases Population OHIP-14 
[162] (2003)  Oral lichen planus  Questionnaire OHIP-14, OHQOL-UK
©
 
[192] (2006)  Behçet’s disease Population/ 
Questionnaire  
OHIP-14, SF-36  
[197] (2007) Oral lichen planus Treatment OHIP 
[198] (2007) Oral erosive lichen planus Treatment OHIP-14  
[199] (2007)  Behçet’s disease and RAU Questionnaire  (OHIP-14) 
[200] (2008) Oral lesion associated with HIV Population  OHIP 
[201] (2009) RAU Treatment  OHIP 
[202] (2009) Behçet’s disease Population OHIP-14 
[189] (2009) OML Population OHIP-14, SF-12, GHQ-12 
[191] (2011) Tongue lesions Population OHIP-14 
[203] (2011) RAU, oral lichen planus, pemphigus vulgaris, mucous 
membrane pemphigoid, orofacial granulomatosis 
Questionnaire/ 
Population  
COMDQ, OHIP-14 
[204] (2012) RAU, oral lichen planus, pemphigus vulgaris, mucous 
membrane pemphigoid, orofacial granulomatosis 
Questionnaire COMDQ 
 
[205] (2012) RAU, oral lichen planus, pemphigus vulgaris, mucous 
membrane pemphigoid, orofacial granulomatosis 
Questionnaire COMDQ 
 
[193] (2012) RAU , oral lichen planus, candidiasis, burning mouth 
syndrome and paraethesia, other OML 
Questionnaire OHIP-14, SF-36 
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Conditions affecting the oral mucosa are often painful disorders, chronic in nature or 
recurrent, mainly seen in oral medicine or dermatology clinical settings [189, 190, 206, 
207] . Many of these conditions are not fatal, but clinical manifestation and treatment 
options in the management of these conditions may end up in significant morbidity, 
resulting in psycho-social and functional impacts [162, 208-210]. Hegarty et al. [194] 
were the first to study the impact of OML upon quality of life by evaluating the 
performance of the Oral Health Impact Profile (OHIP-14) and OHQoL-UK in patients 
with erosive lichen planus. The study suggests that these instruments performed well in 
the management of OML and supports the use of OHRQoL measures in patients with 
OML, specifically the chronic and the recurrent lesions. Chronic Oral Mucosal 
Diseases Quality of Life Questionnaire (COMDQ) is the first discipline-specific 
OHRQoL measure introduced to the field of oral medicine by Ni Riordain et al. [179]. 
The measure has proven to be valid, reliable and responsive to assess OHRQoL in 
patients with lichen planus, RAU, oral pemphigus and oral pemphigoid [203]. 
However, this measure does not allow comparison across diseases.  
The OIDP inventory is an OHRQoL instrument widely used to assess impacts that 
affect individuals’ daily life [175]. This inventory is based on a theoretical framework 
modified from the WHO International Classification of Impairment, Disabilities and 
Handicaps (ICIDH) [211] which has been amended for dentistry by Locker [212] 
(Figure.1). The ICIDH provides bases for the empirical exploration of the links 
between different dimensions or levels of consequence variables and consists of the 
following key concepts: impairment, functional limitations, pain, discomfort, disability 
and handicap. The first level (oral status) includes oral impairments that show the 
immediate biophysical outcomes of disease, usually assessed by clinical indicators. 
The second level (intermediate impacts) includes possible early negative impacts 
caused by oral health status: dissatisfaction with dental appearance, functional 
limitations, pain and discomfort. The latter two are related to the experiential aspects 
of oral conditions in term of symptoms. Any of the dimensions mentioned at the first 
and second level may lead to the third level (ultimate impacts) of outcomes which 
express any difficulties in performing daily life’s activities. The OIDP focuses on 
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measuring the third level, corresponding to the WHO and Locker’s concept of 
disability and handicap [211, 212].  
 
Figure 1: Theoretical framework of consequences of oral impacts (Modified from 
WHO’s International Classification of Impairment, Disabilities and Handicaps 
[211]) 
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The OIDP inventory can be used either as a generic or a condition-specific OHRQoL 
measure. It has proven to be reliable and valid in general population based studies, as 
well as in studies of patients with specific oral disorders [213-215]. The OIDP 
provides a significant endpoint outcome scale for oral conditions within a concise, 
reliable and valid instrument. A cross-sectional study precludes the assumption that a 
measure proven to be reliable and valid is appropriate for detecting meaningful clinical 
changes. These changes within individuals could be natural or as a result of clinical 
intervention. Here, instruments with properties such as responsiveness, longitudinal 
validity and interpretability are recommended [216]. The first step in selecting an 
appropriate measure of OHRQoL is therefore to determine clearly the specific 
objectives of the study, whether they are descriptive, predictive , discriminative or 
evaluative and the exact purpose of using such a measure [217]. 
1.6 General and oral health services in the Sudan 
At the time of the present study, Sudan had 25 State Ministries of Health (SMoH), one 
in each State. Within each state, a number of localities (134 in total) are managed 
through a district health system.The main body; The Federal Ministry of Health 
(FMoH) is responsible for the development of national health policies, strategic plans, 
monitoring and evaluation of health systems activities. Under the FMoH we find: 
 1. The SMoH which are mainly responsible for policy implementation, detailed health 
programming and project formulation.  
 2. The district health system which is responsible for implementing the national 
health policy through the primary health care concept. 
 The primary health care, at village level represents the first level of contact 
between the community and the health services. 
 Secondary health care is available in small towns through rural hospitals and 
urban health systems. 
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 Tertiary health care services comprise provincial, regional, university and 
specialist hospitals. 
Health services are provided through different partners including, in addition to FMoH 
and SMoH, Armed Forces, Police and Security Forces, Health Insurance 
Organizations, the Ministry of Higher Education through its university hospitals, civil 
society and the private sector. The private sector in Sudan has grown substantially 
during recent years, predominantly in urban areas. It focuses mainly on curative rather 
than preventive services. Those partners play an important role in filling some of the 
gaps in coverage of the government system and serving populations. However, all 
partners act in isolation, due to poorly designed administrative systems for 
coordination and guidance [218-220]; this creates significant disparity in the referral 
system and the geographic distribution of health facilities and personnel. In dental 
health services, the dentist : population ratio in the Northern states of Sudan was 
1.8 : 100.000, while in Khartoum state the ratio was 3.2 : 100.000 [221]. There were 
about 1.8 times as many dentists serving the Khartoum state alone than served the 
remaining population in the Northern states of Sudan. Wide regional variations were 
still evident in urban areas (1:30.000) versus rural areas (1: 130.000) [221, 222]. A 
similar trend has been found among medical doctors in Northern states of Sudan 
(35.8:100.000) and in Khartoum state (56.5:100.000). In the dermatology field, the 
ratio of dermatologists to population was 0.4:100.000, with the majority based in 
Khartoum state [221].  
Before the early 1990s, health services were provided free of charge, but after that time 
the government has introduced user fees. The National and Social Health Insurance 
Corporation have been implemented in response to the impact of the financial reform 
policy and the introduction to the used fees in public facilities. The insurance 
companies cover most of basic medical services expenses as well as the basic dental 
procedures [220]. Total health expenditure as a proportion of Gross Domestic Product 
(GDP) was 6%, and out-of-pocket health expenditure from the total health expenditure 
was 64.3% [221]. 
 47 
There is a deficiency in the available information regarding standardized referral 
protocols and coordination between oral health and general health system in Sudan, in 
particular the dermatology and oral health schemes. 
1.7 Justification  
Sudan is a country with striking diversity in all aspects. The epidemiological profile of 
the country is typical of sub-Saharan African countries; malnutrition and 
communicable diseases dominate the health scene with high vulnerability to outbreaks 
of disease [223]. Whilst general health is well documented, little is known about oral 
health in the Sudanese population. There is a lack of studies regarding the frequency, 
distribution and psycho-social consequences of OML as well as studies addressing 
clinical and histological features of oral pemphigus in the Sudanese population. 
This is a concern because many skin lesions that are highly associated with oral lesions 
could be misdiagnosed by the dentist due to lack of information or improper 
examination [224]. Although the dentist is often the first health professional to be 
consulted by patients who develop acute oro-facial symptoms of different systemic 
diseases and various other lesions and infections, this has not received adequate 
attention. 
KTH is the largest national referral hospital in Sudan. It receives patients from all over 
the country and is located in the most densely populated area in Sudan, Khartoum state. 
It has a high number of patients who present with various oral manifestations. The 
importance of the diagnosis of oral conditions in dermatology has been underlined due 
to the frequency and diversity of oral lesions. For the moment, no clear strategy has 
been developed for the management of such cases at any hospital in Sudan. Therefore, 
improving knowledge about the frequency and diversity of OML at the dermatology 
clinic will strengthen and enhance interdisciplinary and multispectral approaches, as 
opposed to a single sector approach in the management of such patients.  
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The clinical diagnosis of OML may provide a signal about its cause and prognosis, but 
may fail to indicate the level of impairment that will follow. Studies have shown that 
OML negatively affects oral health quality [189, 190].  
 OML is a significant public health problem, since some are life-threatening and others 
have great impact on individuals and society in terms of pain, discomfort, social and 
functional limitations. The significance of evaluating the Sudanese skin disease 
patients’ own perceptions of the impact of their oral health on daily living has not been 
investigated. 
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2. Aims of the study  
2.1 General aim 
The overall aim of this study was to contribute new information regarding the 
frequency, socio-behavioural distribution, socio-psychological consequences and 
clinical and histopathological features of oral mucosal lesions in patients with skin 
disease in the Sudan. This information is crucial for determining the magnitude, risk 
indicators and burden of such diseases and provides data essential for formulating 
health policy in order to meet the health care needs of patients.  
2.2 Specific objectives  
 To estimate the frequency, diversity and socio-behavioural correlates of 
different types of OML in adult patients with dermatological diseases (Paper 1).  
 To assess the relationship between oral health related quality of life (OHRQoL), 
OML and reported oral symptoms, perceived general and oral health conditions 
and caries experience (Paper II). 
 To evaluate the clinical and histological characterization of oral pemphigus 
lesions, and to assess the diagnostic significance utility of the light microscope 
in patients with pemphigus along with IHC examination, using the patient’s 
formalin-fixed, paraffin-embedded oral tissue biopsy specimens (Paper III).  
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3. Materials and methods 
3.1 Study area 
                                      
This thesis is based on a study conducted in KTH dermatology outpatient clinic. The 
study took place before the referendum in January 2011. At the time of the study, 
Sudan was the largest country in Africa and it bordered the Red Sea and nine other 
African countries. The total land area was 2.6 million square kilometres, extending 
from latitude 4 to 22 degrees North and from longitude 22 to 38 degrees East. Sudan 
was a multiethnic multicultural country. However, two major and distinct ethnicities 
prevailed – Arab (north) and African (south) – with hundreds of ethnic and tribal 
divisions and languages. The environment in Sudan ranged from tropical damp and 
rainy in the south, to desert and savannah in the central and northern areas [201, 202]. 
At the study time, Sudan had 25 states; Khartoum state was the most densely populated 
and had an area of 22,122 square kilometres, with population rapidly exceeding 6 
million, including over 2 million internally displaced persons from the Southern war- 
affected zone as well as Western and Eastern war or drought-affected areas. Khartoum 
city, the national capital of Sudan, was the capital of Khartoum state [218].  
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Quick facts about Sudan population before January 2011 [220, 225, 226]  
 Population; 41.406.498 (the Southern region has a population of around 8 
million and was predominantly rural) [221]. 
 Males accounted for 51.3% with nearly the same proportions in Khartoum state 
[221]. 
 Population living in urban areas: 44%. 
 Population < 15 years: 42.6% [221]. 
 Population > 60 years: 5.3% [221]  
 Annual population growth rate: 0.2%. 
 Life expectancy at birth; 59 years. 
 Infant mortality rate (< 1 year old): 66/1000 live births. 
 Literacy: 61.1%.   
 Religions: Islam (official), Christianity and indigenous beliefs (Southern Sudan)  
 Languages: Arabic (official), English (official), tribal languages e.g.: Nubian, 
Beja, Fur, Nuban, Ingessana, etc. 
 Work force: agriculture: 80%; industry and commerce: 7%; government: 13%. 
3.2 Study population and study group 
In the present study, the target population consisted of outpatients attending KTH 
dermatology department, in Khartoum city. The KTH is a tertiary health care service 
and is the oldest and largest national and teaching hospital in Sudan. It is an open 
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public and referral hospital receiving patients from Khartoum state and other parts of 
Sudan. The patients’ socio-economic status is mainly low and middle class.  
3.3 Study design 
To achieve the specific objective of this project, a cross sectional hospital-based study 
was carried out focusing on patients aged 18 years and above attending the outpatient 
dermatologic clinic at KTH from October 2008 to January 2009. 
3.4  Sample size calculation 
The required sample size was calculated separately for each specific objective of the 
present study. The largest sample size attained was presumed to be satisfactory and 
implemented for the whole study. The sample size that was necessary for estimating 
the prevalence of oral manifestations in patients with skin diseases was assumed 
satisfactory and adopted. It was based on common skin lesions that were seen in the 
KTH; lichen planus, eczema and psoriasis (reported by consultant dermatologist 
dermatologist Adil Bashir). A minimum sample size of 500 patients was calculated 
based on an assumed prevalence of OML in skin disease patients of 5%, a confidence 
interval (CI) of 95%, and an absolute precision of 0.02 (i.e. standard error). Complete 
data and consent were available for 588 patients (588/1540, 38.1%). The sample 
profile is depicted in Figure 2. 
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Figure 2: Sample profile 
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3.5 Interview 
Phase 1 
A structured interview schedule including questions regarding socio-demographics, 
health and oral health related behaviours and OHRQoL was initially constructed in 
English, translated to Arabic (the official language of Sudan) and then translated back 
into English (Appendix 1). Sensitivity to culture and selection of appropriate words 
were considered. OHRQoL was assessed using the Arabic version of the eight item 
OIDP frequency inventory (Appendix 2). Interviews were administered in face to face 
settings by two trained dentists. The interviews were conducted in the Arabic language 
and were pilot tested before being used in the field. 
Phase 2 
An expert dermatologist (Dr Hussein Salman) evaluated each patient’s dermatological 
diseases through information obtained in a structured interview conducted in the 
outpatient department of the dermatology clinic (Appendix 3).  
3.6 Clinical oral examination 
Phase 3 
A full mouth clinical oral examination was conducted in accordance with the WHO 
criteria for diagnosis of OML [48] by one trained and calibrated dentist, Nada M. 
Suliman. Full details of the oral examination are provided in Paper I. Caries experience 
was assessed under field conditions and scored according to the criteria described by 
the WHO [227]. Decayed, missing and filled teeth (DMFT) index was computed as the 
sum of decayed, missing and filled teeth. Clinical parameters were recorded using a 
structured questionnaire modified from the WHO assessment form for oral mucosal 
diseases [48, 227] (Appendix 4). In those cases requiring further examination, 
diascopy, smears for Candida albicans, and punch or incision biopsies were 
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performed. Smears were taken of lesions suspected of being candidiasis and sent 
immediately to Sudan National Laboratory, Khartoum, where they were processed.  
3.7 Oral tissue biopsies  
Biopsies were obtained from lesions where diagnosis was uncertain by clinical 
examination. The Minor operation room in the dermatology outpatients department 
was used to perform biopsies. Only 12% (n=70) of the patients agreed to undergo 
biopsy. To obtain lesion and peri-lesion biopsies, punch biopsies (diameter 6 mm) and 
incisional biopsies were performed under lidocaine local anaesthesia. For 
vesiculobullous lesions, punch biopsies were taken from normal-appearing intact oral 
mucosa, close to the lesion. Immediately, the specimens were kept in tubes filled with 
10 % buffered formalin and labelled with subject’s code number, date, and location. 
The formalin: specimen ratio was 10:1. The wounds were closed with 0/3 silk suture 
material, and patients came back after one week for suture removal. All tissue 
specimens were embedded in paraffin, sectioned, and routine stained with 
Hematoxylin and Eosin (H & E) at the Gade institute, University of Bergen, Norway. 
Furthermore, selected sections were stained for examination of Candida albicans or 
melanin. IHC examination was performed on formalin-fixed, paraffin-embedded oral 
PV tissue specimens by an expert technician (Edith Fick). 
Final diagnoses of all lesions were confirmed by an expert oral pathologist (Anne C. 
Johannessen). Skin lesions and OML encountered during the data collection, were 
photographed using a digital camera (Canon EOS 400D).  
3.8 Procedure for immunohistochemistry on formalin-fixed 
paraffin embedded oral tissue 
Formalin-fixed paraffin embedded tissue from 11 oral tissue biopsies were used. 
Sections, 4µm thick, were cut and mounted on glass slides (Super Frost Plus) and 
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heated at 56 °C overnight. The sections were deparaffinized in xylen and rehydrated in 
alcohol. For C3c, sections were incubated in target retrieval solution (pH6, DAKO, 
Glostrup, Denmark S1699), microwaved for 15 minutes after the buffer had come to a 
boil, then allowed to cool down on the bench and then washed slightly under running 
tap water for 5 minutes. Primary anti-human C3c polyclonal rabbit Compliment 
(DAKO, A0062) at a dilution of 1:15000 were incubated for 30 minutes at room 
temperature. For IgG, sections were incubated in epitope retrieval solution (proteinase 
type XXIV bacterial, Sigma P 8038 37) for 10 minutes at 37 °C. Primary antibody 
polyclonal Rabbit Anti-Human IgG, (A 0423) at a dilution of 1:60000 were incubated 
for 60 minutes. Endogenous peroxidase activity was blocked by 0.03% hydrogen 
peroxide (H2O2) for 7 minutes. Detection was performed using Peroxidase labeled 
polymer conjugated to goat anti-rabbit immunoglobulin (Envision + ® DAKO, K5007) 
for 30 min. Between each of the above steps, sections were washed with Tris-Buffered 
Saline with Tween (TBST, pH 7.6, DAKO S3306) for 10 minutes. The reaction was 
then visualized using 3, 3’- Diaminobenzidine (DAB). The sections were 
counterstained with hematoxylin, dehydrated and mounted with a non-aqueous 
mounting medium (Eukitt; O.Kindler GmbH & Co., Freiburg, Germany).  
3.9 Diagnostic criteria for oral mucosal lesions 
An OML was defined as any abnormal change or any swelling on the oral mucosal 
surface. Diagnostic criteria for OML were based on Axéll’s criteria and those defined 
in previous studies and reviews [22, 48, 228, 229].  
3.10 Data characteristic and Statistical analysis 
 Data for Papers I and II were extracted from the main study group (n = 588). The 
target population was patients with a confirmed diagnosis of skin diseases (n = 
544). The population was divided into three groups, patients with, without, and 
with ≥ 2 OML. The frequency was obtained from the whole population (n = 544), 
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from the population diagnosed with OML (n = 315), and from each group of 
OML defined in the study. OHRQoL was assessed in patients without OML, with 
one, and with more than one OML. 
 Material for Paper III was generated from the total study group (n = 588). The 
study group was patients with oral pemphigus.  
 Data analyses were carried out using PASW Statistics version 18.0 (SPSS Inc., 
Chicago). The significant level was set at 0.05 with 95% confidence interval.  
 
Table 8: Statistical tests and methods used in Paper I, II, and III 
Statistical tests/ methods used Paper I Paper II Paper III 
Frequencies  + + + 
Pearson’s Chi square  + + + 
Logistic regression  +  
Mann Whitney  +  
Cronbach’s alpha  +  
Kruskal-wallis test   +  
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3.11 Ethical considerations  
The research complied with the Helsinki Declaration and requirements for ethical 
clearance, and approval letters were obtained by the participating institutions’ ethics 
committees (University of Science and Technology (UST) and KTH, Department of 
Dermatology) in Sudan. In Norway, the ethical approval was obtained from the 
Regional Committee for Medical Research Ethics of Western Norway (3.2008.1434). 
The patients were verbally informed about the study and received fully documented 
information regarding the study and that they could decline to participate or withdraw 
at any time without negative consequences, after having given consent. Written 
informed signed consent or finger print for participation and publication of the study 
was obtained from patients or their parents or guardians. Confidentiality of the 
patients’ data was maintained, participants were informed about their oral conditions 
and health education was provided. Those who needed dental services were referred to 
the UST, Faculty of Dentistry, for further investigation and management. 
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4. Results  
4.1 Paper I: Oral mucosal lesions in patients with skin 
disease attending a dermatologic clinic: a cross-sectional 
study in Sudan 
Results: A total of 57.9% (315/544) of the patients were diagnosed with at least one 
clinically recognized type of OML. Sex was associated significantly with OML (63.2% 
men versus 52.6% women, p<0.05). Among the 14 groups of OML recognized in the 
study, tongue lesions were the most frequently diagnosed group (23.3%), followed in 
descending order by white lesions (19.1%), red and blue lesions (11%) and 
vesiculobullous diseases (6%). White lesions and ulcerative conditions occurred most 
frequently in older patients and men, respectively, p<0.05. OML was most often 
associated with the skin diseases vesiculobullous reaction pattern (72.2%), lichenoid 
reaction pattern (60.5%), infectious lesions (56.5%), psoriasiform reaction pattern 
(56.7%), and spongiotic reaction pattern (46.8%). Tongue lesions were the most 
frequently occurring OML group across the various skin diseases, registering the 
highest prevalence among psoriasiform reaction pattern. OML in patients with skin 
disease was most frequently observed in older age groups (62.4% older versus 52.7% 
younger, p<0.05), in patients with a systemic disease (65.2% with systemic versus 
51.9% without systemic disease, p<0.05) and among current users of smokeless 
tobacco (toombak) (77% current use versus 54.8% no use, p<0.00). 
4.2 Paper II: Oral health related quality of life in a Sudanese 
dermatologic clinic: influence of oral mucosal lesions and 
oral symptoms: a cross sectional study  
Results: The Arabic version of the OIDP inventory maintained the overall concepts of 
the original English version and showed acceptable reliability in terms of Cronbach’s 
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alpha coefficient of 0.89 in the study group, and in the separate groups (0.81, no 
OML), (0.89, one type of OML) and (0.92, > one type of OML). A total of 35.6% 
(190/544) patients reported at least one OIDP (Mean OIDP total score 11.6, sd = 6.7). 
The prevalence of caries experience was 89.9%, oral symptoms 84.4%, and systemic 
health conditions 45.5% in the whole study population. The prevalence of any oral 
impact was 30.5%, 36.7% and 44.1 % in patients with respectively no OML, one type 
of OML and more than one type of OML. Numbers of types of OML and number and 
types of oral symptoms were consistently and positively associated with higher OIDP 
scores. Patients who reported bad oral health, ≥ 1 dental visit, patients with > 1 type of 
OML, and patients with ≥ 1 type of oral symptoms were more likely than their 
counterparts in the opposite groups to report any OIDP. The odds ratios (OR) were 
respectively, 2.9 (95% CI 1.9-4.5), 2.3 (95% CI 1.5-3.5), 1.8 (95% CI 1.1-3.2) and 6.7 
(95% CI 2.6-17.5). Vesiculobullous and ulcerative lesions of OML disease groups 
discriminated statistically significantly between subjects with and without OIDP.  
4.3 Paper III: Clinical and histological characterization of 
oral pemphigus lesions in dermatologic patients: a cross 
sectional study from Sudan. 
Results: Twenty-one patients were diagnosed with pemphigus vulgaris (PV), 19 of 
them (mean age: 43.0; range: 20 - 72 yrs.) presented with oral manifestations (ulcers or 
erosions). Pemphigus foliaceus was diagnosed in one patient. In PV, female: male ratio 
was 1.1:1. Missing information occurred in some categories: the majority of the 
patients were < 50 years old (68.4%, 13/19), low education (84.2%, 16/19), married 
(77.8%, 14/18), had outdoor jobs (52.6%, 10/19), and resided outside Khartoum state 
(57.9%, 11/19). Use of toombak was reported by 11.1% (2/18), smoking by 21.0% 
(4/19) and alcohol use by 10.5% (2/19). Buccal mucosa and hard palate were the most 
commonly affected sites. Exclusively oral lesions were detected in 14.2% (3/21). In 
patients who had experienced both skin and oral lesions during their life time, 50.0% 
(9/18) had oral mucosa as the initial site of involvement, 33.3% (6/18) had skin as the 
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primary site, and simultaneous involvement of both skin and oral mucosa was reported 
by 5.5% (1/18). Oral lesion activity score was higher in those who reported living 
outside of Khartoum, were outdoor workers and had lower education and belonged to 
central and Western tribes compared with their counterparts. Histologically, all tissues 
except one had suprabasal cleft and acantholytic cells. By IHC, IgG and C3 were 
demonstrated intercellularly in the oral epithelium. 
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5. Discussion  
5.1 Methodological considerations 
5.1.1 Study design  
The data used in these reports were collected in a cross-sectional hospital based study. 
Data were collected by face-to-face interviews, oral clinical examination, and smears 
and biopsies in cases of a clinically uncertain diagnosis. The studies were designed to 
estimate the prevalence and socio-behavioural distributions of OML and the oral 
impacts of daily performances in patients with skin disease aged ≥ 18 yr. attending the 
KTH dermatology department, in Khartoum city. The study was also designed to 
describe clinical and histological features of oral pemphigus vulgaris. 
Cross-sectional studies are used to describe the prevalence and socio-behavioral 
distribution of oral diseases and other oral health related characteristics. Risk 
indicators, outcomes and confounders of oral conditions are measured concurrently, 
which implies difficulty to determine whether the exposure precedes or follows the 
outcome. Nevertheless, cross sectional studies can be used to generate hypotheses 
about risk factors that should be tested in subsequent longitudinal prospective studies. 
Estimates derived from cross-sectional studies are subject to various sources of error, 
which may bias the results and conclusions presented [230]. Bias is any systematic 
error in the data and there are two major categories: selection bias and information bias 
[231]. Selection bias stems from the study participants, for instance selective non-
response, whereas information bias stems from errors in the information collected from 
participants, such as recall bias, socially desirable responses and misclassification. In 
general, cross-sectional studies are characterized by high probability of recall bias, 
medium selection bias, medium cost and medium time required compared with other 
types of observational study [231]. The separate reports have discussed in detail the 
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methodological problems associated with the present design. In the following section, 
some of the most important limitations are discussed. 
5.1.2 Reliability  
Reliability concerns the degree of consistency or repeatability with which an 
instrument measures an attribute [232]. It reflects the amount of error, both random 
and systematic, inherent in any measurement [233]. A reliable instrument should 
minimize the error component and maximize the true component of a measurement 
score. An instrument is named reliable when repeated measurements made by it, under 
constant conditions, give the same result [234].  
Consistency and reliability over time 
To achieve reliable measures, several actions were taken in this study. They comprised 
training of research assistants, use of pilot studies and repeated checks during the data 
entry process. Furthermore, all clinical examinations (OML and DMFT) were 
performed by one trained and calibrated dentist (NMS) to reduce variability in physical 
and psychological factors that can affect the judgment of examiners with respect to 
diagnosing OML and scoring DMFT. 
To examine measurement consistency of DMFT, intra-examiner reliability (test-retest 
reliability) was assessed. It measures the degree to which similar outcomes are 
recorded when using the same test on the same sample on two different occasions. Due 
to some logistic considerations, test-retest was performed in a group of ten dental 
assistants. The number of subjects included in the test was lower than the WHO 
recommendation of at least 20 subjects [227]. Dental assistants were expected to have 
low caries experience and this was assumed to be remembered by the examiner in 
retesting the individuals. To overcome these problems, the test-retest reliability was 
performed at a two week interval. In addition, dental assistants were told not to have 
any dental treatment before the second examination. It was assumed that the two week 
interval was too short for clinical changes to take place in their caries experience. This 
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was supported by a study of knee function that found that retest results at two days 
were similar to those after two weeks [235]. In the present study, Cohen’s Kappa for 
DMFT was 1.0, indicating perfect agreement according to Landis and Koch [236, 
237]. The high level of agreement might be due to the small sample size and the short 
interval. 
 As most OML are quite rare, a calibration process that required replicate examinations 
was not done. Instead, during the clinical training period in Bergen, the investigator 
studied clinical photographs of the OML that could be expected to be observed in the 
field using an atlas of diseases of the oral mucosa [5]. One day before data collection, a 
test -retest approach was applied on more than 40 photographs of OML, using the 
same atlas with a time intervals of five hours between each test. The agreement was 
100 %. The disadvantages of this approach were that photographs only provide a two 
dimensional view for one stage of the diseases, and the possibility of selection bias 
through memorizing specific oral diseases. Furthermore, different sources of light, 
different patient positions and level of cooperation might influence the real nature of 
the diseases. The approach does provide exposure and training to a wide spectrum of 
OML that are seen infrequently.  
For economical and ethical considerations, test –retest reliability assessments for the 
structured interview (self-reported data) and OIDP inventory were not conducted.  
Internal consistency reliability 
Internal consistency reliability for the OIDP inventory was assessed using Cronbach’s 
alpha. This measure assesses correlation (homogeneity) between different items 
constituting a scale. It is a measure of how well a test addresses different constructs 
and delivers reliable scores. The more homogeneous the items, the higher the 
correlation (Cronbach’s alpha), and therefore the more reliable the measure, indicating 
that the items comprising the scale measure the same underlying concept. Alpha 
coefficients above 0.80 are rated as exemplary, 0.70 to 0.79 as extensive, and those in 
the range 0.60 to 0.69 indicate only moderate internal consistency [238]. In Paper II, 
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the 8-item adult-OIDP inventory showed Cronbach’s alpha of 0.89 for the total study 
group. In the separate groups, Cronbach’s alpha was 0.81 (no OML), 0.89, (one type of 
OML) and 0.92 (> one type of OML). The values of internal consistency obtained in 
this thesis indicate exemplary internal consistency.  
5.1.3 Validity 
There are two main aspects of validity, internal validity and external validity. Internal 
validity is defined as the degree to which a test is capable of measuring what it is 
intended to measure [238]. External validity refers to whether findings of the study 
group can be generalized to a wider population [231]. 
Internal validity  
Internal validity is the degree to which the results of an observation are correct for a 
particular group of people being studied [231]. Examples of systematic errors that 
constitute a threat to internal validity are misclassifications in clinical registrations and 
information bias in terms of recall- and social desirability bias in self-reported data.  
With regards to OML, a wide range of mucosal conditions has been documented 
(Appendix 5). Each has distinctive associated aetiological, clinical, and 
histopathological features, creating a difficult and complex environment when studying 
more than one lesion. The difficulty lies in the inconsistency of clinical presentations 
for a given condition, which may differ from early to late stages, as well as 
discrepancies in the extent, severity, and location of the lesions [47]. This situation 
leads to an absence of a consensus on clinical diagnostic criteria to be used for 
epidemiological research. To reduce misclassification in the clinical recordings, 
Axéll’s diagnostic criteria for OML were used [22] in addition to the WHO guidelines 
for diagnosis of oral mucosal diseases [48]. The WHO guidelines provide a 
comprehensive systematic approach to examine the oral mucosa which ensures that all 
parts of oral cavity are included in the examination. More details and other diagnostic 
criteria that were used in this study can be found in Paper I.  
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Oral tissue biopsies of the lesion are the best source of accurate and definite diagnoses 
of OML [239]. In this study, few participants agreed to have oral tissue biopsies, which 
may entail the misclassification of a number of lesions. To achieve more accurate 
diagnoses, mucosal smears were obtained when indicated and analysis was done by the 
Sudan National Laboratories. With regard to vesiculobullous lesions, punch biopsies 
were taken from normal oral mucosa immediately adjacent to the lesion. It was 
possible that the twisting motion used to take the specimen could have displaced the 
oral mucosa. Nevertheless, the procedure was carried out in uninflamed areas as 
carefully as possible. The IHC for oral PV biopsies was performed by an expert 
technician (Edith Fick). Furthermore, an expert oral pathologist (ACJ) acted as a 
validator and verified all the diagnoses on the basis of the diagnostic criteria, the 
patients’ clinical photographs, biopsies, and disease history.  
Optimal diagnosis of dental caries needs adequate lighting, radiography and a precise 
dental history to obtain reasons for tooth loss. The oral examinations were carried out 
under field conditions following the WHO criteria of DMFT for field surveys [227]. 
Due to the impracticability of using more advanced equipment such as radiography 
machines etc., underreporting of the dental caries prevalence cannot be ruled out. To 
overcome misclassification regarding dental caries, the examiner was trained and 
calibrated before the main study. 
In this study, data regarding risk indicators and subjective oral health status were 
collected by face-to-face interviews. Although personal interviews provide an excellent 
opportunity for probing and explicative questions, one could argue that the method is 
expensive, time consuming, sensitive and invasive with regard to personal issues. 
Thus, social desirability could threat the validity of this approach and socially desired 
(tooth brushing) and undesired (use of toombak) behaviours might have been over- or 
under-estimated in this study. To minimize these problems, interviewers received 
adequate training before data collection. The interview was carried out before the oral 
examination and patients were informed that confidentiality and anonymity would be 
preserved. In the field of OHRQoL, studies have shown that impact scores are not 
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affected by the method of interview administration (i.e. personal interview vs. self-
performed questionnaire) [240]. 
Recall bias is another systematic bias that is associated with participants’ recollection. 
Patients are more likely to remember past exposure, especially if it is commonly known 
to be associated with the outcome under investigation. The use of a six month period 
for the assessment of the adult OIDP inventory might reduce recall bias. Nevertheless, 
the Sudanese version of adult-OIDP inventory has been used previously and validated 
in Sudan [241]. Paper II describes in detail the procedure in testing the psychometric 
properties of the Sudanese version of adult-OIDP inventory used in the present study. 
External validity 
To estimate the prevalence of OML among patients with skin disease in Sudan, the 
entire adult population of Sudanese with skin disease or a randomly selected 
representative sample of this population should preferably have been investigated, but 
this was too demanding of time and money resources to be practical. Considering that 
KTH is the largest public main referral hospital in Sudan, and assuming that patients 
attending during the study period do not differ from patients attending other times of 
the year, the study participants might capture the variety in characteristic of patients 
with skin disease attending dermatologic clinics in Sudan. As the study participants in 
these studies came from a cross-sectional hospital based study, conducted in a 
relatively short period of time, it is difficult to ascertain how representative the 
participants were, with respect to the adult population of dermatology patients inside or 
outside Khartoum. 
To secure cooperation and to increase the respondents’ motivation to co-operate, 
detailed full information was delivered verbally and in writing to all patients before 
examination. Participation was voluntary, and participants were informed that they 
could withdraw from the study at any time. A bias towards health conscious 
participants is a well-known problem in studies where participation is voluntary [231]. 
Differences due to self-selection may have created a discrepancy between the selected 
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study group that should reflect the study population of interest, and the actual study 
participants. Although written and verbal explanations were provided to present the 
purpose of the study, lack of knowledge of OML, and in particular the association 
between skin and oral diseases, strongly affected the response rate. Another reason for 
non-response was the HIV test. It was requested that suspected participants should be 
tested. Fear of taking a biopsy, especially for asymptomatic lesions, was an important 
reason for refusal to participate and for non-participation. Furthermore, the time taken 
to accomplish the interview, the oral examination, the photographs and biopsy required 
about 40 to 60 minutes for each patient. That was too long for patients who had 
another priority (skin lesion) than our research interest. Nevertheless, lack of 
information about non-respondents impedes any solid assumption about selection and 
non-response biases and implies that the results of the present study should be 
interpreted with caution. More detailed information regarding the representativeness of 
the study population is found in Paper I. 
In the present study, data regarding a tribe’s original location could be questioned. 
Intermarriage between different tribes is a common phenomenon in Sudan so that a 
person could be descended from more than one tribe. This was not controlled in our 
data, and the usual practice in Sudanese culture is to report the father’s tribe. This 
could lead to misclassification, as a participant could have parents from tribes that 
originate from two different locations.  
5.2 Discussion of the major findings  
5.2.1 Prevalence of oral mucosal lesions  
Paper I showed that the prevalence of OML among adult Sudanese with skin diseases 
was 57.9%. This is in accordance with the international literature investigating the 
prevalence of OML in different settings (25%-61.6%) [23, 24, 42-44, 242]. In contrast, 
studies from Cambodia and Malaysia have shown a lower prevalence of OML (4.9% 
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and 9.7%, respectively) [53, 54]. Prevalence studies on OML in African populations 
are rare but in a Kenyan survey conducted as a part of a case control study, 48.6% of 
the study participants were diagnosed with OML [36].  
 
According to our knowledge, there are only two studies of OML in dermatology 
outpatient clinics. In Mexico City, specialists in oral medicine and oral pathology 
found that 6% (n=60) of patients that had been referred to a dermatology clinic had 
oral lesions [206]. The most frequently observed OML in that study were PV (18.3%), 
lichen planus (8.3%), candidiasis (8.3%) and RAU (6.6%). Another study, conducted 
by dermatologists in Turkey, reported a prevalence of OML of 22.6% among 1041 
consecutive dermatology outpatients [207]. Here, fissured tongue, coated tongue, RAU 
and linea alba topped the list of the OML identified in that study. In both studies as 
well as in our present study, discrepancies in outcomes were observed. This might be 
attributed to variation in examiners, sample size, diagnostic criteria and other 
methodological issues that have been discussed earlier in the present study. 
Among the patients with skin disease investigated in this study, males were more prone 
than females to have at least one OML. It is likely that the sex differences may be 
attributed to use of toombak, social responsibility and masculinity [243]. A similar sex 
difference in OML has also been observed in previous studies [44, 244] but the 
opposite sex gradient has been reported elsewhere [24]. In our study, the prevalence of 
OML varied according to age in accordance with findings of some previous studies 
[44, 242]. Our study also showed that tongue lesion was the most frequently diagnosed 
OML, amounting to 23%. A relationship between tongue lesions and psoriasis has 
been postulated for many years. A recent metacentric, observational and controlled 
study from Italy suggested that fissured and geographic tongue can be considered as 
oral manifestations of plaque-type psoriasis [245], although the reason for this 
association is not clear. The present result showed that more than half of the 
psoriasiform reaction pattern group had tongue lesions, with fissured tongue being the 
most prevalent one in this particular dermatological disease group. The present study 
recorded RAU at the time of examination and revealed a prevalence of 2.9%. Since 
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active lesions of RAU are recurrent and may not exist at the time of examination, 
patient’s self-reported history has been the main method of defining prevalence of this 
condition globally. A positive history varied from the subject having had one lesion 
over his life span to having one lesion in the past two years.  
In contrast to many previous studies [53, 66], our data do not support an association 
between tobacco habits and leukoplakia. The present study showed a low proportion of 
smokers in the study group with a relatively high proportion of oral leukoplakia. In 
connection with that, previous studies showed that leukoplakia in non-tobacco users 
was more likely to undergo malignant transformation than leukoplakia in tobacco users 
[246, 247]. Knowing that oral leukoplakia, discoid lupus erythematosus and oral lichen 
planus are potentially malignant disorders [68, 248-250], the present study underscored 
that the results of Paper I should be considered alarming findings and close clinical 
follow up is necessary to allow early detection of transformation in these lesions. 
In the present study, as well as in other studies, the underlying distribution of risk 
factors such as tobacco use has a great influence on the total prevalence of OML. In 
order to capture the true prevalence of the OML in this subset of dermatological 
patients, repeated multiple clinical examinations of the same population may be 
necessary, particularly for non-symptomatic conditions which may regress and 
reappear. 
Finally, we can conclude that despite the discussed limitations (Paper 1), our study 
provides an important contribution to the field of oral health, reflecting a wide 
spectrum of OML among Sudanese patients in the dermatology clinic. 
5.2.2 Impacts of oral mucosal lesions and oral symptoms on 
mucocutaneous patient’s daily life activities 
In Paper II, the number of OML, the number and types of oral symptoms, perceived 
oral health as well as dental attendance were statistically significantly associated with 
oral impact on daily performances, OIDP. In addition, patients with vesiculobullous 
 71 
and ulcerative lesions reported the worst OIDP scores. Notably, both disease groups 
are chronic or recurrent in nature. The present study accords with that of Tabolli et al. 
[189] who reported that patients with RAU had mean OHRQoL scores almost twice as 
high as patients with other OML groups. In a prospective study among patients with 
various tongue conditions, OHRQoL was reported to be worse in subjects with tongue 
lesions than in the controls [191]. The study suggested that tongue conditions affect 
quality of life, but not more so than erosive disorders such as RAU or lichen planus 
[190, 209]. That might be due to clinical manifestations and the treatment available in 
the management of such lesions, as reported by Ni Riordain et al. [251, 252].  
In the present study, it is important to mention that despite the fact that OIDP was 
significantly negatively affected in the vesiculobullous and the ulcerative groups, their 
confidence intervals were wide, indicating less precision in the estimated relationships. 
This may be attributed to a limited sample size and limited power of the statistical 
tests. Thus, the present study should be replicated with a larger sample size.  
Paper II showed that the prevalence of dental caries experience (DMFT > 0) was 
89.9%. This result is in agreement with previous studies done among dental attendees 
in Sudan. Caries prevalence has been reported to vary between 87.7% and 96% [253, 
254]. Dental caries causes dental pain and discomfort, functional limitation, and 
dissatisfaction with appearance. These symptoms may in turn transform into social 
problems and low self-esteem [212]. This has been shown in many epidemiological 
studies using the OIDP inventory across different age groups, where significant 
associations between dental caries and poorer OHRQoL have been found [255, 256]. 
Conversely, in the present study, the highly prevalent condition of tooth decay had a 
small negative impact on OIDP. This might be attributed to the fact that patients learn 
to cope with commonly occurring symptoms and conditions that become less disabling 
with recurrence. Also, irrespective to the relatively high DMFT scores in the present 
study, only 38.4% reported at least one visit to a dental clinic, highlighting a low 
utilization of dental care. Clinical indicators like DMFT reflect the end point of the 
disease and provide an indication of treatment needs [257], and they do not reflect the 
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impact of the disease on daily life and activities. The present study showed that dental 
attendance pattern was one of the strongest covariates of oral impacts and it increased 
systematically across the three groups: no OML, one OML, > one OML. That was 
contrary to the widely recognized positive association between dental attendance and 
improved oral health, mostly emanating from industrialized countries [258].  
Based on the existing literature, pain is the principal symptom that affects OHRQoL 
[194, 259]. Even with a low prevalence of OML, pain associated with OML was 
strongly associated with oral impacts, even after controlling for confounding variables. 
This result was supported by a study done in Sudan by Khalifa et al. [251] which 
reported that 90% of patients went to the dentist only when they experienced pain 
[254]. It is likely that the present results may reflect problem-oriented visits, and they 
may partially explain the association between dental attendance and OHRQoL seen in 
our study. The current status of the mouth in this study could have influenced other 
factors that are traditionally recognised as affecting oral health quality of life. Also, we 
cannot ignore other factors such as attitudes, beliefs, and perceptions which might also 
have contributed to the present results.  
The present data provide additional support to a recent study on chronic oral mucosal 
conditions; the study found that QoL was negatively affected in the patients when 
using COMDQ [203-205]. In general, the findings of Paper II support the use of 
generic OHRQoL measures together with objective clinical measures in oral health 
assessment in patients with different OML. Furthermore, the results could reflect the 
efficacy of dental care delivery systems and oral health promotion programs in the 
country. Great improvement may be expected in such patients, if disease management 
approaches include the patients’ overall well-being. 
5.2.3 Oral pemphigus vulgaris 
Acknowledging the findings of Papers I and II, that the vesiculobullous group 
registered the worst OHRQoL scores of all the oral lesion groups, and that oral PV was 
the predominant oral lesion in this group, Paper III went deeper, describing many 
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aspects of Sudanese patients with oral PV attending the main dermatology clinic in 
Sudan.  
In the present study, we found that 95% of pemphigus was PV. Of these cases, 90.4% 
(19/21) had oral involvement; their mean age was 43.0± 16.5 yr. In 50.0% (9/18) of 
those who experienced both skin and oral lesions, the symptoms initially manifested 
themselves in the oral cavity. The oral lesions were manifested as multiple irregular 
ulcers or erosions that sometimes were covered by a white-yellow slough, mainly 
located in the buccal and palatal mucosa. These results are in agreement with the 
international literature and support the paucity of intact bullae or vesicles in the oral 
cavity [141, 260-262]. The results also showed that pemphigus should be considered 
when there are multiple persistent oral ulcerations. Furthermore, the severity of these 
lesions was measured by a modified scoring index, OLAS, which classified lower 
education, having an outdoor job, living outside Khartoum, being a non-smoker and 
belonging to a central and Western tribe as having the severest active oral lesions. In 
the present study, those who reported outdoor jobs (farmer, animal breeder, street seller 
and builder) and lower education were the low income patients. Health illiteracy and 
poor general health were known to be associated with these socioeconomic parameters 
[263, 264]. Living outside Khartoum state might have reflected the geographic 
distribution of health facilities and personnel, in other words, ease of access to health 
services [221]. 
PV is a rare disease that has a distinct geographical distribution and it is associated 
with multiple factors including genetic, environmental, occupational, behavioral, 
medical, infection factors and type of food intake [115]. A review study showed that 
psyche, immunity and skin are commonly related, and a pathogenic link between 
exhaustive emotional stress and an autoimmune skin disorder can often be visualized 
[265]. In connection to that, the present study showed the high level of oral PV and 
OLAS among Western tribes compared with other Sudanese tribes. This result could 
be in part associated with the war in the south and environmental disasters (drought) in 
the Western part of Sudan. The higher prevalence of oral PV among outdoor workers 
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in this study emphasizes the need for sunlight protection measures like sunscreen, cap 
and hat for outdoor workers. 
The results of the present study did not support an association of PV with genetic 
factors and the tribe’s distribution. This may well be due to the old history of 
intermarriage among more than fifty ethnic groups and six hundred tribes in Sudan 
[266]. The small sample size and the absence of a control group preclude any definite 
assertions in this study. PV has been documented in all races and ethnic groups but 
with an increased risk in certain ethnic groups. The association with specific HLA 
class II genes nevertheless suggests a genetic predisposition for the disease [109-111]. 
It would be interesting to study the genetic profile of Sudanese PV patients.  
The presence of a cleft at different levels of the epithelium aids in diagnosing the 
variants of pemphigus. If the clefts are present directly above basal layer, it is PV, and 
if it is seen beneath the granular layer, it is pemphigus foliaceus [260]. In the present 
study, light microscopy revealed the characteristics of PV, suprabasal cleft, 
acantholysis and Tzanck cells in all oral specimens except one. Also, we managed to 
detect IgG and C3 deposited in the keratinocytes intercellular spaces in all specimens 
using IHC on formalin fixed biopsies.  
Despite methodological limitations (see Paper III for limitations), the present study 
provides valuable information on the clinical presentation of oral PV in Sudanese 
patients, the socio-demographic distribution and how it affected the severity of the oral 
lesions. The study also highlights the importance of histopathology and the possibility 
of using IHC on formalin-fixed, paraffin-embedded tissue biopsies to achieve a 
definite diagnosis when a fresh biopsy and a blood sample are not available.  
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6. Conclusions  
 OML were frequently (57.9%) diagnosed in patients with skin disease and the 
highest prevalence was among the groups with vesiculobullous reaction pattern 
and skin tumours. 
 Tongue lesions were the most frequently occurring OML group across the various 
skin diseases. The highest prevalence (33.3%) of tongue lesions was found among 
psoriasiform reaction pattern.  
 OML varied systematically with age, sex, systemic conditions and use of toombak. 
 The prevalence of PV was high in the outpatients investigated. More than 90% of 
patients with pemphigus vulgaris had oral lesions.  
 The socio-demographic, clinical and histological picture of oral PV reported in 
these studies is in good agreement with the literature.  
 In the absence of fresh biopsy, IHC on formalin-fixed, paraffin-embedded tissue 
biopsy can be used to confirm the diagnosis of PV. 
 Routine evaluation of the oral cavity during normal dermatological consultation is 
possible and provides beneficial data for the clinical management of patients with 
mucocutaneous diseases. 
 The Arabic version of the OIDP inventory was able to discriminate between 
patients with skin disease with and without OML. When the influence of numbers 
of OML, types and numbers of oral symptoms and specific OML groups were 
taken into consideration, additional information on OHRQoL was provided. This 
information can be used in efforts aimed to improve the individual’s quality of life.  
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7. Future perspectives  
 Awareness should be increased among patients that an oral cavity examination 
extends beyond purely dental issues and can include the detection of disorders that 
could have more severe and wider consequences for health and wellbeing.  
 In Sudan, the standard diagnostic protocol for OML should be supplemented with 
adjunctive diagnostic devices that could help clinicians to detect early mucosal 
changes, specifically inflammatory and dysplastic lesions.  
 In a country like Sudan, with high population growth and limited resources, 
population-based studies to estimate prevalence, incidence and causal factors of 
OML are difficult to conduct. Sample-based surveys are better. When the 
occurrence of a disease or condition is very rare, there is a high probability that 
neither method will include a single case. In such cases, to maintain a clinical 
recording system within the general health care system should be an important 
goal. This would facilitate retrospective study (e.g. case-control studies) of rare 
conditions such as PV. 
 There is a need for a comparative study focusing on increasing the evidence 
supporting the validity of the OIDP, other adult OHRQoL instruments and the 
recently introduced COMDQ among patients with OML, to ensure a good 
instrument and validate the assessment of the OHRQoL scores between groups 
within and between cultures.  
 We encourage more extensive use of theses OHRQoL instruments for cases of 
OML at outpatient clinics in oral medicine and dermatology clinics.  
 Treatment of patients with OML should extend beyond a merely biological focus 
to social and psychological aspects with a view to producing better quality of life 
for the patients.  
 An interdisciplinary approach in the management of such patients is imperative.  
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 The list of risk factors that trigger pemphigus has grown in the recent years, 
therefore a comprehensive study investigating PV and different risk factors in 
Sudanese patients is recommended. 
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9. Appendix 
 
9.1 Appendix 
 
Adult OIDP inventory-English 
version  
 
Personal information 
Date ……………………                                           
Code: ……………………….                                     
Name………………………………… 
Age…………………. 
 
Section 1: 
1.1 Gender 
1. F 
2. M 
 
1.2 Tribe 
1. Northern 
2. Southern  
3. Western 
4. Eastern 
5. Central 
 
1.3 Marital status 
1. Unmarried 
2. Married 
3. Divorced 
4. Engaged 
5. University 
6. Widows 
7. Other 
 
1.4 Level of education 
1. Illiterate 
2. Primary school    
3. Secondary school 
4. University 
5. Higher studies 
 
1.5 Occupation 
1. Professional  
2. Office labour  
3. Skilled labour  
4. Student  
5. Unemployed  
6. Farmer  
7. Animal breeder  
8. Others (specify) 
 
1.6 Residence during last 5 years 
1. Khartoum state 
2. Northern state 
3. Southern state  
4. Eastern state 
5. Western state 
6. Central state 
7. Out of Sudan 
8. Others(specify) 
 
 
1.7 Family medical History 
1. Yes, specify 
2. No 
 
1.8 Current Treatment 
1. No  
2. Yes, Specify  
 
1.9 Drug history 
1. Known allergic to certain drug 
2. Chronic use for certain drug 
 
1.10 Medical History 
 
Medical History Yes No  
Hypertension   
Heart disease                          
Asthma   
Diabetes   
Thyroid diseases   
Liver disease   
Hepatitis /Jaundice   
Anaemia   
Blooding Disorder   
Kidney disease   
Rheumatoid arthritis   
Allergy    
Radiotherapy   
Chemotherapy   
Epilepsy   
Stomach ulcer   
Intestinal problems   
Psychiatric treatment                         
Respiratory Disorders   
Pregnancy   
Previous hospital admission   
STIs   
Cancer   
 
Section 2: 
During the latest 6 months, have you had problems with your 
mouth and/or teeth    caused you any difficulties with the 
following situations?  
  
2.1 Eating and chewing food 
1. NeverLess than once a month 
2. Once or twice a month 
3. Once or twice a week 
4. Every, or nearly every day  
 
2.2 Speaking and pronouncing clearly 
1. Never 
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week 
5. Every, or nearly every day 
 
2.3 Cleaning your teeth 
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1. Never 
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week 
5. Every, or nearly every day 
 
2.4 Sleeping and relaxing 
1. Never 
2. Less than once a month  
3. Once or twice a month 
4. Once or twice a week  
5. Every, or nearly every day 
 
2.5 Maintaining usual emotional state 
1. Never 
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week 
5. Every, or nearly every day 
  
2.6 Carrying out major work? 
1. Never  
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week 
5. Every, or nearly every day 
 
2.7 Enjoying contact with people 
1. Never 
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week 
5. Every, or nearly every day 
 
2.8 Smiling and showing teeth 
1. Never  
2. Less than once a month 
3. Once or twice a month 
4. Once or twice a week  
5. Every, or nearly every day 
 
Section 3: 
Some questions about how you consider your overall health 
status 
1.1 How do you evaluate your general health status? 
1. Very bad 
2. Bad 
3. Neither good nor bad 
4. Good 
5. Very good 
  
1.2 How do you consider the present condition of 
your mouth and teeth? 
1. Very bad 
2. Bad 
3. Neither good nor bad 
4. Good 
5. Very good 
  
1.3 Are you satisfied with the appearance of your 
teeth? 
1. Strongly disagree 
2. Disagree 
3. Neither agree nor disagree  
4. Agree 
5. Strongly agree 
 
Section 4: 
During the previous 6 month have you experienced? 
4.1 Dental pain/toothache? 
1. Yes 
2. No 
3. I do not know  
 
4.2 Abscessed tooth? 
1. Yes 
2. NO 
3. I do not know 
 
4.3 Dry mouth? 
1. Yes 
2. No 
3. I do not know 
 
4.4 Infected sore gums 
1. Yes 
2. NO 
3. I do not know 
 
4.5 Bleeding gums? 
1. Yes  
2. No 
3. I do not know  
 
4.6 Tooth decay 
1. Yes  
2. No 
3. I do not know  
 
4.7 Broken tooth 
1. Yes 
2. No 
3. I do not know 
 
Section 5: 
Some questions about your life style and Oral health related 
behaviours 
a. Have you ever attended a dentist (dental 
therapist) for treatment? 
1. Yes 
2. No 
3. Don’t know 
 
b. Do you have a dentist (dental therapist) to go to if 
you need one? 
1. Yes                         
2. No 
3. Don’t know 
 
c. Think back on the previous 2 years – how many 
times have you attended a dentist? 
1. Once 
2. Twice 
3. More than twice 
4. Never 
 
d. How often do you brush your teeth? 
1. Several times a day 
2. Daily 
3. Seldom 
4. Never 
 
e. Alcohol-drinking habits 
1. Every day 
2. Several times a week  
3. Some times 
4. Never 
5. Former drinker 
 
f. Tombac use 
1. Every day 
2. Several times a week  
3. Sometimes 
4. Never 
5. Former use 
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g. Smoking habits 
1. Smoke every day 
2. Some times 
3. Former smoker 
4. Never been sm 
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 القسم الأول:  
  لطعام؟اشهر الماضية كم من المرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في الآكل ومضغ ا 6أ/  خلال الـ 
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   / مره أو مرتان في الأسبوع 4
 ال ت ك لم اشهر الماضية كم من المرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في  6ب/  خلال الـ 
  / مره أو مرتان في الشهر 3  لشهر  / اقل من مره في ا2  / ولا مره 1
  / تقريبا َأو كل يوم5   / مره أو مرتان في الأسبوع 4
  اشهر الماضية كم من المرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في نظافة الأسنان : 6ت/  خلال الـ 
  هر / مره أو مرتان في الش3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   / مره أو مرتان في الأسبوع 4
  اشهر الماضية , كم من مرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في النوم والاسترخاء ؟ 6ث/  خلال الـ 
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   سبوع / مره أو مرتان في الأ4
اشهر الماضية , كم من مرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في الابتسام , الضحك أو الخجل من  6د/  خلال الـ 
 إظهار الأسنان ؟
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   سبوع / مره أو مرتان في الأ4
اشهر الماضية , كم من مرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في إظهار الانفعالات العادية دون  6ج/  خلال ال 
 الإحساس بضيق؟
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   بوع / مره أو مرتان في الأس4
  اشهر الماضية , كم من مرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في عمل أدوار رائده في المجتمع ؟ 6ح/ خلال الـ 
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  أو كل يوم / تقريباَ 5   / مره أو مرتان في الأسبوع 4
  اشهر الماضية , كم من مرات عانيت من مشاكل تتعلق بالفم والأسنان مما نتج عنه صعوبة في الاستمتاع بالاختلاط بالآخرين ؟ 6خ/  خلال الـ 
  / مره أو مرتان في الشهر 3  / اقل من مره في الشهر  2  / ولا مره 1
  / تقريبا َأو كل يوم5   / مره أو مرتان في الأسبوع 4
 القسم الثانى:  
 أ/  ما هو تقييمك لصحتك العامة ؟
/ جيده جداَ 5  / جيده 4  / لا إجابة 3  / سيئه 2/ سيئه جدا َ 1
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 ب/ كيف تقيم الحالة الراهنة لفمك وأسنانك؟
/ جيده جداَ 5  / جيده 4  / لا إجابة 3  / سيئه 2/ سيئه جدا َ1
  ت/ هل أنت راضى عن مظهر أسنانك؟ 
  / أوافق بشده5  /أوافق 4  / لا إجابة 3  لا أوافق  /2  / لا أوافق بشده 1
 القسم الثالث
  اشهر الماضية هل كان لديك الام  فى الاسنان؟ 6أ/  خلال ال 
  /لا ادرى         3/  لا           2/ نعم        1                
  اشهر الماضية هل كان لديك خراج فى الاسنان ؟ 6ب/  خلال ال 
  /لا ادرى             3/  لا     2/ نعم        1               
  اشهر الماضية هل كان لديك جفاف فى الفم؟  6ت/  خلال ال 
  /لا ادرى         3/  لا     2/ نعم        1                
  اشهر الماضية هل كان لديك التهاب فى اللثة؟      6ث/  خلال ال 
  /لا ادرى         3لا      / 2/ نعم        1                 
  اشهر الماضية هل كان لديك نزيف فى اللثة؟ 6د/  خلال ال 
  /لا ادرى         3/  لا     2/ نعم                          
  اشهر الماضية هل كان لديك اسنان متسوسة ؟ 6ج/  خلال ال 
  /لا ادرى         3/  لا     2/ نعم        1                 
  اشهر الماضية هل كسرت احدى اسنانك؟ 6ح/  خلال ال 
  /لا ادرى         3/  لا     2/ نعم        1                  
 القسم الرابع 
 أ/  هل زهبت الى عيادة اسنان فى حياتك لتلقى العلاج؟
  / لا أدرى3  / لا 2            / نعم1 
  عيادة اسنان لتلقى علاج ؟ب/  خلال العامين الماضيين , كم مرة ذهبت الى 
  / لم أّذهب4/ اكثر من مرتين      3  / مرتان2/ مره واحدة     1          
 ت/  هل لديك طبيب أسنان تذهب إليه عند الحوجه ؟
  / لا أدرى3  / لا 2  / نعم 1          
 ث/  كم مره تنظف أسنانك بفرشاة الأسنان ؟
  / ولا مره 4/  نادرا               3ره واحده فى اليوم              / م2/ عدة مرات فى اليوم             1
  ماهو معدل التدخين عندك ؟ –د/  إذا كنت من المدخنين 
  /  لا أدخن إطلاقا4/ كنت أدخن فى الماضى    3/ أحيانا     2  / أدخن يوميا1
  ماهو معدل تعاطى الكحول عندك ؟ –ج/  إذا كنت تتعاطى الكحول 
  / كنت أتعاطى فى الماضى     5/ لا أتعاطى الكحول    4/ أحيانا      3/ عدة مرات فى الأسبوع     2ا  /  يومي1
  ما هو معدل إستخدامك ؟ –ح/  إذا كنت من مستخدمى التمباك 
  / كنت أستخدم فى الماضى    5/ لا أستخدم التمباك    4/ أحيانا      3/ عدة مرات فى الأسبوع     2/  يوميا  1
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9.3 Appendix  
Skin examination sheet: 
 
 
Patient Personal Data: 
 
Code: ……………………………                           
 
Date ……………………………..                                    
 
Name ……………………………                             
 
Age ………………………………. 
 
Section 1 
 
1. Chief complains (C/C) 
1. Localised pruritis 
2. Generalised pruritis 
3. Eruption                                                        
4. Dryness 
5. Hypopigmentation 
6. Swelling 
7. Numbness 
8. Hyperpigmentation       
9. Malaise                  
10. Others (specify---------------------------------------- 
 
1.1 Duration of C/c:  
1. Days 
2. Weeks 
3. Months 
4. Years 
 
1.2 The current history of C/C:     
When 
1. Less than 4 days 
2. More than 4 days 
3. More than a week  
                     
1.3 Where    
1. Face 
2. Neck 
3. Chest 
4. Trunk 
5. Genital organs 
6. Upper limbs 
7. Lower limbs 
8. Back 
9. Scalp 
10. Buttocks 
11. Generalized 
 
1.4 Onset/ How 
1. Abrupt 
2. Insidious 
3. Sudden 
4. Rapid 
5. Gradual 
6. Indolent  
 
1.5 Course 
1. Remittent (fluctuant, relapsing) 
2. Progressive  
3. Stationary (static)  
4. Regressive  
 
1.6 Aggravating factors 
1. Sun exposure 
2. Smoking 
3. Alcohol 
4. Spices 
5. Stress 
6. No aggravating factors 
7. Others (specify): ------------------------------------------------- 
 
1.7 Alleviating factors 
1. Sun exposure 
2. Smoking 
3. Alcohol 
4. Spices 
5. Stress 
6. No alleviating factors 
7. Others (specify): ---------------------------------------------------  
 
1.8 Associations       
1. Fever 
2. Loss of weight 
3. Loss of appetite 
4. Diarrhoea    
5. Polyuria 
6. Night cough 
7. Sweating 
8. No association 
9. Others (specify) 
 
1.9 First lesions 
Where 
1. Skin only 
2. Oral cavity only 
3. Skin first and then oral cavity 
4. Oral cavity first and then skin 
5. Skin and oral cavity simultaneously  
 
1.10 Past history of the current condition 
1. Yes 
2. No 
 
2. 1.11 Family history of similar condition 
1. Yes 
2. No 
 
1.12 Treatment 
1. Not under treatment 
2. Under treatment (specify) 
---------------------------------------- 
----------------------------------------- 
 
1.13 Sexual history 
1. Urethral discharge 
2. Genital ulcers 
3. Multiple sexual relationships 
4. Homosexuality 
5. Bisexuality 
6. No sexual history 
 
Section 2 
 
  
2.1 General examinations 
A. General condition 
1. Ill 
2. Febrile 
3. Pale 
4. Cyanotic 
5. Icteric 
6. Emaciated 
7. Wasted 
8. Dehydrated 
9. looks well 
 
B. Vital sign measures 
1. Temperature 
2. Pulse 
3. Blood Pressure 
 
C. Specific organ examination Systemic 
(examination) 
1. Normal condition 
2. Abnormal condition, 
 specify----------------------------------- 
3. Head 
4. Neck 
5. Chest 
6. CVS 
7. LL (oedema, varicose veins )       
8. LN 
9. CN 
 
2.2 Distribution of cutaneous lesion 
A. Localized 
1. Single lesion 
2. Cluster 
3. To specific part (Systematized) 
4. to stereotypical part 
 
B. Widespread 
1. Scattered to individual lesion 
2. Unilateral 
3. Bilateral 
4. Symmetrical 
5. Asymmetrical 
6. Along a line of Cleavage; Pityriasis rose 
7. Diffuse involvement 
8. Universal 
 
2.3 Configuration of cutaneouslesions 
A. Linear 
1. Confluent 
2. Separated in file 
 
B. Arciform 
1. Annular 
2. Polycyclic 
3. Serpentine 
 
C. Circular 
1. Guttate 
2. Nummular 
 
D. Grouped 
1. Herpitiform 
2. Zosteriform 
3. Corymbiform 
4. Agminated 
5. Moniliform 
 
2.4 Morphology of individual lesions (Fundamental 
cutaneous lesions)  (words) 
1. Macules 
2. Papules 
3. Nodules 
4. Vesicles 
5. Bullae 
6. Pustules 
7. Patche 
8. Plaques 
9. Crust 
10. Keratosis 
11. Scale crust 
12. Eschars 
13. Erosions 
14. Ulcers 
15. Fissures 
16. Atrophies 
17. Telangiectasia 
18. Burrows 
19. Cords. 
 
2.5 Lesion colour 
1. White 
2. Yellow 
3. Brown 
4. Red 
5. Violet 
6. Blue 
7. Black  
8. Others 
 
2.6 Palpation of cutaneous lesion 
1. Soft 
2. Firm 
3. Hard 
4. Fluctuant 
5. Compressible 
6. Doughy 
7. Others. 
 
 
 
 
2.7 Provisional diagnosis 
………………… 
 
2.8 Confirmatory investigations 
1. Skin biopsy 
2. Skin scraping for fungal infection 
3. Nail clip for fungal infection 
4. Skin smear for Leishmania Donovani bodies 
(L.D.bodies) 
5. Skin snip for Oncocerca Volvulous (O.V.) 
6. Skin swab for culture and sensitivity (C&S) 
7. Skin swab for Alcoholic Acid Fast Bacilli (A.A.F.B.) 
8. Slit skin smear of  Mycobacterium Librae 
 
2.9 Final diagnosis 
 ………………… 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 
 102 
9.4 Appendix  
Oral examination sheet: 
 
 
 
 
 
Patient Personal Data: 
 
Code: -------------------------------------- 
 
Date: ---------------------------------------                        
 
Name: -------------------------------------      
 
Age: ---------------------------------------- 
 
  
Section 1 
 
A. Patient’s chief complaint (C/C)   
1. Burning sensation 
2. Dryness 
3. Pain 
4. Swelling 
5. Numbness 
6. Hyperpigmentation 
7. Difficult eating/swallowing 
8. No complain 
9. Bleeding 
10. Bad taste or smell 
11. Swelling or tenderness of adjacent lymph nodes 
12. Other (specify) : ………………………………………….. 
  
B. Duration of C/C: 
1. Days 
2. Weeks.         
3. Months             
4. Years 
 
C. History of C/C:  
1. Trauma 
2. Habits 
3. medicine  
4. food 
5. Toothpaste        
6. Denture 
7. Toothache 
8. No reason                   
9. Others(specify)------------------------------------- 
 
D. Onset/ How 
1. Insidious 
2. Sudden 
3. Rapid 
4. Gradual 
5. Indolent  
 
E. Course  
1. Remittent (fluctuant, relapsing) 
2. Progressive  
3. Stationary (static) 
4. Regressive 
       
F. Aggravating factors 
1. Sun exposure 
2. Smoking 
3. Alcohol 
4. Spices 
5. Stress 
6. No aggravating factors 
7. Others (specify) ---------------------------------------------------- 
 
G. Alleviating factors 
1. Sun exposure 
2. Smoking 
3. Alcohol 
4. Spices 
5. Stress 
6. No Alleviating factors 
7. Others (specify) ---------------------------------------  
         
H. Change in physical character 
1. Lump to ulcer 
2. Vesicle to ulcer 
3. No change 
4. Others(specify)------------------------------------- 
 
5. K. Current treatment for the current lesion  
1. No 
2. Yes          specify---------------------------------  
 
Section 2 
   
2.1 Extra Oral Examination 
 
Exra oral location code 
Upper lip 1 
Lower lip 2 
Perioral area 3 
Commissures 4 
Vermilion boarder 5 
LN (head & neck) 6 
 
Condition Code  
normal extra-oral appearance 0 
Ulceration, sores, erosions, 
fissures 
1 
hemorrhagic crust (lips) 2 
Blister/vesicle 3 
Atrophy 4 
Hypopimentation 5 
 
 
location Condition 
  
  
  
 
 
Section 3 
 
3.1 Intra Oral Examination Oral mucosa  
        
A. Number of different types of lesions 
1. Single 
2. Two 
3. Multiple 
4. No lesion detected 
        
B. Size of the lesion 
1. Less than 0.5 cm 
2. More than 0.5 cm 
3. More than 1.0cm 
        
C. Surface of the lesion 
1. Smooth 
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2. Irregular 
3. Covered by yellow fibrineous membrane 
4. Lobulated 
5. Filmy/milky surface 
6. Verrocous growth 
7. Granular 
8. Atrophic 
       
D. Ulcer base 
1. Smooth 
2. Full of granulation tissue 
3. Fungated 
4. Covered with slough membrane or scab 
 
E. Consistency/ texture of the lesion - palpation 
1. Soft 
2. Firm 
3. Hard 
4. Indurated (hard or firm) 
5. Fluctuation 
6. Spongy 
      
F. Mobility of the  lesion  
1. Fixed 
2. Movable 
3. Matted 
        
G. Presence of pulsation 
1. Yes 
2. No 
        
H. Margin of the lesion 
1. Flat 
2. Rolled 
3. Raised 
4. Everted 
5. Irregular (ill-defined margin) 
6. Well demarcated 
       
3.2 Describe pain 
1. No pain 
2. Pain 
3. Mild 
4. Moderate 
5. Severe    
      
3.3 Past history of the current lesions          
1. Yes 
2. No 
 
3.4 Family history of similar condition      
1. Yes 
2. No  
 
3.5 History of RAU if present  
              Times of recurrence 
1. Once during the last year 
2. Twice during the last year 
3. More than two during the last year 
4. First time 
 
 
 
 
 
3.6 Condition and Location 
 
Condition code 
No abnormal condition 0  
blister/vesicle 1  
bulla 2 
Leukoplakia 3 
Candidiasis 4 
Pustules 5 
Haemorrhagic crust                                             6
Fissures                                                               7 
Erythema                                                              8
Erosion                                                             9
Ulceration                                                        10 
Papule 11 
Plaque 12  
Nodule                                                              13
Macule 14  
Nikolsky sign                                                   15  
Atrophy                                                                                                                   16
Leukoedema                                17 
Lichenplanus                                                                           18
Keratosis                                                                                   19 
 
 
 
location Code  
Vermilion boarder 1 
Commisure 2 
Lips 3 
Sulci 4 
Buccal mucosa 5 
Floor of the mouth 6 
Tongue 7 
Soft palate 8 
Hard palate 9 
Alveolar ridge/ gingiva                                                  10
Not recorded 0 
 
Condition location 
  
  
  
  
 
3.7 Biopsy 
Incision 
1. Excision 
2. Punch 
3. Nobiopsy taken 
 
a. Differential Diagnosis: 
 ------------------------------------------------------------------------------
------------------ 
 
b. Investigations 
1. Histopathology 
2. Haematology 
3. Microbiology 
4. Other 
 
 
c. Results: -----------------------------------------
---------------------------------------------------
------ 
 
 
d. Final Diagnosis: ------------------------------
-------------------------------------------------- 
 
 
 
 
 
 Section 4 
 Dentition status registration: (DMFT): 
 
 
                     UR                                      UL 
1
8 
1
7 
1
6 
1
5 
1
4 
1
3 
1
2 
1
1 
2
1 
2
2 
2
3 
2
4 
2
5 
2
6 
2
7 
2
8 
                
                    LR                                     LL 
4
8 
4
7 
4
6 
4
5 
4
4 
4
3 
4
2 
4
1 
3
1 
3
2 
3
3 
3
4 
3
5 
3
6 
3
7 
3
8 
                
 
 
 
Criteria and codes for dentition registration: 
 
CODE CRITERIA 
0 Sound 
1 Decayed 
2 Filled with decay 
3 Filled no decay 
4 Missing due to caries 
5 Missing any other reason 
6 Fissure sealant 
7 Bridge, abutment, crown 
8 Un-erupted crown 
9 Trauma/fracture  
10 Not recorded  
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9.5 Appendix 
 
Oral mucosal lesions encountered during the study period 
                     
Coated                            Geographic                    Fissured               Atrophy of papillae        Geographic+ fissured            Tongue tie  
     
Snuff dipper lesion        Frictional keratosis          Leukoplakia code                   Nicotinic stomatitis                     Lupus erythromatosus                                                                                          
                     
Vitiligo                                                  Unspecified nicotinic stomatitis                      Lichen planus                         Lichenoid lesion                                               
                     
Erythema                                         Petechia                           Erosion                               Erosion                           Hemangioma                         
                                        
Pemphigus vulgaris                 Chickenpox                         Bullous pemphigoid              Herpes labialis               Vesic.bullous not verified     
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      RAS                                                  Drug reaction                                     Stevens-johonson syndrome                  Erythema multiform 
 
                                                     
Oral melanotic macules             Oral melanotic macules       Gingival tattoo                     Fibroepithelial polyp     Denture induced fibrous   
                                                                                                                                                                                         hyperplasia 
             
Erythematous candidiasis     Median rhomboid glossitis   Pseudomembranous candidiasis    Angular cheilitis      Hyperplastic candidiasis                                                 
                       
Soft tissue like lesion                    Palatal tori                          Exostosis                      Perioral dermatitis                   Perioral wart 
                         
Hypopigmented lip                    Cheilitis glandularis                 Unspecified cheilitis    Papillary hyperplasia      Focal epithelial hyperplasia   
    
Mucocele                                                  Kaposi sarcoma 
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10. Original papers I -III 
 
RESEARCH ARTICLE Open Access
Oral mucosal lesions in skin diseased patients
attending a dermatologic clinic: a cross-sectional
study in Sudan
Nada M Suliman1, Anne N Åstrøm2, Raouf W Ali3, Hussein Salman4 and Anne C Johannessen1,5*
Abstract
Background: So far there have been no studies focusing on the prevalence of a wide spectrum of oral mucosal
lesions (OML) in patients with dermatologic diseases. This is noteworthy as skin lesions are strongly associated with
oral lesions and could easily be neglected by dentists. This study aimed to estimate the frequency and socio-
behavioural correlates of OML in skin diseased patients attending outpatient’s facility of Khartoum Teaching
Hospital - Dermatology Clinic, Sudan.
Methods: A cross-sectional hospital-based study was conducted in Khartoum from October 2008 to January 2009.
A total of 588 patients (mean age 37.2 ± 16 years, 50.3% females) completed an oral examination and a personal
interview of which 544 patients (mean age 37.1 ± 15.9 years, 50% females) with confirmed skin disease diagnosis
were included for further analyses. OML were recorded using the World Health Organization criteria (WHO). Biopsy
and smear were used as adjuvant techniques for confirmation. Data were analysed using the Statistical Package for
Social Science (Version 15.0.1). Cross tabulation and Chi-square with Fisher’s exact test were used.
Results: A total of 438 OML were registered in 315 (57.9%, males: 54.6% versus females: 45.6%, p < 0.05) skin
diseased patients. Thus, a certain number of patients had more than one type of OML. Tongue lesions were the
most frequently diagnosed OML (23.3%), followed in descending order by white lesions (19.1%), red and blue lesions
(11%) and vesiculobullous diseases (6%). OML in various skin diseases were; vesiculobullous reaction pattern (72.2%),
lichenoid reaction pattern (60.5%), infectious lesions (56.5%), psoriasiform reaction pattern (56.7%), and spongiotic
reaction pattern (46.8%). Presence of OML in skin diseased patients was most frequent in older age groups (62.4%
older versus 52.7% younger, p < 0.05), in males (63.2% males versus 52.6% females, p < 0.05), patients with a
systemic disease (65.2% with systemic versus 51.9% without systemic disease, p < 0.05) and among current users of
smokeless tobacco (toombak) (77% current use versus 54.8% no use, p < 0.00).
Conclusions: OML were frequently diagnosed in skin diseased patients and varied systematically with age, gender,
systemic condition and use of toombak. The high prevalence of OML emphasizes the importance of routine
examination of oral mucosa in a dermatology clinic.
Background
Epidemiological studies of oral mucosal lesions (OML)
are rare globally in comparison with studies on caries
and periodontal diseases [1]. Whilst caries and periodon-
tal diseases constitute the most prevalent oral diseases
worldwide, cancrum oris, oral manifestations of HIV/
AIDS, and oral cancer constitute the main burden of oral
diseases in deprived communities in sub Saharan Africa
[2]. As the pattern of oral diseases vary across countries,
site specific epidemiological studies are needed to address
the most commonly occurring oral diseases in order to
plan for oral health care service [1,3]
To estimate the prevalence, incidence, distribution and
causal factors of OML, studies from the general popula-
tion are needed. However, population based studies are
difficult to carry out because they are expensive and time
consuming. The most extensive surveys on OML have
been reported from Sweden, America, Malaysia and India
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[4-7]. Thus, the majority of publications are based upon
selected population groups; hospital attendees, the elderly,
school children and patients with specific diseases, such as
hepatitis C, diabetes, renal and skin diseases [8-16].
Absence of use of standardized methodological design in
epidemiological studies of OML has shown substantial dis-
parity in the prevalence of these lesions across different
settings worldwide. In general, previous studies have
shown that OML tend to increase with age and being a
male, and also with lifestyle patterns such as tobacco and
alcohol consumption [6,12,17].
In oral medicine, dermatologic diseases have got special
attention as OML may be the primary clinical feature or
the only sign of various mucocutaneous diseases [18-20].
Focusing on patients referred to a dermatologic clinic,
Ramirez-Amador et al [21] reported a prevalence of 35%
OML in subjects affected with mucocutaneous conditions.
Pemphigus vulgaris, lichen planus, candidiasis, and recur-
rent aphthous ulcers were the most frequently diagnosed
conditions [21]. Yet, there has been no studies focusing on
the prevalence of a wide spectrum of different types of
OML in patients with dermatologic diseases. This is note-
worthy as a certain amount of skin lesions are strongly
associated with oral lesions and could be neglected by
dentists due to lack of information and/or improper diag-
nosis [22]. Dentists are often the first to be consulted by
patients who develop acute oro-facial pain. Therefore,
improving the knowledge about the frequency and diver-
sity of OML at the dermatology clinic will strengthen and
enhance interdisciplinary and multispectral approaches as
opposed to a single sector approach in the management of
such patients. Moreover, OML in skin diseases deserve
special attention, considering that some are life-threaten-
ing, while others have great impact on individuals and
society in terms of pain, discomfort and social and func-
tional limitations [1]. In the Sudan, studies on OML have
focused on toombak (Sudanese smokeless tobacco)-asso-
ciated lesions since several clinical and epidemiological
studies have identified toombak use as a possible risk fac-
tor for oral cancer [23,24].
Purpose
The purpose of this study was to estimate the frequency,
diversity and socio-behavioural correlates of different
types of OML in adult patients with dermatological dis-
eases attending outpatient’s facility of Khartoum Teaching
Hospital (KTH) - Dermatology Clinic, Sudan.
Methods
Sampling procedure
A cross sectional hospital-based study was carried out
focusing on patients aged 18 years and above with skin
lesions, attending an outpatient dermatologic clinic at
KTH from October 2008 to January 2009. KTH is the
largest national hospital in Sudan. It is an open public and
referral hospital receiving patients from all states of the
country. A minimum sample size of 500 patients was cal-
culated based on an assumed prevalence of OML in skin
diseased patients of 5%, a confidence interval of 95%, and
an absolute precision of 0.02. All patients (n = 4235)
attending the outpatient facility during the survey period
were invited to participate in the study. The patients were
informed in detail about the study procedure and that
they could decline at any time without negative conse-
quences, after having given consent.
A total of 1540 subjects (36.4%) accepted verbally to par-
ticipate in the study. Fear of taking biopsy for asympto-
matic lesions and time consuming examinations (oral
examination, interview, and biopsy when needed) were the
main reasons for not volunteering to participate. Some
refusals did not give reason for non-participation. Among
those who initially accepted to participate, 544 (544/1540,
35.3%) patients were included in the study. Reasons for
none consenting were patients’ disappearance and limited
resources. Confidentiality of the patients was maintained.
The participants were informed about their oral condi-
tions, and health education was provided. Those who
needed dental services were referred to the University of
Science and Technology (UST), Faculty of Dentistry, for
further investigation and management. Participation was
voluntary. Written informed consent or finger print for
participation and publication of the study was obtained
from patients or their parents/guardians. The research
conformed to the Helsinki Declaration and ethical clear-
ance, and approval letters were obtained by the participat-
ing institutions’ committees (UST and KTH, Department
of Dermatology, in Sudan). In Norway, the ethical
approval was obtained from the Regional Committee for
Medical Ethics in Research.
Interview
A face-to-face interview was conducted by two trained
dentists. The structured interview schedule contained
questions regarding socio-demographics (gender, age,
education, occupation and place of residence during the
last 5 years), health and oral health related characteristics
and lifestyle (smoking, use of toombak or alcohol). The
interview schedule was constructed in English and then
translated and used in Arabic. Forward and backward
translations were done by two independent Sudanese
professional translators in Arabic and English language.
Oral health related behaviours were assessed in terms of
use of toombak, alcohol and smoking. Use of alcohol and
use of toombak was assessed using a 5-point scale: (1)
Every day; (2) Several times a week; (3) Sometimes; (4)
Never; (5) Former use. Two dummy variables were con-
structed yielding the categories 0 = never (including the
original categories 4), 1 = yes (including the original
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categories 1, 2, 3 and 5). Smoking habit was assessed
using a 4-points scale: (1) Every day; (2) Sometimes; (3)
Former use; (4) Never. Those scales were dichotomized
into 1 = smoke (including the original categories1, 2 and
3), 0 = never smoke (including the original categories 4).
Skin examination
An expert dermatologist (HS) evaluated the patient’s der-
matological disease through information obtained in a
structured interview conducted in the outpatient depart-
ment of the dermatology clinic. Elements evaluated during
skin examination were chief complains, and duration and
history of chief complains. Past history and family history
were also recorded.
Clinical oral examination
Systematic comprehensive extra-oral and intra-oral clini-
cal examinations based on visual inspection and palpa-
tion, following the World Health Organization (WHO)
criteria for field surveys [25] were carried out by a dentist
(NMS) who received a standard training in diagnosis of
OML before the data collection (The Gade Institute,
Section for Pathology, and Department of Clinical
Dentistry-Section for Oral Surgery and Oral Medicine,
University of Bergen, Norway). Oral examination was
performed with the subject lying on a medical couch in
the outpatient’s section of the Department of Dermatol-
ogy, KTH. All instruments used for oral examination and
biopsy were obtained from UST. A head light and an arti-
ficial light, mouth mirrors, spatulas, and sterile gauze
were used. Occasionally, a cotton swab was used to
remove debris to test whether a white lesion could be
wiped off. Dentures were removed prior to examination.
In those cases requiring further examination; diascopy,
smears for Candida albicans, punch and incision biopsies
were performed to establish precise accurate diagnosis. In
addition, selected sections were stained for examination
of Candida albicans or melanin. Final diagnoses of all
lesions were confirmed by an expert oral pathologist
(ACJ). Skin lesions and OML encountered during the
survey were photographed using a digital camera (Canon
EOS 400D).
Clinical parameters were recorded using a structured
questionnaire modified from the WHO OML form
assessment [25,26]. Parameters which were recorded
were; chief complains, disease history, clinical features of
the lesion, anatomical location, size, colour, past history,
medications used, and associated etiological factors. Self-
reported condition of the oral mucosa was also ascer-
tained by asking the patients about dryness of mouth,
ulceration, pain, difficulties in swallowing, and burning
sensation. The clinical diagnoses of OML were sorted
into 14 disease groups, and the total number of types of
lesions within each disease group was assessed. In
addition, the total number of patients who were diag-
nosed with any lesion in each separate disease group was
counted. Individual patient could have more than one
type of OML diagnosed. Consequently, the number of
OML would exceed the number of patients.
Diagnostic criteria for oral mucosal lesions
An OML was defined as any abnormal change or any
swelling on the oral mucosal surface. Diagnostic criteria
for OML were based on Axell criteria and those defined in
previous studies and reviews [5,25,27,28]. Thus, median
rhomboid glossitis was defined as asymptomatic, smooth
to lobulated well demarcated erythematous zone, sur-
rounded by a sharp furrow that affects midline of posterior
dorsal tongue. Atrophy of tongue papillae not compatible
with the criteria set for median rhomboid glossitis, has
been registered as atrophy of tongue papillae. Vitiligo was
defined as depigmented macules and patches that have
relatively distinct and possibly hyperpigmented margins
present in the lips. The lesion should associate with diag-
nosed vitiligo elsewhere in the skin. Lichenoid lesions
were defined as lesions that have in common basal cell
damage, have a lichen planus like aspect, but that lack one
or more characteristic clinical aspects [29]. Erythema was
defined as redness of the mucosa, caused by hyperemia of
the mucosal capillaries. The lesion should disappear on
finger pressure (blanching).
In addition to strictly intraoral lesions, angular cheilitis
and perioral dermatitis were also recorded. Linea alba,
cheek biting, leukoedema, lingual varicose, Fordyce’s gran-
ules, and excessive melanin racial pigmentation were
excluded from the study.
Statistical analysis
Data were analyzed using the Statistical Packages for
Social Sciences (SPSS, version 15.0). The level of statistical
significance was set at 5%. Cross tabulation and Chi-
square with Fisher’s exact test were used to test the statis-
tical significance of the relationships between skin disease
groups and types OML on the one hand side and socio-
behavioural variables on the other.
Results
Sample profile
A total of 544 patients with a skin disease diagnosis parti-
cipated in the present study. The mean age was 37.1 ±
15.9 years (range 18-85), 50% were females and 77% were
permanent residents of Khartoum during the previous 5
years. Males were more frequently employed than females
(72.6% versus 27.4%, p < 0.001), whereas use of smoking,
toombak or alcohol was more reported in males than
females (p < 0.05). Totals of 17.7%, 12.7% and 4.3% con-
firmed former or current smoking, use of toombak and
alcohol use, respectively (Table 1).
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Skin diseases profile
Ninety-four different types of skin lesions, grouped into
22 categories of skin diseases, were diagnosed. The cate-
gories of skin diseases that affected less than 10 patients
(13 of the 22 categories) were grouped together and
labelled “others”. Spongiotic reaction pattern was the
most frequently diagnosed dermatological disease group
(126/544, 23.2%), followed in descending order by skin
infectious diseases (115/544, 21.1%, i.e. fungal infections
9.6%, viral infection 6.8%, bacterial infection 2.9%, and
protozoal infection 1.8%), vesiculobullous reaction
pattern (54/544, 9.9%), and disorders of cutaneous appen-
dages (48/544, 8.8%). The least frequently diagnosed
group was tumours (12/544, 2.2%) (Figure 1). Disorder of
pigmentation was more common in females than in
males (78% versus 22%, p < 0.001). Vesiculobullous reac-
tion pattern and disorders of cutaneous appendages were
most common in older (32.7% versus 67.3%) and younger
(85.4% versus 14.6%) patients, respectively (p < 0.05).
Oral mucosal lesions profile
In total, 315 of the 544 patients included in the study
had at least one clinically recognized type of OML
(57.9%). A certain amount of the patients had more
than one type of OML, thus the total number of OML
recorded in the 315 patients was 438. Of those affected,
202 (64.1%) had one type of OML, 78 (24.8%) had two
types of OML, and 35 (11.1%) had three or more types
of OML. A total of 51 different clinical diagnoses were
recorded. For each patient, one type of OML was only
recorded once, although in some patients the OML
could be manifested at several locations. Only 15.9%
(n = 50) of the patients agreed to undergo punch biopsy
confirmation. Absence of epithelial dysplasia was con-
firmed in all biopsies taken from lesions such as oral
leukoplakia, frictional lesion, and snuff dipper’s lesions.
The age of patients affected by OML ranged from 18 to
81 years, with an average of 38.6 years (±16.5).
As shown in Table 2, tongue lesions were the most fre-
quently diagnosed OML (23.3%) followed in descending
order by white lesions (19.1%), red and blue lesions (11%)
and vesiculobullous diseases (6%). The least frequently
diagnosed OML group was malignant tumours (0.2%).
White lesions (42.2% versus 57.8%) and the red and blue
lesions (37.3% versus 62.7%) occurred most frequently in
older patients (p < 0.05). Ulcerative conditions were most
frequently diagnosed in males (18% versus 6%, p < 0.05).
Coated tongue (48.0%) and tongue tie (3.1%) were the
most frequently occurring OML within tongue lesions,
whereas snuff dipper lesions/toombak-associated lesions
Table 1 Socio-demographic and behavioural distribution of patients with skin disease by sex (n = 544)
Variables Female n (%) Male n (%) Total n (%)
Age
Younger (18-32 yrs) 144 (51.6) 135 (48.4) 279 (52.2)
Older (33-85 yrs) 123 (48.2) 132 (51.8) 255 (47.8)
Occupation
Employed 89 (27.4) 236 (72.6)* 325 (59.9)
Unemployed 183 (83.9) 35 (16.1) 218 (40.1)
Education
Lower education (illiterate/primary school) 143 (53.6) 124 (46.4) 267 (49.9)
Higher education 126 (47) 142 (53) 268 (50.1)
Residence
Residence last 5 yr: Khartoum 207 (49.9) 208 (50.1) 415 (77)
Residence last 5 yr: outside 65 (52.4) 59 (47.6) 124 (23)
Medical history
No systemic condition 138 (46.5) 159 (53.5) 297 (54.6)
Presence of systemic condition 134 (54.3) 113 (45.7) 247 (45.4)
Smoking
Never 263 (59.5) 179 (40.5) 442 (82.3)
Former/current use 6 (6.3) 89 (93.7)** 95 (17.7)
Toombak use
Never 263 (56.3) 204 (43.7) 467 (87.3)
Former/current use 8 (11.8) 60 (88.2)** 68 (12.7)
Alcohol use
Never 269 (52.5) 243 (47.5) 512 (95.7)
Former/current use 2 (8.7) 21 (91.3)** 23 (4.3)
• * p < 0.05 ** p < 0.001.
• The total number in the different categories did not add to 544 owing to missing values.
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(28.8%), erythema (48.3%), and pemphigus vulgaris
(46.9%) were the most frequently occurring diagnoses in
white lesions, red and blue lesions and vesiculobullous
diseases, respectively. A total of 0.2% of the patients
investigated presented with Kaposi’s sarcoma, the only
lesion in the group of malignant tumours.
Table 3 depicts the frequency distribution of OML
groups within each skin disease group investigated. OML
occurred most frequently in the group of skin vesiculo-
bullous reaction pattern (72.2%), followed in descending
order by tumours (66.7%), and lichenoid reaction pattern
(60.5%). OML occurred least frequently in the skin dis-
ease group of spongiotic reaction pattern (46.8%). Tongue
lesions were the most frequently occurring OML group
across the various skin diseases. The highest prevalence
(33.3%) of the tongue lesions was found among psoriasi-
form reaction pattern. On the other hand, white lesions
occurred most frequently in the skin disease groups of
disorders of pigmentation and lichenoid reaction pattern
amounting to 43.9% and 34.2%, respectively.
As shown in Table 4, OML occurred more frequently in
older than younger patients (62.4% versus 52.7%, p <
0.05), in males than in females (63.2% versus 52.6%, p <
0.05) and more frequently in patients with than without a
medical diagnosis (65% versus 51.9%, p < 0.05). Moreover,
OML occurred more frequently in toombak users than in
their counterparts who had never used toombak (77.9%
versus 54.8%, p < 0.00).
Discussion
Frequency and diversity of oral mucosal lesions
To our knowledge this study is the first to assess the fre-
quency and diversity of OML in dermatologic patients, a
selected group of the Sudanese adult population. The
study group comprised patients with a wide range of der-
matological diseases, yielding small numbers in each
group, thus limiting the probability for stratified analyses.
The most frequently occurring groups of dermatological
diseases were spongiotic reaction pattern, infectious dis-
eases, and vesiculobullous diseases. This accords with the
results of a recent survey by the International Foundation
of Dermatology, reporting that infectious disease, derma-
titis, and HIV-related skin disease are the main skin der-
matological conditions at the community level worldwide
[30].
According to the present results, about 58% of the sub-
jects investigated suffered from at least one type of OML,
and the occurrence of any OML varied across groups of
dermatological diseases from 46.8% in spongiotic to
72.2% in vesiculobullous reaction patterns. Tongue lesions
were the most frequently occurring OML group (23.3%)
followed by white lesions (19%), red and blue lesions
(11%) and vesiculobullous diseases (6%). White lesions
and red and blue lesions varied systematically with age,
being most frequent in older persons, whereas ulcerative
conditions were most common in males. Coated tongue,
snuff dippers lesion, erythema and pemphigus vulgaris
Figure 1 Frequencies of skin disease categories.
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Table 2 Prevalence of oral mucosal lesions in the total group of skin diseased patients (n = 544), in the group of skin
diseased patients with OML and within the 14 most frequently occurring OML groups
Oral mucosal lesions Proportion with a specific
lesion in the total group of
patients
(n = 544)
Proportion with a specific lesion
in the total group of patients
with any OML
(n = 315)
Proportion with specific
lesion within 14 OML
groups
Biopsy
Tongue lesions n (%) % %
Coated tongue 61 (11.2) 19.4 48.0
Fissured tongue 26 (4.8) 8.3 20.5
Geographic tongue 23 (4.2) 7.3 18.1 2(+ve)*
Atrophy of tongue papillae 17 (3.1) 5.4 13.4 1(+ve)
Geographic tongue+Fissured
tongue
12 (2.2) 3.8 9.4
Tongue-tie 4 (0.7) 1.3 3.1
Total number of patients with
any tongue lesion ¶
127 (23.3) 40.3
White lesions
Snuff dipper’s lesion 30 (5.5) 9.5 28.8 8(+ve)
Frictional lesions 25 (4.6) 7.9 24.0 4(+ve)
Leukoplakia 17 (3.1) 5.4 16.3 5(+ve)
Vitiligo 16 (2.9) 5.1 15.4
Nicotine stomatitis 7 (1.3) 2.2 6.7
Lichen planus 5 (0.9) 1.6 4.8 3(+ve)
Lupus erythematosus 4 (0.7) 1.3 3.8 1(-ve)§
Unspecified nicotine stomatitis 3 (0.6) 1.0 2.9
Lichenoid lesions 1 (0.2) 0.3 1.0 1(+ve)
Total number of patients with
any white lesion ¶
104 (19.1) 33.0
Red and blue lesions
Erythema 29 (5.3) 9.2 48.3 2(-ve)
Petechia 25 (4.6) 7.9 41.7
Erosion 7 (1.3) 2.2 11.7
Hemangioma 3 (0.6) 1.0 5.0
Total number of patients with
any red and blue lesion ¶
60 (11) 19.0 100
Vesiculobullous diseases
Pemphigus vulgaris 15(2.8) 4.8 46.9 9(8+ve)
Chickenpox 8(1.5) 2.5 25
Bullous pemphigoid 6(1.1) 1.9 18.7 3(-ve)
Herpes labialis 2(0.4) 0.6 6.2
Vesiculobullous lesion (not
verified)
1(0.2) 0.3 3.1
Total number of patients with
any vesiculobullous disease
32 (6) 10.2 100
Ulcerative conditions
RAS 16 (2.9) 5.1 66.7 1(+ve)
Drug reaction 3 (0.6) 1.0 12.5
Stevens-Johonson syndrome 2 (0.4) 0.6 8.3
Erythema multiforme 1 (0.2) 0.3 4.2
Traumatic ulcer 1 (0.2) 0.3 4.2
Unspecified ulcer 1 (0.2) 0.3 4.2
Total number of patients with
any ulcerative condition
24 (4.5) 7.6 100
Pigmented Lesions
Melanotic macules 20 (3.7) 6.3 95 1(+ve)
Gingival tattoo 1 (0.2) 0.3 4.8
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Table 2 Prevalence of oral mucosal lesions in the total group of skin diseased patients (n = 544), in the group of skin
diseased patients with OML and within the 14 most frequently occurring OML groups (Continued)
Total number of patients with
any pigmented Lesion
21 (3.9) 6.7 100
Connective tissue lesions
Fibroepithelial polyp 9 (1.7) 2.9 81.8 4(+ve)
Denture induced fibrous
hyperplasia
2 (0.4) 0.6 18.2
Total number of patients with
any connective tissue lesion
11 (2.1) 3.5 100
Fungal infections
Acute erythematous candidiasis 3 (0.6) 1.0 30 1(-ve)
Median rhomboid glossitis 3 (0.6) 1.0 30
Pseodomembranous candidiasis 3 (0.6) 1.0 30
Angular cheilitis 2 (0.4) 0.6 20
Chronic hyperplastic candidiasis 1 (0.2) 0.3 10
Total number of patients with
any fungal infection ¶
10 (1.8) 3.2 100
Benign nonodontogenic tumors
Soft tumor like lesion 4 (0.7) 1.3 66.7 1(-ve)
Exostosis 1 (0.2) 0.3 16.7
Palatal tori 1 (0.2) 0.3 16.7
Total number of patients with
any benign nonodontogenic
tumor
6 (11) 1.9 100
Perioral lesions
Perioral dermatitis 4 (0.7) 1.3 80
Perioral wart 1 (0.2) 0.3 20
Total number of patients with
any perioral lesion
5 (0.9) 1.6 100
Lip lesions
Unspecified cheilitis 2 (0.4) 0.6 40
Hypopigmented lips 2 (0.4) 0.6 40
Cheilitis glandularis 1 (0.2) 0.3 20
Total number of patients with
any lip lesion
5 (1.0) 1.6 100
Verrucal papillary lesions
Papillary hyperplasia 3 (0.6) 1.0 75 1(+ve)
Focal epithelial hyperplasia 1 (0.2) 0.3 25
Total number of patients with
any verrucal papillary lesion
4 (0.7) 1.3 100
Salivary gland diseases
Mucocele 2 (0.4) 0.6 100 2(+ve)
Total number of patients with
any salivary gland disease
2
Malignant tumours
Kaposi sarcoma 1 (0.2) 0.3 100
Total number of patients with
any malignant tumour
1
If we exclude the diagnosis of (fissured tongue + geographic tongue) as one disease entity;
• Total no. of fissured tongue will be 38 (7% of study population)
• Total no. of geographic tongue will be 35 (6.4% of study population)
* (+ve) = Confirmed diagnosis
§ (-ve) = Not confirmed, final diagnosis based on history and clinical picture.
¶ The sum of the categories listed may not equal the total number due to the present of more than one lesion in one patient.
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Table 3 Frequency distribution n (%) of patients with any OML within the 10 most common groups of skin diseased patients
Skin diseases (groups) Patients with any OML
(n = 315)
Tongue
(n = 127)
White
(n = 104)
Red
(n = 60)
Vesiculobullous
(n = 32)
Ulcerative
(n = 24)
Pigmented
(n = 21)
Connective
(n = 11)
Fungal
(n = 10)
Others
(n = 23)
Spongiotic 59 27 22 16 - 3 6 - 1 5
(n = 126) (46.8) (21.4) (17.5) (12.7) (02.4) (04.8) (00.8) (04.0)
Infectious lesions 65 25 18 12 9 2 3 - 1 7
(n = 115) (56.5) (21.7) (15.7) (10.4) (07.8) (01.7) (02.6) (00.9) (06.1)
Vesiculobullous 39 11 3 - 22 5 3 1 4 2
(n = 54) (72.2) (20.4) (05.6) (40.7) (09.3) (05.6) (01.9) (07.4) (03.7)
Cutaneous 26 9 9 3 - 3 1 3 - 1
(n = 48) (54.2) (18.8) (18.8) (06.3) (06.3) (02.1) (06.3) (02.1)
Pigmentation 24 7 18 7 - - 1 2 - -
(n = 41) (58.5) (17.1) (43.9) (17.1) (02.4) (04.9)
Lichenoid 23 11 13 5 - 2 1 1 1
(n = 38) (60.5) (28.9) (34.2) (13.2) (05.3) (02.6) (02.6) (02.6)
Psoriasiform 17 10 7 5 - - 1 1 1 1
(n = 30) (56.7) (33.3) (23.3) (16.7) (03.3) (03.3) (03.3) (03.3)
Vasculopathic 13 8 2 3 - 3 1 - 1 -
(n = 25) (52.0) (32.0) (08.0) (12.0) (12.0) (04.0) (04.0)
Tumour 8 3 1 - - 1 1 - 2
(n = 12) (66.7) (25.0) (08.3) (08.3) (08.3) (16.7)
Others 41 16 11 9 1 5 4 2 1 5
(n = 55) (74.5) (29.1) (20.0) (16.4) (01.8) (09.1) (07.3) (03.6) (01.8) (09.1)
• OML (others); non odontogenic tumors, perioral lesions, lip lesions, verrucal papillary lesions, mucocele, oral malignancy
• Some patients were recorded more than one time because they appeared under more than one disease group
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were the OML most frequently observed in the groups of
tongue lesions, white lesions, red and blue lesions and
vesiculobullous diseases, respectively.
Study Limitations
The present findings should be interpreted with caution
due to some limitations. Patients’ refusal to volunteer for
biopsy might have led to some misclassifications. Thus,
some lesions that needed histological confirmation
(leukoplakia, lupus erythematosus, pemphigus vulgaris,
fibroepithelial polyp, chronic hyperplastic candidiasis,
cheilitis glandularis, focal epithelial hyperplasia, Kaposi’s
sarcoma and some others) were diagnosed clinically and
might contain error. Absence of standard methodological
approaches and lack of agreed-upon diagnostic criteria,
make comparison of epidemiological studies concerning
the prevalence of OML difficult. In spite of the limita-
tions associated with diagnostic criteria, all mucosal
pathological alterations were identified in the present
study.
Being a hospital based study; it is not possible to gen-
eralize from the study group to any larger population of
skin diseased individuals inside or outside Khartoum.
This is due to the rich geographical and socio-cultural
diversity within Sudan, as well as the low utilization rate
of health facilities generally observed in any developing
country [31,32]. Although the KTH received patients
that have been referred from all over the country, biases
in the study group might have been introduced due to
differing referral procedures as well as the moderate
response rate.
It is unsure how close an approximation the present
figures are to the prevalence of OML in the general adult
population of Sudan. Probably, the rates of OML pre-
sented in this study might be overestimated both with
respect to the Sudanese population in general as well as to
the population of adults suffering dermatological pro-
blems. Self-selection bias was considered to influence the
result of the study as patients were more likely to respond
when they had OML (the characteristic of interest).
Table 4 Skin diseases with oral lesions and with at least two OML by socio-demographic and behavioural factors (n = 544)
Skin disease with OML Skin disease with ≥ 2 oral lesions
N = 315 N = 113
Age n (%) n (%)
Younger (18-32 yrs) 147 (52.7) 42 (28.6)
Older (33-85 yrs) 159 (62.4)* 69 (43.4)
Sex
Females 143 (52.6) 43 (30.1)
Males 172 (63.2)* 70 (40.7)
Employment status
Employed 197 (60.6) 69 (35)
Non employed 117 (53.7) 44 (37.6)
Education
Lower education (illiterate/primary school) 162 (60.7) 65 (40.1)
Higher education 146 (54.5) 47 (32.2)
Residence
Khartoum 235 (56.6) 88 (37.4)
Outside Khartoum 77 (62.1) 24 (31.2)
Medical diagnosis
No systemic condition 154 (51.9) 53 (34.4)
Presence of systemic condition 161 (65.2)* 60 (37.3)
Toombak use
Never 256 (54.8) 90 (35.2)
Former/current use 53 (77.9)** 22 (41.5)
Smoking
Never 251 (56.8) 89 (35.5)
Former/current use 60 (63.2) 23 (38.3)
Alcohol
Never 293 (57.2) 103 (35.2)
Former/current use 16 (69.6) 9 (56.3)
• * p < 0.05 ** p < 0.00.
• The sum of the categories listed may not equal the total number due to lack of information.
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Moreover, with respect to the diversity of the types of
OML, the present figures might be biased towards those
for which people are more inclined to seek treatment,
whereas other conditions are less likely to be identified in
hospital based prevalence studies. Community based sur-
veys based on random samples from the broader adult
population should be recommended for future studies to
estimate the actual prevalence and the health burden of
OML in this country.
Since the precision of estimates tend to decrease with
decreasing prevalence, the prevalence rates of rare condi-
tions (≤ 1%) should be interpreted with particular caution.
In addition, populations with different distributions of the
risk factors identified for OML are not directly comparable
without adjustment. Noteworthy the absence of an official
patient’s medical journal has created uncertainty regarding
participants’ self-reported medical condition and lifestyle
patterns. A major limitation of self-reported data is recall
biases in terms of underreporting of socially undesired
events and a tendency to recall events as having occurred
more recently than they actually did [33]. Sensitive events,
tobacco and alcohol use and some medical diagnoses
would probably be under reported due to social stigma
and social desirability.
Comparison of present findings with those of previous
studies
In spite of its limitations, the present study provides
important information about the frequency and diversity
of OML in patients with various dermatological diseases
as well as the social and behavioural factors that discrimi-
nate between skin diseased patients with and without
OML. Moreover, OML in the present study may appear as
a part of mucocutaneous diseases, a manifestation of
systemic diseases (metabolic or immunological), or an
expression of drug reaction. Some OML diagnosed could
be attributed to trauma, infection, or denture use, or they
could be a manifestation of specific cultural habits, like
use of toombak. Due to the cross sectional nature of the
present study, any causal relationship could, however, not
be concluded upon.
Compared with the frequency of patients with OML
observed in this study (57.9%), previous ones have shown
point prevalence in the range 25% - 61.6% [6,9,34-36].
Specifically, the frequency of patients with OML in the
present study group was higher than those observed in
the Cambodian (4.9%) [37] Malaysian (9.7%) [7], Spanish
(51%) [12] and Turkish (42%) populations [36]. It was
lower than that observed in population in Ljubljana
(61.6%), but almost similar to the prevalence estimated in
Spanish dental patients (58.7%) [8,35]. In accordance
with the NHANES III [6] and the Swedish study pub-
lished by Axell [5], the present study used the WHO
diagnostic criteria and Axell’s diagnostic criteria [5,25].
Thus, the present results are to some extent comparable
with those previous studies, in spite that NHANES III
and the study by Axell used large probability samples
from the general populations. The frequency observed in
this study was higher than that reported in NHANES III,
amounting 28% in US adults aged 17 years and above.
Consistent with the results of NHANES III and other
studies, the frequency of patients with OML presented in
this study varied systematically and positively with being
a male and with increasing age. Other epidemiological
studies have shown an opposite sex gradient or no
systematic variation according to sex [9,38,39]. Sex differ-
ences in the occurrence of OML might be attributed to
the high consumption of toombak by males, differences
in genetic factors, social responsibility and masculinity
believes [40]. Use of toombak was reported by 12.5% of
the total study group. In a study emanating from north-
ern Sudan, the frequency of toombak use was estimated
to 40% (43, 44). Males adopt a more active outdoor life-
style and are exposed to some environmental risk factors
to a higher extent than women. In contrast, women are
more health conscious and faster to detect abnormality
in earlier stages. Older people have higher risk to develop
chronic diseases in general because of increased risk with
increasing age due to metabolic changes, medications,
prosthetic use, and psychological problem. Moreover,
economic constraints and physical status of older people
may limit their access to health care services [41,42].
Epidemiological studies have revealed that tongue
lesions constitute a considerable proportion of OML,
with prevalence rates varying across different parts of the
world. Number and type of tongue lesions involved in dif-
ferent studies have been an important factor in this varia-
bility. The present figure amounting to 23%, is lower than
that reported in some previous studies [43,44], but higher
than the rates assessed in NHANES III and in the Hun-
garian population [6,45]. Of interest was that 17 out of
30 patients (56.7%) with psoriasiform reaction pattern
had OML and that tongue lesions (33.3%) were the most
frequently occurring OML in this particular dermatologi-
cal disease group (Table 3). A study of Brazilian psoriatic
patients revealed that 59% presented with tongue lesions,
which was the most dominant OML [46]. Similar find-
ings have been reported by Hernandez-Perez et al [19].
With respect to fissured tongue, the total of 7% of
patients with fissured tongue observed in this study cor-
roborates the range reported previously [5,45,47,48].
Some few studies have reported high frequency of fis-
sured tongue [35,39,43]. Over the past few years an asso-
ciation between geographic tongue, fissured tongue and
psoriasis has been postulated. Some authors believe that
it is a natural developmental anomaly and a coincidence
finding [46,49] while others suggest a pathogenic relation
between them [50].
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Snuff dipper’s lesion was observed in 5.5% of the study
group (Table 2). This frequency is higher than that
reported in the American and Kenyan population (1.2%
and 0.4%, respectively) [6,51], but lower than that observed
in the Swedish population (15.9%) [52]. Toombak has
been known to play a major role in the aetiology of oral
cancer in the Sudan [23]. It contains at least 100-fold
higher concentrations of the carcinogenic factor tobacco
specific N-nitrosamines compared with American and
Swedish commercial snuff brands [53]. A recent study
showed that toombak induces DNA damage and cell
death in normal human oral cells more than the Swedish
snuff [54].
The frequency of oral leukoplakia (3.1%) disclosed in
this study is comparable to findings from Sweden (3.6%),
but higher than that reported in NHANES III (0.38%) [6].
Leukoplakia is a premalignant lesion with transformation
rates varying from 15.6% to 39.2% [55]. It is highly asso-
ciated with cigarette smoking [8,27,56]. Although we have
not done any further analysis of smoking as a possible risk
factor of leukoplakia, the low frequency rate of cigarette
smoking concomitant with a relatively high frequency of
oral leukoplakia as observed in this study deserves further
investigation. The high frequency of leukoplakia should be
taken seriously as leukoplakia in non-smokers is more
likely to undergo malignant transformation than leukopla-
kia in smokers [55].
A total of 4 patients (0.7%) with oral manifestation of
discoid lupus erythematosus (DLE) on vermilion border
were diagnosed in this study (Table 2). This condition has
rarely been registered in OML investigation studies. Axel
[5] reported 0.01% in a Swedish population, while Ramirez
et al [21] reported 5% in lupus patients referred to a der-
matology clinic because of oral complaints. The difference
between the present figure and that reported by Ramirez
et al may be attributed to the fact that although both data
were collected in dermatology clinic, the selection of
patients was different. The precancerous potential of oral
DLE is a controversial topic. Lu and Le [57] reported an
incidence of 13.6% epithelial dysplasia in DLE. Another
report from Scully et al [58] postulated that DLE on the
lip showed a premalignant potential. Sun exposure plays a
crucial role in the induction or exacerbation of the lupus
erythematosus and actinic cheilitis [28,59,60]. In connec-
tion to that, Wakisa et al [61] reported oral cell carcinoma
on lips of black patients with oral DLE. Noteworthy the
tropical climate in Sudan and the summer temperature
which often exceed 43°C has to be considered in interpret-
ing such lesions.
Frequency of recurrent aphthous stomatitis (RAS) has
been recorded as life time prevalence, point prevalence
and as combination of both. The present study revealed
a point prevalence of 2.9%, which is higher than 2% and
0.8% reported by Axell [5] and NHANES III [6]
respectively. Yet, it was lower than 60% and 55% in US
female student nurses and professional school students
respectively [62]. This illustrates how RAS varies accord-
ing to the study group examined. A number of factors
have been attributed to the occurrence of this pathology,
including immune dysfunction [28].
Conclusions
In conclusion, taking into consideration the selected
study group and the cross-sectional design of the study,
the results presented here cannot be generalized to a
broader population or discussed in terms of causal rela-
tionship. The results revealed that OML were frequently
diagnosed in skin diseased patients attending KTH and
varied systematically with age, gender, systemic condition
and use of toombak. Thus, this study provides informa-
tion regarding the frequency, diversity and socio-beha-
vioural correlates of OML of an important sub group of
the Sudanese population that has never been disclosed
before. Of particular significance are those lesions having
a potential of malignant transformation. Accordingly, fre-
quent and regular inspection of the oral cavity of the skin
diseased patients must be emphasized. Consequently, an
interdisciplinary approach in the management of such
patients is highly recommended.
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http://www.biomedcentral.com/1472-6831/12/19RESEARCH ARTICLE Open AccessInfluence of oral mucosal lesions and oral
symptoms on oral health related quality of life in
dermatological patients: a cross sectional study in
Sudan
Nada M Suliman1*, Anne C Johannessen1,2, Raouf W Ali3, Hussein Salman4 and Anne N Åstrøm5Abstract
Background: There are only few studies considering the impact of oral mucosal lesions (OML) on the oral quality
of life of patients with different dermatological conditions. This study aimed to assess the relationship between oral
health-related quality of life (OHRQoL) and OML and reported oral symptoms, perceived general and oral health
condition and caries experience in adult skin diseased patients attending an outpatient dermatologic clinic in
Sudan.
Methods: A cross-sectional survey was carried out with 544 diagnosed skin diseased patients (mean age 37.1 years,
50 % females), during the period October 2008 to January 2009. The patients were orally examined and OML and
caries experience was recorded. The patients were interviewed using the Sudanese Arabic version of the OIDP.
OHRQoL was evaluated by socio-demographic and clinical correlates according to number of types of OML
diagnosed (no OML, one type of OML, > one type of OML) and number and types of oral symptoms.
Results: An oral impact (OIDP> 0) was reported by 190 patients (35.6 %) (mean OIDP total score 11.6, sd = 6.7). The
prevalence of any oral impact was 30.5 %, 36.7 % and 44.1 %, in patients with no OML, one type of OML and more
than one type of OML, respectively. Number of types of OML and number and types of oral symptoms were
consistently associated with the OIDP scores. Patients who reported bad oral health, patients with≥ 1 dental
attendance, patients with> 1 type of OML, and patients with≥ 1 type of oral symptoms were more likely than their
counterparts in the opposite groups to report any OIDP. The odds ratios (OR) were respectively; 2.9 (95 %
CI 1.9-4.5), 2.3 (95 % CI 1.5-3.5), 1.8 (95 % CI 1.1-3.2) and 6.7 (95 % CI 2.6-17.5). Vesiculobullous and ulcerative lesions
of OML disease groups associated statistically significantly with OIDP.
Conclusion: OIDP was more frequently affected among skin diseased patients with than without OML. The
frequency of the impacts differed according to the number of type of OML, oral symptoms, and OML disease
groups. Dentists and dermatologists should pay special attention to skin diseased patients because they are likely to
experience oral impacts on daily performances.
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Oral mucosal lesions (OML) may be the initial feature or
the only clinical sign of mucocutaneous diseases, a group
of mainly chronic diseases, commonly observed in a der-
matologic practice [1–4]. In a previous study considering
Sudanese adults with mucocutaneous diseases attending
an outpatient dermatology clinic in Khartoum, the preva-
lence of patients with OML was high, amounting to 57.9 %
[5]. Patients with OML experience a wide range of chronic
and recurrent conditions that may have detrimental effect
on functioning, social life and psychological well-being.
Evidently, mucocutaneous diseases have impacts on the
quality of life of patients comparable to that of other med-
ical conditions [6,7]. Patient reported outcomes in terms
of oral health related quality of life (OHRQoL) measures
have seldom been assessed in relation to mucocutaneous
conditions [8–15]. Whereas the relationship of dental and
periodontal status with OHRQoL measures has been
examined across various socio-cultural contexts, few stud-
ies have considered the impact on OHRQoL of patients
with disorders that are of relevance to oral medicine and
dermatological practice [11,13,16,17]. This is so, although
patient reported outcomes of OHRQoL may provide valu-
able information, for example by identifying treatment
needs, selecting therapies, evaluating treatment outcomes
and monitoring patient progress [18].
Several generic and disease specific OHRQoL measures
have been developed to provide better understanding of
the consequences of oral diseases upon quality of life and
to complement traditional clinical measures [6,19].
Whereas specific OHRQoL measures assess impacts that
are attributable to specific oral diseases, the generic ones
take into account numerous oral conditions, some occur-
ring simultaneously, thus providing information on the
wider implications of oral status [20]. One promising gen-
eric OHRQoL measure is the Oral Impacts on Daily Per-
formance (OIDP) scale [21,22]. The OIDP was developed
to measure oral impacts that seriously affect a person’s
daily life. It is based on the conceptual framework of the
World Health Organisation’s International Classification of
Impairments, Disabilities and Handicaps (ICIDH) [23],
which has been amended for dentistry by Locker [24]. The
OIDP concentrates only on the measurement of “ultimate”
oral impacts, thus covering the fields of disability and
handicap [22] . This inventory assesses the impact of oral
conditions on basic activities and behaviours that cover the
physical, psychological, and social dimensions of daily liv-
ing. Considering respondent burden, the OIDP is suitable
for use in population surveys and clinical practices, not
only in terms of being easier when measuring behaviours
rather than feeling states, but also in being short. It is ori-
ginally calculated by multiplying frequency and severity
scores of daily performances, providing an overall score for
each OIDP item. However, applications of the weightedOIDP scores revealed no significant improvement over the
use of OIDP frequency or severity scores [22]. Thus, it has
been proposed to use either the frequency or the severity
OIDP scores for simplicity and efficiency. Since its devel-
opment, the OIDP has shown to be reliable and valid in
general population based studies [25–28], as well as in
studies of patients with specific oral disorders, such as
traumatic injuries, periodontal disease and malocclusion
[16,17,29]. Although an Arabic version of the 8 item OIDP
inventory has been applied previously with Sudanese chil-
dren [30] and dental attendees from a Sudanese adult
population [31], this study necessitated reestablishment of
its psychometrical properties. The generic OIDP inventory
has yet to be applied in the context of patients with muco-
cutaneous diseases.
This study aimed to assess the relationship between
oral health related quality of life (OHRQoL) and OML
and reported oral symptoms, perceived general and oral
health condition and caries experience in Sudanese adult
skin diseased patients attending an outpatient dermato-
logic clinic in Sudan.
Methods
Sampling procedure
The present study is a part of a cross sectional hospital
based study that was carried out from October 2008 to
January 2009 [5]. The study was focusing on patients aged
18 years and above with mucocutaneous diseases, attend-
ing an outpatient dermatologic clinic at Khartoum Teach-
ing Hospital (KTH). KTH is the largest national hospital
in Sudan, located in Khartoum, the capital city. It is an
open public and referral hospital receiving patients from
all states of the country. A minimum sample size of 500
patients was calculated to estimate differences in OHR-
QoL between patients with and without oral mucosal
lesions assuming the proportions of oral impacts to be
0.60 and 0.40 among patients with and without OML
lesions, significance level (two sided test) of 5 % and statis-
tical power of 80 %. All patients (n= 4235) attending the
outpatient facility during the survey period were invited to
participate in the study. A total of 1540 subjects (36.4 %)
initially accepted to participate. Fear of taking biopsy for
asymptomatic lesions and time consuming examinations
(oral examination, interview, and biopsy when needed)
were the main reasons for not volunteering to participate.
Of those who initially accepted to participate, 544 (544/
1540, 35.3 %) patients were included in the study. Unex-
plained disappearance of patients and limited financial
resources were the main reasons for withdrawal from the
study. Thus, the final participation rate was 544/4235,
12.8 %. Confidentiality of the patients was maintained, par-
ticipants were informed about their oral conditions, and
health education was provided. Those who needed dental
services were referred to the University of Science and
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gation and management. Written informed consent or fin-
ger print (illiterates) for participation and publication of the
study was obtained from patients or their parents/guar-
dians. The research conformed to the Helsinki Declaration,
and ethical clearance and approval letters were obtained by
the participating institutions’ committees in Sudan (UST
and KTH, Department of Dermatology). In Norway, the
ethical approval was obtained from the Regional Commit-
tee for Medical Research Ethics of Western Norway.
Survey instrument
A pilot study revealed a considerable number of illiterate
patients, and thus a structured questionnaire was interviewer
administered by two trained dentists. The interview schedule
contained questions regarding socio-demographics, health
and oral health related characteristics and lifestyles. The
interview schedule was constructed in English and then
translated and used in Arabic. Forward and backward trans-
lations were performed by two independent Sudanese pro-
fessional translators in Arabic and English language.
Sensitivity to culture and selection of appropriate words
were considered by use of simple common Arabic words.
OHRQoL was assessed using the eight items OIDP fre-
quency inventory [21,22]; ‘During the past 6 months, how
often have problems with your mouth and teeth caused you
any difficulty with: eating and chewing food; speaking and
pronouncing clearly; cleaning teeth; sleeping and relaxing;
smiling and showing teeth without embarrassment; main-
taining usual emotional state; carrying out major work and
social role, and enjoying contact with people?’. Each item
was assessed using a 5-point scale: (1) Never affected; (2)
Less than once a month; (3) Once or twice a month; (4)
Once or twice a week; (5) Every, or nearly every day. Ini-
tially, an additive sum score (OIDP ADD) was constructed
from the 8 items as originally scored (1–5, range 8–40).
Secondly, each OIDP frequency item was dichotomised,
yielding the categories: (0) never affected (including the ori-
ginal category 1), (1) affected (including the original cat-
egories 2, 3, 4, and 5). Simple count scores (SC) were
created for the OIDP by adding the eight dichotomised
variables. For the purpose of cross-tabulation and logistic
regression analysis, the OIDP SC scores (0–8) were dichot-
omised as 0=no daily performance affected and 1= at least
one daily performance affected. The distribution of the
OIDP SC scores supported this cut-off point.
Socio-demographic characteristics were assessed in term
of gender, age, education, tribes, marital status, and place
of residence. Gender was assessed as: (1) female; (2) male.
Age was recorded by asking, ‘how old are you?’ and the
answers were dichotomized into 2 equally sized groups;
(0) 18–32 years and (1) 33+ years. Participants were classi-
fied according to their educational level using five categor-
ies: (1) illiterate; (2) primary school; (3) secondary school;(4) university; (5) higher studies. Two dummy variables
were constructed yielding the categories 0= lower educa-
tion (including the original categories 1 and 2) and
1=higher education (including the original categories 3, 4,
and 5). Medical condition was assessed as a sum score of
the following: heart diseases, hypertension, asthma, dia-
betes, liver diseases, hepatitis /jaundice, anaemia, bleeding
disorders, kidney diseases, rheumatoid arthritis, allergy,
cancer, epilepsy, stomach ulcer, intestinal disorders, psy-
chiatric/mental disorders, respiratory disorders, and preg-
nancy. The sum scores were dichotomized into 0 =none
and 1=≥ one. Perceived health status was recorded from
(1) very bad to (4) very good. Two dummy variables were
created in terms of 0= good and 1=bad. Perceived oral
health status was measured using a 5-point rating by ask-
ing; ‘How do you consider the present condition of your
mouth and teeth?’ with response categories: (1) very bad;
(2) bad; (3) neither good nor bad; (4) good; (5) very good.
This variable was dichotomized in terms of 0= good (in-
cluding the original categories 4 and 5) and (1) = bad (in-
cluding the original categories 1, 2 and 3). Reported oral
symptoms were assessed by the question ‘During the pre-
vious 6 months have you experienced: dental pain/tooth-
ache, abscessed tooth, dry mouth, bleeding gums, infected
sore gums, tooth decay, or broken tooth. Each symptom
was assessed as present (1) and absent (0). Frequency of
dental attendance was assessed by asking ‘How many
times have you attended a dentist during the previous
2 years?’ with response categories: (1) once; (2) twice, (3)
more than twice; (4) never. A dummy bivariable was con-
structed yielding the response categories 1 = attended den-
tal clinic (including the original categories 1, 2 and 3) and
0=never attended dental clinic.
Clinical examination
Systematic comprehensive extra-oral and intra-oral clinical
examinations based on visual inspection and palpation, fol-
lowing the World Health Organization (WHO) criteria for
field surveys [32], were carried out by a dentist (NMS) who
received a standard training in diagnosis of OML before
the data collection (The Gade Institute, Section for Path-
ology, and Department of Clinical Dentistry, Section for
Oral Surgery and Oral Medicine, University of Bergen,
Norway). Caries experience was assessed under field condi-
tions and scored according to the criteria described by the
WHO [33]. A tooth was recorded as decayed when a cavity
was apparent on visual inspection. Missing tooth was
recorded if there was a history of extraction because of
pain and/ or a cavity prior to extraction. DMFT, was com-
puted as the sum of decayed, missing and filled teeth and
dichotomized into caries free DMFT=0 and having any
caries experience DMFT> 0. The oral clinical examination
and information with respect to OML and oral habits have
been detailed elsewhere [5].
Table 1 Socio-demographics, behavioural- and clinical characteristics of patients with mucocutaneous diseases
according to number of types of OML
No OML% (n) One type of OML% (n) > One type of OML% (n) Total% (n)
Gender
Female 56.3 (129) 49.5 (100) 38.1 (43) 50.0 (272)
Male 43.7 (100) 50.5 (102) 61.9 (70) 50.0 (272)
Age
Younger (18–32 years) 57.9 (132) 53.3 (105) 37.8 (42) 52.2 (279)
Older (33–85 years) 42.2 (96) 46.2 (90) 62.2 (69) 47.8 (255)
Education
Low 46.3 (105) 49.5 (97) 58.0 (65) 49.9 (267)
High 53.7 (122) 50.5 (99) 42.0 (47) 50.1 (268)
Systemic condition
None 62.4 (143) 50.0 (101) 46.9 (53) 54.6 (297)
≥ one 37.6 (86) 50.0 (101) 53.1 (60) 45.4 (247)
Perceived general health status
Bad 31.1 (71) 27.1 (54) 44.1 (49) 32.3 (174)
Good 68.9 (157) 72.9 (145) 55.9 (62) 67.7 (364)
Perceived oral health status
Bad 36.0 (82) 39.5 (79) 36.6 (41) 37.4 (202)
Good 64.0 (146) 60.5 (121) 63.4 (71) 62.6 (338)
Dental attendance
Never attended dental clinic 67.3 (152) 60.0 (120) 52.2 (59) 61.6 (331)
Attended dental clinic 32.7 (74) 39.4 (78) 47.8 (54) 38.4 (206)
Number of reported oral symptoms
None 18.2 (38) 15.0 (26) 11.2 (11) 15.6 (75)
≥ one 81.8 (171) 85.0 (147) 88.8 (87) 84.4 (405)
Specific reported oral symptoms
Dental pain (yes) 44.6 (100) 45.2 (89) 48.6 (54) 45.7 (243)
Tooth decay (yes) 58.7 (132) 50.8 (101) 65.5 (72) 57.1 (305)
Abscess (yes) 9.0 (20) 9.6 (19) 10.7 (12) 9.6 (51)
Broken tooth (yes) 14.4 (32) 19.1 (36) 11.4 (12) 15.5 (80)
Dry mouth (yes) 21.3 (48) 22.1 (43) 22.0 (24) 21.7 (115)
Bleeding gum (yes) 36.4 (83) 37.9 (75) 44.1 (49) 38.5 (207)
Infected sore gum (yes) 12.4 (28) 16.7 (32) 23.4 (26) 16.3 (86)
OML pain (yes) 1.3 (3) 19.3 (39) 11.5 (13) 10.1 (55)
DMFT
DMFT= 0 8.7 (20) 12.9 (26) 8.0 (9) 10.1 (55)
DMFT> 0 91.3 (209) 87.1 (176) 92.0 (104) 89.9 (489)
The total number in the different categories did not add to 544 owing to missing values.
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An OML was defined as any abnormal change or any
swelling on the oral mucosal surface. A single lesion with
confirmed diagnosis was referred to as a ‘type of OML’.
Diagnostic criteria for OML were based on Axéll criteria
and those defined in earlier studies and reviews [32,34,35].Statistical analysis
Data were analysed using PASW Statistics version 18.0
(SPSS Inc., Chicago). Non-parametric statistics were used
because the OIDP-total scores were not normally distribu-
ted. Bivariate relationships were assessed using cross-
tabulation, chi-square statistics and Mann Whitney - U
Table 2 Percentage distribution and mean scores (SD) for the eight OIDP frequency items and the OIDP ADD score in
skin diseased patients by number of types of OML
OIDP items No OML N=229 One type of OML N=202 > One type of OML N=113 Total population N=544
Affected% (n) Mean (SD) Affected% (n) Mean (SD) Affected% (n) Mean (SD) Affected% (n) Mean (SD)
Eating 26.4 (60) 1.7 (1.4) 33.0 (66) 2.0 (1.6) 39.8 (45) 2.2 (1.6) 31.7 (171) 1.9 (1.5)
Emotional state 16.2 (37) 1.5 (1.2) 25.9 (51) 1.8 (1.4) 30.4 (34) 1.9 (1.5) 22.7 (122) 1.7 (1.3)
Cleaning 17.1 (39) 1.5 (1.2) 23.4 (46) 1.7 (1.4) 26.8 (30) 1.8 (1.5) 21.4 (115) 1.6 (1.3)
Sleeping 12.7 (29) 1.3 (1.0) 18.3 (36) 1.5 (1.2) 16.2 (18) 1.5 (1.2) 15.5 (83) 1.4 (1.1)
Speaking 4.80 (11) 1.1 (0.6) 8.0 (16) 1.2 (0.8) 15.9 (18) 1.4 (1.1) 8.3 (45) 1.2 (0.8)
Contact people 4.40 (10) 1.1 (0.6) 9.5 (19) 1.3 (1.0) 10.6 (12) 1.3 (1.0) 7.6 (41) 1.2 (0.9)
Major work 4.40 (10) 1.1 (0.6) 7.7 (15) 1.2 (0.9) 9.8 (11) 1.3 (1.0) 6.7 (36) 1.2 (0.8)
Smiling 1.8 (4) 1.0 (0.4) 8.5 (17) 1.2 (0.8) 11.5 (13) 1.4 (1.2) 6.3 (34) 1.2 (0.8)
OIDP> 0 30.5 (69) 0.8 (1.5) 36.7 (72) 1.3 (2.1) 44.1 (49) 1.5 (2.3) 35.6 (190) 1.1 (1.9)
OIDP ADD 10.4 (4.8) 12.1 (7.2) 13.1 (8.4) 11.6 (6.7)
Means and % varied according to the total number of respondents in each OIDP item due to lack of information in 2–11 patients across the OIDP items.
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Cronbach’s alpha. To adjust for potential confounding fac-
tors, multiple variable logistic regression analyses were per-
formed and OR and Nagelkerkes R2 were calculated. The
relationship between OIDP and number of different types
of OML was assessed in unadjusted and fully adjusted
models. The relationship between OIDP and each type of
reported symptoms and OML disease groups was assessed
in unadjusted, fully adjusted and mutually adjusted models.
Result
Sample profile
A total of 544 patients with mucocutaneous diseases
participated in the present study. The mean age was
37.1 years, sd = 15.9 years (range 18–85), 50 % were
females, 77 % were permanent residents of Khartoum
during the previous 5 years, 47.8 % belonged to the older
age group (33–85 years) and 50.1 % reported higher edu-
cation. A total of 57.9 % of the patients were diagnosed
with at least one clinically recognized type of OML. Full
details of the prevalence of OML (types and group dis-
eases) of the participants studied are described elsewhere
[5]. A particular type of OML was recorded only once
although it could be manifested at several locations in
the same patient. The age of patients affected by OML
ranged from 18 to 81 years, with an average of 38.6 years
(sd = 16.5). A total of 6 OML group diseases, each in-
cluding at least 20 patients, were recognized for the
present study. Tongue lesions were the most frequently
diagnosed OML group diseases (23.3 %) followed in des-
cending order by white lesions (19.1 %), red and blue
lesions (11 %), vesiculobullous diseases (6 %), oral ulcera-
tive lesions (4.5 %) and pigmented lesions (3.9 %). Table 1
depicts the distribution of patients’ socio-demographic,
behavioural, oral symptoms and clinical features by
number of types of OML. As shown, a total of 89.9 %had caries experience, 84.4 % reported more than one
oral symptom and 45.5 % reported more than one sys-
temic health condition. The most and least frequently
reported conditions were tooth decay (57.1 %) and ab-
scess (9.6 %), respectively.
Psychometric properties of the OIDP
In the present study, small number of missing responses (2–
11) adds support to face validity of the OIDP frequency in-
ventory. As depicted in Table 2, One hundred and ninety
patients (35.6 %) perceived at least one oral impact (OIDP
> 0). The mean OIDP ADD was 11.6 (sd=6.7) The preva-
lence of any oral impact was 30.5 %, 36.7 % and 44.1 % in
patients with respectively, no OML, one type of OML and
more than one type of OML. A problem with eating was the
most frequently reported impact. Problems with work, con-
tact people, and smiling were the least frequently reported
impacts across the three OML groups as well as in the total
study group. As shown in Table 3, Cronbach’s alpha for the
OIDP in the study group was 0.89 with corrected item-total
correlation ranging from 0.57 (smiling) to 0.70 (emotional
state). The standardized items alpha in the separate groups
was 0.81 (no OML), 0.89 (one type of OML) and 0.92 (>
one type of OML). The corrected item-total correlation
across the three groups was above the minimum level of 0.2
required for including an item into a scale [36].
The association between the frequency of oral impacts
(OIDP total >0) and factors known to be associated with
oral health; socio-demographic-, clinical and behavioural
variables were assessed using cross tabulation and multiple
variable logistic regression analyses. As depicted in Table 4,
the frequency of subjects having at least one impact (OIDP
> 0) increased significantly with increasing number of types
of OML both in unadjusted and adjusted analysis with sub-
jects having more than one type of OML being about twice
as likely as their counterparts without OML to report oral
Table 3 Corrected item total correlation and Cronbach’s
alpha of OIDP by number of types of OML
No OML (N=226) Cronbach's Alpha (Standardized Items) = 0.811
OIDP items Corrected Item-Total
Correlation
Cronbach's Alpha
if Item Deleted
Eating .675 .757
Speaking .447 .792
Cleaning .592 .767
Smiling .269 .808
Sleeping .634 .759
Emotional state .655 .755
Carrying out major work .564 .779
Contact .391 .796
One type of OML (N = 196)
Cronbach's Alpha (Standardized Items) = 0.894
Eating .721 .867
Speaking .586 .878
Cleaning .713 .865
Smiling .614 .876
Sleeping .715 .865
Emotional state .680 .870
Carrying out major work .646 .874
Contact .683 .870
> One type of OML (N = 111)
Cronbach's Alpha (Standardized Items) = 0.921
Eating .700 .909
Speaking .711 .906
Cleaning .751 .902
Smiling .657 .910
Sleeping .751 .902
Emotional state .779 .900
Carrying out major work .766 .903
Contact .747 .904
Total study population (N= 533)
Cronbach's Alpha (Standardized Items) = 0.890
Eating .694 .863
Speaking .606 .869
Cleaning .692 .859
Smiling .572 .872
Sleeping .698 .858
Emotional state .703 .858
Carrying out major work .671 .864
Contact .642 .866
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tus remained statistically significantly associated with OIDP
after having included all variables in the model. Multiple lo-
gistic regression analysis revealed that socio-demographic,behavioural variables and medical conditions entered in the
first step explained 20 % of the variance (Nagelkerke
R2=0.20). Entering number of types of OML in step 2 raised
the explainable variance by 1 % (Nagelkerke R2=0.21).
As shown in Table 5, six out of eight specific symptoms
were associated with impaired OHRQoL in adjusted logis-
tic regression analyses. When all reported symptoms were
accounted for, only OML pain (OR 10.3, 95 % CI 4.2-25.4),
infected sore gums (OR 4.1, 95 % CI 1.9-8.6), dental pain
(OR 3.1, 95 % CI 1.8-5.3) and tooth decay (OR 1.8, 95 % CI
1.0-3.1) remained statistically significantly associated with
OIDP. Pain associated with mucosal lesion had the stron-
gest impact OR 10.2 (95 % CI 4.2-25.0), and dry mouth the
weakest impact OR 0.9 (95 % CI 0.4-1.7) on OIDP. As
depicted in Table 6, the OML disease groups of vesiculo-
bullous and ulcerative lesions discriminated statistically sig-
nificantly between subjects with and without OIDP in
adjusted as well as in mutually adjusted logistic regression
analyses. A total of 72.4 % versus 33.5 % (p< 0.001) of the
participants with and without vesiculobullous lesions and
77.3 % versus 33.9 % of participants with and without oral
ulcerative lesions (p< 0.001) had oral impacts on their daily
performances. When adjusting for socio-demographics,
subjects with vesiculobullous lesions were 7.4 times OR 7.4
(95 % CI 2.9-18.8) and subjects with oral ulcerative lesions
were 5.7 times OR 5.7 (95 % CI 1.9-16.9) more likely than
their counterparts without those OML disease groups to re-
port oral impacts. The corresponding mutually adjusted
ORs were 8.2 (95 % CI 3.2-20.9) and 6.7 (95 % CI 2.2-20.0).
Discussion
This is the first study considering OHRQoL in patients
with various mucocutaneous diseases, using an Arabic
version of the OIDP frequency inventory. Arabic versions
of OHRQoL instruments such as the Oral Health Impact
Profile (OHIP-14), the Geriatric Oral Health Assessment
Index (GOHAI) and the OHQoL-UK inventory have been
reported to be reliable and valid for use in adult popula-
tions from Saudi Arabia, Egypt and Syria [37–39]. The
results of this study indicate that, when used with patients
having mucocutaneous diseases, the Arabic OIDP version
is valid and reliable demonstrating psychometric proper-
ties similar to the original English version [27] as well as
the Thai [26], Greek [28] and Norwegian versions of the
OIDP [40]. Moreover, the OIDP has shown to be usable
across various subgroups of the Sudanese population
[30,31], first applied as a self-administered questionnaire
in dental attendees from the general population, secondly
in personal interviews with schoolchildren and more re-
cently in personal interviews with patients in a dermatolo-
gic clinic. Thus, internal consistency reliability in terms of
Cronbach’s alphas of 0.89 was satisfactory and well above
the recommended level of 0.70 [36]. Moreover, the cor-
rected item-total correlation coefficients were above the
Table 4 Unadjusted and adjusted associations of OIDP with socio-demographics, behaviours and number of types of
OML in skin diseased patients (n = 544). Percentage (n), odds ratio (OR) and 95 % Confidence Interval (CI)
Variables OIDP> 0N=190% (n) Unadjusted OR (95 % CI) Adjusted OR (95 % CI)
Gender
Male 30.7 (81) 1 1
Female 40.5 (109)* 1.5 (1.0-2.2) 1.4 (0.9-2.1)
Age
18-32 yr 34.7 (95) 1 1
33-85 yr 36.4 (91) 1.0 (0.7-1.5) 0.9 (0.6-1.5)
Education
Lower 31.2 (82) 1 1
Higher 39.3 (103)* 1.4 (0.9-2.0) 1.4 (0.9-2.3)
Perceived oral health status
Good 24.5 (82) 1 1
Bad 54.8 (108)** 3.7 (2.5-5.4) 2.9 (1.9-4.5)**
Perceived health status
Good 30.5 (110) 1 1
Bad 46.7 (79) ** 2.0 (1.3-2.9) 1.5 (0.99-2.4)}
Dental attendance
Never attended dental clinic 27.4 (90) 1 1
Attended dental clinic 48.8 (98)** 2.5 (1.7-3.6) 2.3 (1.5-3.5)**
Medical conditions
None 30.1 (87) 1 1
At least one 42.2 (103)* 1.6 (1.1-2.4) 1.3 (0.8-2.1)
Number of types of OML ♯
None 30.5 (69) 1
One 36.7 (72) 1.2 (0.7-1.9)
>one 44.1 (49)* 1.8
(1.1-3.2)*
* p< 0.05, ** p< 0.001, } p = 0.05)
♯ Number of types of OML; no OML (p = 0.06), one type OML (p = 0.3), >one type OML (p = 0.02)
The sum of the categories listed may not equal the total number due to lack of information.
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across patients with and without OML [36]. Although no
approach guarantees cross-cultural equivalence, the
Arabic version of OIDP seemed to preserve the overall
concepts of the English version and did not differ in terms
of sequence of questions, the Likert scale and the recall
memory period (6 months) used. Notably, the respondents
had few difficulties in completing the 8 item OIDP inter-
view. This highlights the feasibility of employing the
Arabic version of the OIDP frequency inventory in oral
medicine and dermatologic clinical settings in Sudan. Rec-
ognizing the frequency and severity of the OIDP scores to
have similar predictive power, using the OIDP frequency
score in this study, should be the better single choice be-
cause of its better reproducibility [22]. However, the de-
gree of impact could not be accounted for by this model.
According to the present results, the frequency of oral
impacts varied systematically and in the expecteddirection with self-reported oral health status, clinical
dentition status and number of reported oral symptoms
across patients having none, at least one and more than
one type of OML. Moreover, patients having more than
one type of OML were more likely to report oral
impacts than their counterparts without OML and with
only one type of OML, suggesting a cause – effect rela-
tionship. Notably, cross-sectional studies cannot provide
definite information about cause - and- effect relation-
ships since both predictor and outcome variables have
been measured at the same point in time. Longitudinal
studies are needed to improve the interpretation of fac-
tors influencing OIDP in adult patients with OML. The
moderate fit of the overall multivariable model indicates
that other essential variables were not included in the
model. Types of OML have fluctuated from asymptom-
atic lesions (snuff dipper lesions) to the most chronic
and painful one (oral pemphigus vulgaris) [5]. In the
Table 5 Unadjusted, adjusted and mutually adjusted associations of OIDP with reported oral symptoms in skin
diseased patients (n =544). Percentages (n), odds ratios (OR) and 95 % confidence interval (CI)
Reported symptoms
previous 6 months
OIDP> 0% (n) Unadjusted OR
(95 % CI)
Adjusted aOR
(95 % CI)
Mutually adjusted bOR
(95 % CI)
Dental pain
No 20.0 (57) 1 1 1
Yes 55.2 (132)** 4.9 (3.3-7.2) 4.3 (2.8-6.6)** 3.1 (1.8-5.3)**
Tooth decay
No 21.8 (49) 1 1 1
Yes 46.4 (140)** 3.1 (2.1-4.5) 2.8 (1.8-4.3)** 1.8 (1.0-3.1)*
Abscess
No 31.7 (150) 1 1 1
Yes 74.0 (37)** 6.1 (3.1-11.8) 4.7 (2.3-9.5)** 2.3 (1.0-5.3)*
Broken tooth
No 36.2 (155) 1 1
Yes 35.4 (28) 0.9 (0.5-1.5) 0.8 (0.4-1.4) - -
Dry mouth
No 32.7 (133) 1 1 1
Yes 46.5 (53)* 1.7 (1.1-2.7) 1.5 (0.9-2.4) 0.9 (0.4-1.7)
Bleeding gum
No 27.0 (88) 1 1 1
Yes 49.3 (100)** 2.6 (1.8-3.7) 2.5 (1.6-3.7)** 1.3 (0.7-2.2)
Infected sore gum
No 27.8 (122) 1 1 1
Yes 78.0 (64)** 9.2 (5.2-16.2) 7.4 (4.0-13.4)** 4.1 (1.9-8.6)**
OML pain
No 31.3 (151) 1 1 1
Yes 76.5 (39)** 7.1 (3.6-13.9) 11.2 (5.2-23.9)** 10.3 (4.2-25.4)**
Number of symptoms
None 9.6 (7) 1 1
At least one 41.0 (164)** 6.5 (2.9-14.6) 6.7 (2.6-17.5)**
*p< 0.05, **p< 0.001
a) Adjusted for sex, age, education, perceived health status, dental attendance and medical condition.
b) Adjusted for sex, age, education, perceived health status, dental attendance, medical condition and other symptoms.
The sum of the categories listed may not equal the total number due to lack of information.
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considered as chronic OML has proven to decrease
quality of life [41].
Both type and number of reported oral symptoms dis-
criminated between patients with and without oral
impacts (OIDP> 0). Dental attendance was one of the
strongest predictors of oral impact in this study.The as-
sociation between dental attendance and improved oral
health has been widely documented [42]. However, in
this study, dental attendance was associated with dete-
riorated OHRQoL.That pattern might reflect perceived
treatment need among the study population [43]. This is
consistent with results reported previously [44,45] . Al-
though pain was the second less commonly reportedsymptom, it emerged as the strongest predictor of oral
impacts among the symptoms investigated both in
adjusted and mutually adjusted logistic regression ana-
lyses. This is consistent with the multidimensional na-
ture of pain that affect physical, social and psychological
well-being [10,46]. In the context of oral health, oral
pain influences eating, drinking, and other oral every
day activities. Conversely, the highly prevalent condition
of tooth decay had a small negative impact on OIDP.
This might be attributed to the fact that patients learn
to cope with commonly occurring symptoms and condi-
tions that become less disabling with recurrence.
The present results corroborate findings with other
OHRQoL measures. Generic OHRQoL measures
Table 6 Models for the association between OML disease groups and OIDP (n =544)
OML disease
groups
N OIDP> 0N=190%
(n)
Unadjusted OR
(95 % CI)
AdjustedaOR
(95 % CI)
Mutually adjustedbOR
(95 % CI)
Tongue lesions
No 417 34.8 (142) 1 1
Yes 127 38.4 (48) 1.1 (0.7-1.7) 1.0 (0.6-1.6)
White lesions
No 440 34.7 (149) 1 1
Yes 104 39.8 (41) 1.2 (0.8-1.9) 1.3 (0.7-2.1)
Red and blue lesions
No 484 36.1 (171) 1 1
Yes 60 32.3 (19) 0.8 (0.4-1.4) 0.9 (0.9-1.0)
Vesiculobullous lesions
No 513 33.5 (169) 1 1 1
Yes 31 72.4 (21)** 5.2 (2.2-11.9) 7.4 (2.9-18.8)** 8.2 (3.2-20.9)**
Oral ulcerative lesions
No 520 33.9 (173) 1 1 1
Yes 24 77.3 (17)** 6.6 (2.4-18.3) 5.7 (1.9-16.9)* 6.7 (2.2-20.0)*
Pigmented lesions
No 523 35.7 (183) 1 1
Yes 21 35.0 (7) 0.9 (0.3-2.4) 0.7 (0.2-2.3)
*p< 0.05, **p< 0.001
a) Adjusted for sex, age, education, perceived health status, dental attendance and medical condition.
b) Adjusted for sex, age, education, perceived health status, dental attendance, medical condition and other OML disease groups.
The sum of the categories listed may not equal the total number due to lack of information.
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valid and reliable in patients with oral lichen planus
(OLP) [10]. Moreover, oral health in patients with symp-
tomatic OLP was reported to have an increased burden
on their life quality compared to those with non-
symptomatic OLP. Mc Grath et al [8] found that
patients with ulcers, erosions and symptomatic oral
lesions had bad OHIP-14 scores, suggesting that they
had increased quality of life impairments compared to
their counterparts with non-symptomatic lesions. Simi-
lar results have been presented in studies of patients
with Behçet’s disease using the OHIP-14 inventory [47].
In another study of UK patients, attending an outpatient
oral medicine clinic, Llewellyn et al [9] found that
patients with stomatological disease to have higher levels
of functional limitations, physical pain and psychological
discomfort than the general population. Oral ulceration
associated with Behçet's disease and recurrent aphthous
stomatitis (RAS) have been reported to impair life satis-
faction and the performance of daily activities [11,13]. A
Spanish study comparing OHRQoL in patients with
OLP with healthy controls concluded that impairments
were greatest in the former group of patients across all
dimensions of the OHIP inventory [14]. According to
this study results, about 30-40 % of the patients with theOML disease groups of tongue lesions, white lesions,
red and blue lesions and pigmented lesions reported oral
impacts. On the other hand, the impact frequency
among patients suffering oral ulcerative conditions and
vesiculobullous diseases amounted to 77 % and 72 %, re-
spectively. A previous study revealed that RAS and pem-
phigus vulgaris were the most frequently occurring
diagnosis among oral ulcerative conditions and vesiculo-
bullous diseases in mucocutaneous diseased patients
attending the KTH [5] . Evidence that RAS has the high-
est impact on patients’ quality of life as compared to
other oral mucosal diseases in dermatology patients has
been shown elsewhere [13]. The present findings suggest
that practitioners should notify type and number of
OML and reported symptoms when making their treat-
ment plan for this category of patients.
This study suggests that Sudanese patients with muco-
cutaneous diseases suffer moderate impairments of their
OHRQoL, which is measureable by the Arabic version
of the generic OIDP inventory. Moreover, eating, emo-
tional problems and cleaning were the most frequently
reported impacts, followed by problems with sleeping
and speaking across subjects with and without OML.
This compares to what has been observed among subjects
with other medical conditions as well as with subjects from
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countries [25,40,48]. The present frequency of OIDP ran-
ging from 30 % to 44 % is comparable to the estimates of a
national Greek survey (39 %), but is higher than those
reported from national surveys in Norway (18 %) and
Great Britain (12 %) [28,40]. On the other hand, this figure
is lower than those observed in older adults in other cul-
tures (50-60 %) [26], and from dental attendees in Khar-
toum (79 %) [31]. The present figures are also lower than
those observed among Swedish adult patients (50-54 %)
reporting regular medication according to the Anatomical
Therapeutic Chemical classification system and having spe-
cific diagnoses of diseases categorized according to the
WHO International Classification of Diseases, the ICID-10
[48].
Some limitations should be considered when interpret-
ing the results. First, the cross sectional design restricts
ability to make inferences with respect to the direction
of the observed associations. Secondly, being a hospital
based study; it is not possible to generalize findings to
any larger population of mucocutaneous diseased indivi-
duals inside or outside Khartoum. Nevertheless, as KTH
is the largest public main referral hospital in Sudan, re-
ceiving patients referred from all district in Sudan, the
dermatology clinic-outpatients may capture the variety
in characteristic of patients with skin diseases. In
addition, self- reports and a recall period of 6 months
can result in underestimation of health consequences,
but might provide valid estimate for ultimate impact
[49]. Self-selection and non-response bias might have
influenced the results as patients were probably more
likely to respond when they had OML. The present
study suffered from lack of information regarding non-
responders and thus non –response biases are difficult
to estimate. Moreover, with respect to the diversity of
the types of OML, the present figures might be biased
towards those for which people are more inclined to
seek treatment, whereas other conditions are less likely
to be identified in hospital based prevalence studies. Ab-
sence of normative OIDP scores of the general Sudanese
adult population, further limits possibility to use the
general population as control group. Moreover, it should
be acknowledged that the observations related to specific
types of OML disease groups were based on small num-
bers and that the reported impacts cannot be attributed
to specific diseases, symptoms and lesions. On the other
hand, the generic OIDP scores might be compared
across oral diseases and across specific patient groups
and the general population. A generic OHRQoL instru-
ment, such as the OIDP could help dermatologists to
detect oral impacts, improve the patient doctor commu-
nication and provide the basis for better management of
the dermatological patients, involving patients’ as well as
the doctors’ perspectives.Conclusions
OIDP was more frequently affected among skin diseased
patients with than without OML. The frequency of the
impacts differed according to the number of type of
OML, oral symptoms, and OML disease groups. Den-
tists and dermatologists should pay special attention to
skin diseased patients because they are likely to experi-
ence oral impacts on daily performances.
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pemphigus lesions in patients with skin diseases:
a cross sectional study from Sudan
Nada M Suliman1*, Anne N Åstrøm2, Raouf W Ali3, Hussein Salman4 and Anne C Johannessen1,5Abstract
Background: Pemphigus is a rare group of life-threatening mucocutaneous autoimmune blistering diseases.
Frequently, oral lesions precede the cutaneous ones. This study aimed to describe clinical and histological features
of oral pemphigus lesions in patients aged 18 years and above, attending outpatient’s facility of Khartoum Teaching
Hospital - Dermatology Clinic, Sudan. In addition, the study aimed to assess the diagnostic significance of routine
histolopathology along with immunohistochemical (IHC) examination of formalin-fixed, paraffin-embedded biopsy
specimens in patients with oral pemphigus.
Methods: A cross-sectional hospital-based study was conducted from October 2008 to January 2009. A total of 588
patients with confirmed disease diagnosis completed an oral examination and a personal interview. Clinical
evaluations supported with histopathology were the methods of diagnosis. IHC was used to confirm the diagnosis.
Location, size, and pain of oral lesions were used to measure the oral disease activity.
Results: Twenty-one patients were diagnosed with pemphigus vulgaris (PV), 19 of them (mean age: 43.0; range:
20–72 yrs) presented with oral manifestations. Pemphigus foliaceus was diagnosed in one patient. In PV, female:
male ratio was 1.1:1.0. Buccal mucosa was the most commonly affected site. Exclusive oral lesions were detected in
14.2% (3/21). In patients who experienced both skin and oral lesion during their life time, 50.0% (9/18) had oral
mucosa as the initial site of involvement, 33.3% (6/18) had skin as the primary site, and simultaneous involvement
of both skin and oral mucosa was reported by 5.5% (1/18). Two patients did not provide information regarding the
initial site of involvement. Oral lesion activity score was higher in those who reported to live outside Khartoum
state, were outdoor workers, had lower education and belonged to Central and Western tribes compared with their
counterparts. Histologically, all tissues except one had suprabasal cleft and acantholytic cells. IHC revealed IgG and
C3 intercellularly in the epithelium.
Conclusions: PV was the predominating subtype of pemphigus in this study. The majority of patients with PV
presented with oral lesions. Clinical and histological pictures of oral PV are in good agreement with the literature.
IHC confirmed all diagnoses of PV.
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Pemphigus is a group of chronic inflammatory auto-
immune bullous diseases. Although rare, they are poten-
tially life-threatening diseases that are associated with
high morbidity and mortality, if not properly treated [1,2].
The disease is associated with immunoglobulin (Ig) G and
complement factor (C) 3 antibodies against intercellular
adhesion structural components in the epithelium [3].
The immune reaction eventually breaks down the ad-
hesion components and leads to epithelial cell detach-
ment, which is clinically seen as intraepithelial blisters,
erosions or ulcers in the skin and mucous membranes
[4]. The underlying cause and activating mechanism
that initiates the immune response is unidentified.
However, both genetic and environmental factors have
been postulated to play a role in the pathogenesis of
pemphigus [5]. In this context, social habits like use of
traditional cosmetics and smoking have been impli-
cated [6-8].
Pemphigus has several subtypes, of which three have
been associated with oral mucosal involvement; pemphigus
vulgaris (PV), pemphigus foliaceus (PF), and paraneoplastic
pemphigus [9]. The first two subtypes are differing with
respect to the localization of intraepithelial blisters. In
PV, the blisters are located suprabasally, while in PF
they are more superficially located. Paraneoplastic pem-
phigus, although uncommon, is associated with internal
malignant neoplasia [10].
Oral lesions present as vesicles or bullae that quickly
break, leaving painful erosions or ulcers with irregular
borders; they most often affect buccal mucosa and gingi-
vae and heal slowly, without scarring. In PV, the oral le-
sions are reported as the initial sign of the disease in
50% of patients, yet these oral lesions have the greatest
resistance to efficient treatment.
PV is the most predominant type of pemphigus, affects
middle-aged adults without gender predilection [9,11-16]
and has an incidence varying from 0.76 to 32 per million
inhabitants per year [17-19]. While PV is a prevailing
diagnosis in the Mediterranean region, South Asia and
in the Jewish population [20,21], it is a rare disease in
Northern Europe, USA, South Africa and northern re-
gion of Africa [6,18,19,22-24]. Reports from Mali and
South Africa have shown that PV is rare in the black
ethnicity [22,24].
Diagnosis of pemphigus is based on careful correlation
of disease history and clinical findings with histopatho-
logic characteristics. Direct immunofluorescence (DIF)
on sections from a fresh frozen biopsy or indirect im-
munofluorescence (IIF) performed on patient’s serum
are important for verifying the diagnosis [25]. However,
in situations where IF is difficult to perform, immuno-
histochemistry (IHC) on formalin-fixed tissue samples
may be an alternative test to confirm the diagnosis [26].A study conducted in a dermatology clinic of
Khartoum Teaching Hospital (KTH) in Sudan in 1998,
focusing mainly on skin lesions, showed that PV was the
dominant variant of pemphigus, constituting 88% of all
cases diagnosed [27]. According to that study, oral mu-
cosa was the second most common site of the lesion to
occur after the trunk. The highest frequency of PV was
found in the third decade of life [27]. Another study
conducted in the same clinic in 2008, revealed a preva-
lence of oral PV of 2.8% among skin diseased outpatient
attendees [28]. This study also showed that the fre-
quency of oral PV among patients with skin disease
with any oral mucosal lesions was 4.8%. In both stud-
ies, clinical information and conventional histological
examination of biopsies using haematoxylin and eosin
(H&E) staining were the only methods for diagnosing
skin lesions.
Sudan is a large country with a multi-cultural multi-
ethnic society. The prevailing ethnicities are Arabic and
African, with hundreds of tribal divisions. The epidemio-
logic profile is typical of Sub-Saharan African countries;
malaria, infectious diseases, hypertension, diabetes melli-
tus, and nutrition disorders are among the prominent
diseases treated in the health units of Sudan [29]. On
the basis of these considerations and due to the scarce
information available regarding pemphigus in sub-
Saharan African populations, the present study, present-
ing a further analysis of the data conducted in 2008 [28],
aimed to describe clinical presentation of patients with
oral pemphigus attending the dermatologic clinic of
KTH. Given the fact that conventional histology was the
only diagnostic tool in public hospitals in Sudan, the
study also evaluated the diagnostic significance of com-
bining this technique with IHC analysis of the formalin-
fixed, paraffin-embedded oral biopsy specimens.
Methods
Sampling procedure
A cross sectional hospital based study was carried out
focusing on patients aged ≥18 years with mucocutaneous
diseases, attending an outpatient dermatologic clinic at
KTH from October 2008 to January 2009. KTH is the
largest national hospital in Sudan, located in Khartoum,
the capital city. It is an open public and referral hospital,
receiving patients from all the states of the country. For
the present study, a minimum sample size of 500 pa-
tients was calculated based on an assumed prevalence of
oral mucosal lesions (OML) in patients with skin dis-
eases of 5%, a confidence interval of 95%, and an abso-
lute precision of 0.02 [30]. All patients (n = 4235)
attending the outpatient facility during the survey period
were invited to participate in the study. A total of
1540 subjects (36.4%) initially accepted to participate.
Fear of taking biopsy for asymptomatic lesions and
Suliman et al. BMC Oral Health 2013, 13:66 Page 3 of 12
http://www.biomedcentral.com/1472-6831/13/66time consuming examinations (oral examination, inter-
view, and biopsy when needed) were the main reasons
for not volunteering to participate. Of those who ini-
tially accepted to participate, 588 (588/1540, 38.1%)
patients were finally included in the study.
Confidentiality of the patients was maintained, partici-
pants were informed about their oral conditions, and
health education was provided. Those who needed den-
tal services were referred to the clinics of the Faculty of
Dentistry, University of Science and Technology (UST),
Umdurman, for further investigation and management.
Written informed consent or finger print (illiterates) for
participation and publication of the study was obtained
from patients or their parents/guardians. The research
conformed to the Helsinki Declaration, and ethical clear-
ance and approval letters were obtained from the partici-
pating institutions’ committees in Sudan (UST and KTH,
Department of Dermatology) and Norway (The Regional
Committee for Medical Research Ethics of Western
Norway).
Socio-demographic characteristics and clinical
examination
A structured questionnaire was administered by two trained
dentists in face to face interviews. Socio-demographic
characteristics were measured in terms of gender, age,
tribe, occupation, marital status, place of residence and
oral habits. Participants were also asked about history of
PV among first-degree relatives (parents, grandparents,
siblings, children, and grandchildren). Medical condition
and treatment were assessed according to the following
conditions: heart diseases, hypertension, asthma, diabetes,
liver diseases, hepatitis /jaundice, anaemia, bleeding disor-
ders, kidney diseases, rheumatoid arthritis, allergy, cancer,
epilepsy, stomach ulcer, intestinal disorders, respiratory
disorders, pregnancy, psychiatric treatment, radiotherapy
and chemotherapy. Furthermore, the patients were asked
if their medical condition was diagnosed by a specialist
and if they were under medication.
An expert dermatologist (HS) evaluated the patient’s
skin diseases based on history of the disease and clinical
findings, and the diagnosis was subsequently confirmed
by histological examination when it was considered ne-
cessary. Details of involved sites at presentation and clin-
ical course of the lesions were registered.
Systematic comprehensive extra-oral and intra-oral clin-
ical examinations based on visual inspection and palpa-
tion, following the World Health Organization (WHO)
criteria for field surveys [31], were carried out by a dentist
(NMS) who received a training in diagnosis of OML be-
fore the data collection (The Gade Institute, Section for
Pathology, and Department of Clinical Dentistry, Section
for Oral Surgery and Oral Medicine, University of Bergen,
Norway). An OML was defined as any abnormal changeor any swelling in the oral mucosal surface. Diagnostic
criteria for OML were based on Axéll’s criteria and
those defined in former studies and reviews [31-33].
The oral clinical examination and additional informa-
tion with respect to OML and oral habits have been re-
ported elsewhere [28]. Data on location, size, clinical
presentation of the oral lesion (vesicle, erosion/ulcer)
and clinical course were recorded. Skin lesions and oral
lesions were encountered during the survey and were
photographed using a digital camera (Canon EOS
400D). Final diagnoses of all biopsies were given by an
expert oral pathologist (ACJ).Assessment of clinical oral lesions’ activity
To assess the clinical severity of the oral lesions, an oral
lesion activity score (OLAS) was constructed. The score
was based on three components. Firstly, clinical exten-
sion of the OML was assessed. A modified system based
on an established protocol [34] was used to register the
extension of an oral lesion at10 anatomical locations;
upper lip, lower lip, gingival mucosa, unilateral buccal
mucosa, bilateral buccal mucosa, tongue, floor of the
mouth, hard palate, soft palate and oropharynx. Each lo-
cation was assessed as 0 = no lesion, 1 = presence of le-
sion, resulting in a total score ranging from 0 to 10.
Secondly, size of the lesion was determined according to
the largest diameter of a lesion at any location present at
examination and scored as; 1 < 1 cm, 2 ≥ 1 cm. Thirdly,
severity of symptoms was evaluated by asking patients to
describe any pain associated with eating and drinking
and was reported as: 0 = no pain, 1 =mild to moderate
pain, and 2 = severe pain. Based on a former report [35],
the OLAS for each patient was constructed as the sum
of objective score (location, size) and subjective score
(pain), ranging from 1 to 14, and reported in terms of
means.Assessment of oral tissue biopsy
Oral tissue biopsies were taken from the periphery of
the lesions. The tissue was fixed in formalin and embed-
ded in paraffin. Sections were stained with hematoxylin
and eosin (H&E) and examined using light microscope.
To evaluate inflammation, number of inflammatory cells
(mononuclear and polymorphonuclear cells) in the
superficial parts of the connective tissue adjacent to the
tip of the epithelial rete ridges, were counted in 6 ran-
dom fields (one field = 250 μm2) per section using an
ocular grid and high power magnification (40 ×). The in-
flammatory cells were counted 3 times per each field,
and results were expressed as a mean per specimen
(mean ± SD/1500 μm2). The variation of degree of in-
flammation between specimens was evaluated.
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paraffin-embedded oral tissue
IHC for IgG and C3 was performed on formalin-fixed,
paraffin-embedded oral mucosal specimens from 11 pa-
tients. Sections, 4 μm-thick, were cut on a Leica RM2155
microtome and mounted on glass slides (Super Frost Plus,
Gerhard Menzel Gmbh, Germany) and heated at 56°C
overnight. The sections were deparaffinized in xylene and
rehydrated in alcohol. For C3c, sections were incubated in
target retrieval solution (pH6, S1699, DAKO, Glostrup,
Denmark), microwaved for 15 minutes after the buffer
had come to a boil, then let to cool down on bench and
thereafter washed slightly under running tap water for
5 minutes. Primary anti-human C3c polyclonal rabbit
compliment (A0062, DAKO) at 1:15000 dilutions was
incubated for 30 minutes at room temperature. For IgG,
sections were incubated in epitope retrieval solution
(proteinase type XXIV bacterial, Sigma P 8038 37) for
10 minutes at 37°C. Primary antibody polyclonal rabbit
anti-human IgG (A 0423, DAKO) at 1:60000 dilutions
were incubated for 60 minutes. Endogenous peroxidase
activity was blocked by 0.03% hydrogen peroxide (H2O2)
(S2023, DAKO) for 7 minutes. Detection was performed
using peroxidase labeled polymer conjugated to goat anti-
rabbit/mouse immunoglobulins (K5007, Envision +W,
DAKO) for 30 minutes. Between each of the above steps,
sections were washed with tris-buffered saline with Tween
(TBST, pH 7.6, S3306, DAKO) for 10 minutes. Reaction
was then visualized using 3, 3′- diaminobenzidine (DAB)
(K5007, DAKO). The sections were thereafter counter-
stained with hematoxylin (S3301, DAKO), dehydrated and
mounted with a non-aqueous mounting medium (Eukitt,
O.Kindler GmbH & Co., Freiburg, Germany).
Statistical analysis
Descriptive statistical analysis was done using PASW
Statistics version 18.0 (SPSS Inc., Chicago, USA).
Results
A total of 588 outpatients participated in the study. Out
of those participants, there were 22 patients with pem-
phigus, where PV was the most frequent disease (95.4%,
21/22) followed by PF (4.5%, 1/22). Fourteen patients
(63.6%, 14/22) were already diagnosed, coming with new
active lesions, while 7 patients (31.8%, 7/22) were newly
diagnosed cases. In one patient there was no information
about disease history. Of the 588 patients, 359 had at
least one type of OML, while oral PV was registered in
19 patients.
Demographic features of patients with oral PV
Of the 19 patients diagnosed with oral PV (mean age
43.0, range 20–72 yrs), 10 were females (mean age,
35.8 yrs) and 9 were males (mean age, 38.3 yrs). None ofthe females were pregnant. As shown in Table 1, the ma-
jority of the patients were <50 yrs (68.4%), low education
(84.2%), married (77.8%), had outdoor jobs (52.6%), and
were residing outside the Khartoum state (57.9%). Pa-
tients who reported Western tribes were 47.4% (9/19)
compared to 21% (4/19) from Northern tribes, 26.3%
(5/19) from Central tribes and only one reported Southern
tribes. Totals of 11.1%, 21.1%, and 10.5% confirmed use of
toombak, smoking and use of alcohol, respectively. These
habits were exclusively reported by males.
History and aggravating factors
Negative family history (first degree- relatives) was re-
ported by all patients. The systemic conditions reported
by the patients included hypertension (5 patients), intes-
tinal problems (4 patients), and allergy, anaemia, arth-
ritis, and diabetes each was reported by 3 patients.
Moreover, peptic ulcer, hepatitis, thyroid and liver dis-
eases were reported by one patient each. No neoplastic
diseases were recorded. Aggravating factors like eating
spicy food, stress and smoking were reported by 3 patients.
Concerning medications, one patient had taken penicillin
and another one co-trimoxazole before eruption of the
disease. All patients were scheduled to be treated with sys-
temic steroids.
Clinical presentation of oral lesions of PV
At time of examination, 76.1% (16/21) of the patients
with PV had both oral and skin lesions. Exclusively oral
lesions were observed in three females 14.2% (3/21), and
a former history of skin lesions was reported by two of
them. In patients who experienced both skin and oral le-
sions during their life time, 50.0% (9/18) had oral mu-
cosa as the initial site of involvement, 33.3% (6/18) had
skin as the primary site, and simultaneous involvement
of both skin and oral mucosa was reported by 5.5% (1/18).
Two patients did not provide information regarding the
initial site of involvement. In addition to oral lesions, ex-
tremities and trunk were the most common cutaneous
sites involved followed by scalp, genitalia and eyes. As
shown in Figure 1, bilateral buccal mucosa was the most
commonly affected site followed by hard palate. The
sites least affected were oropharynx and unilateral buc-
cal mucosa. The clinically predominant oral lesions
were mucosal erosions and ulcers. Vesicles were evident
in one patient only.
Oral lesions which were > 1 cm in diameter were regis-
tered in 52.6% (10/19), and those which were ≤ 1 cm in
diameter were registered in 47.4% (9/19) of patients.
Pain was reported as severe by 43.8% (7/16), moderate
by 37.5% (6/16) and no pain by 16.7% (3/18) of patients.
Missing information was noted in each category of pain
description. With respect to the OLAS total scores,
scores 3 and 4 were registered in one patient each
Table 1 Socio-demographic distribution of study participants with oral PV according to gender and means of oral
lesions activity scores (OLAS)
Female Male OLAS
n (%) n (%) n (Mean ± SD)
Age
< 50 years 8 (80.0) 5 (55.6) 11 (8.7 ± 3.5)
≥ 50 years 2 (20.0) 4 (44.4) 5 (8.6 ± 2.3)
Education
Low education (illiterate + primary) 9 (90.0) 7 (77.8) 13 (9.3 ± 2.8)
High education 1 (10.0) 2 (22.2) 3 (6.0 ± 3.0)
Marital status
Unmarried 2 (20.0) 2 (25.0) 4 (8.0 ± 3.7)
Married 8 (80.0) 6 (75.0) 11 (8.7 ± 3.1)
Occupation
Indoor job (professional, skilled labour and unemployment) 6 (60.0) 3 (33.3) 7 (6.7 ± 3.2)
Outdoor job (farmer, animal breeder, street seller and builder) 4 (40.0) 6 (66.7) 9 (10.2 ± 2.0)
Tribal distribution
Northern region 2 (20.0) 2 (22.2) 4 (5.7 ± 2.0)
Southern region 1 (10.0) 0 1 (7.0)
Western region 5 (50.0) 4 (44.4) 8 (9.6 ± 3.0)
Central region 2 (20.0) 3 (33.3) 3 (10.6 ± 2.5)
Residence during last 5 years
Khartoum state 5 (50.0) 3 (33.3) 6 (6.1 ± 2.3)
Out of Khartoum state 5 (50.0) 6 (66.7) 10 (10.2 ± 2.5)
Habits
Toombak user 0 2 (25.0) 1 (6.0)
Non-user 10 (100) 6 (75.0) 14 (8.8 ± 3.2)
Smoker 0 4 (44.4) 4 (8.0 ± 0.8)
Non-smoker 10 (100) 5 (55.6) 12 (8.9 ± 3.5)
Alcohol user 0 2 (22.2) 2 (7.5 ± 0.7)
Non-user 10 (100) 7 (77.8) 14 (8.8 ± 3.3)
The total number in the different categories did not add to 19 owing to missing values.
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recorded in two patients each (12.5%). The total mean of
the OLAS was 8.27 (range 3–13).
As shown in Table 1, the mean of the OLAS was high
with those who resided out of Khartoum state and with
outdoor workers (10.2) compared with those living in
Khartoum state (6.1) and indoor workers (6.7). Also, it
was high with lower education (9.3) compared to higher
education (6.0), and with those who reported Central
(10.6) and Western (9.6) tribes compared to other tribes
from Northern and Southern parts of Sudan.
Microscopic examination
Eleven out of 16 patients with oral lesions agreed to have
a biopsy taken. The histological characteristics were
comparable in all tissue specimens. Ten out of elevenbiopsies were covered by non-keratinized epithelium.
Few inflammatory cells (lymphocytes and neutrophils)
were present in the superficial epithelial layer of 5 biop-
sies. No candida hyphae could be demonstrated by PAS
staining. Nearly all biopsies demonstrated spongiosis in
the lower spinous cell layers, in addition to presence of
neutrophils and lymphocytes in 6 biopsies. Apoptotic
cells were seen in the spinous layer of 3 specimens.
Suprabasal epithelial clefts were detected in 10 out of
11 biopsies, while one patient biopsy showed spongiosis
only. However, in that patient, the diagnosis of PV was
based on histopathology of a skin biopsy. In some sec-
tions, 1 to 2 layers of suprabasal keratinocytes were at-
tached to basal cells forming part of floor of the cleft. In
6 biopsies, the clefts were especially seen on the tip of
the epithelial rete ridges (Figure 2). The basal cells
Figure 1 Distribution of oral manifestations in patients with pemphigus vulgaris.
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same section as well as between sections, displaying
complete loss of intercellular attachment (tombstones)
or showing intact attachment, where all basal cells
remaining attached to the basement membrane and lam-
ina propria. Inside the cleft, partially and completely de-
tached keratinocytes (acantholytic cells) from the basal
and lower prickle cells layers were spotted as single cells
or clusters. In addition, lymphocytes and neutrophils
were the main inflammatory cells inside the cleft.
In all tissue sections, the superficial parts of the con-
nective tissue were characterized by edema, small blood
vessels, loose fiber arrangements and both interstitial
and perivascular inflammatory infiltrates. MononuclearFigure 2 Histology of oral mucosa of pemphigus vulgaris
shows acantholysis in the lower spinous cell layers. Basal layer
cells are attached to the connective tissue and suprabasal cleft are
seen at the tips of the epithelial rete ridges (scale = 200 μm).cells were the principal inflammatory cells, and there
were only few neutrophils and eosinophils. The total
number of mononuclear cells varied across the 6 fields
for each specimen (Table 2), from 151 cells (mean: 25.1 ±
4.2; range: 22–31 cells) to 407 cells (mean: 67.8 ± 10.2;
range: 53–79 cells). Mononuclear cells in the specimens
were not influenced by the level of the OLAS. Deeper in
the connective tissue, mast cells and perivascular mono-
nuclear cell infiltrates were seen in 7 specimens.
Immunohistochemistry
IgG and C3 were detected intercellularly in the epithe-
lium of all specimens examined. The staining was stron-
gest in the suprabasal layer of the epithelium (Figures 3
and 4).
Discussion
This is the first study to report on the clinical character-
istics of patients with oral pemphigus in Sudan, specific-
ally in outpatients of a dermatology clinic in KTH. In
this study, the prevailing variant of pemphigus was PV
(95.4%), and oral mucosal involvement was present in
90.4% of the patients. An initial oral involvement was re-
ported by 50% of those with both skin and oral lesions.
The majority of the patients were in their fifth decade of
life. Palate and buccal mucosa were the most common
locations followed by tongue and lower lip. Based on the
OLAS, the highest severity of the oral lesions was found
in patients with low education, having outdoor jobs,
from Central and Western tribes, living out of Khartoum
state and being non-smokers. The histopathological pic-
tures of all specimens were in agreement with the IHC
findings. However, our findings should be interpreted
with caution since several limitations were inherited in
Table 2 Distribution of mononuclear cells in the superficial parts of the connective tissue adjacent to the tip of the
epithelial rete ridges (6 random fields per section)
Patients Number of mononuclear cells Sum (Mean ± SD) Range
Area 1 Area 2 Area 3 Area 4 Area 5 Area 6
1 68 26 32 66 38 85 315 (52,5 ± 23,7) 26–85
2 40 45 33 35 44 38 235 (39,1 ± 4,7) 33–45
3 30 22 22 31 22 24 151 (25,1 ± 4,2) 22–31
4 44 15 18 39 43 60 219 ( 36,5 ± 17,0) 15–60
5 47 28 19 13 16 48 171 (28,5 ± 15,5) 13–48
6 36 37 44 43 32 84 276 (46 ± 19,1) 32–84
7 48 28 49 42 46 45 258 (43 ± 7,7) 28–49
8 24 19 13 28 29 50 163 (27,1 ± 12,6) 13–50
9 53 79 77 73 60 65 407 (67,8 ± 10,2) 53–79
10 75 38 45 44 73 70 345 (57,5 ± 16,8) 38–75
11 70 50 50 24 47 60 301 (50,1 ± 15,3) 24–70
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sign of this study and the small sample size of the study
populations hindered statistical evaluation of the findings.
In addition, the relatively short period for data collection
and the potential effect of selection bias were considered
to influence the results and limit generalization. While the
KTH is one of the largest national referral hospitals in
Sudan, other referral and private hospitals could also re-
ceive patients from other parts of Khartoum and the rest
of the country. In spite of the limitations mentioned
above, the study may be beneficial as a first step in study-
ing a new issue and to generate hypotheses.
Pemphigus is primarily considered to be a dermatologic
disease. The fact that PV commonly and initially affects
the oral mucosa and then the skin [16], gives dentists a
great opportunity to detect the disease at an early stage.Figure 3 Immunohistochemistry staining used to detect IgG in
formalin-fixed, paraffin-embedded oral tissue biopsy from
patients with pemphigus vulgaris. IgG (brown colour) is seen in
the intercellular junction of keratinocytes reliable with the location
of desmoglein 3 (scale = 50 μm).The present study showed that 90.4% of the patients had
oral mucosal lesions, which is in accordance with a previ-
ous report [36]. Moreover, a multicentre study by Brenner
et al. [37], found varying prevalence of oral lesions in pa-
tients with PV; 66% in Bulgarian patients, 83% in Italian,
and 92% in Israeli patients. Our result is higher than those
reported by Ramirez et al. [38], who found a prevalence of
18% of oral lesions in PV patients examined in a dermato-
logic clinic in Mexico City.
Generally, PV has been reported to affect men and
women equally [9]. Several studies registered the highest
frequency in females [21,39-46], while a few studies have
reported males’ dominance [41,47]. In general, estrogen
(exogenous and endogenous) has been accused for the
females’ predominance in autoimmune diseases [48].
Supporting the hypothesis, 80% of the females in theFigure 4 Immunohistochemistry staining used to detect C3 in
formalin-fixed, paraffin-embedded oral tissue biopsy from
patients with pemphigus vulgaris. C3 (brown colour) is seen in
the intercellular junction of keratinocytes reliable with the location
of desmoglein 3 (scale = 50 μm).
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old). A prospective case–control study among Tunisian
females found that traditional cosmetics, commonly used
after marriage (henna, kohl, souak), was associated with
occurrence of pemphigus diseases in younger women [6].
In that respect, we found that 80% of women were mar-
ried. Sudanese married women use on daily basis trad-
itional home-made cosmetics like skin exfoliating scrub
paste, oils, perfumes, henna, and smoke-baths, beside
modern cosmetic skin whiteners, which are used among
both married and single women.
Evidences from Western countries indicate that auto-
immune diseases are increasing in frequency and show a
female predominance [48,49]. Accordingly, some authors
hypothesized that this could be, at least partially, attrib-
utable to new or modified patterns of exposure to che-
micals, including environmental estrogens [48]. Many
organochlorine pesticides are suspected to impair nat-
ural hormonal function in organisms by mimicking en-
dogenous estrogen. The hypothesis proposes that the
impact of pesticides and gardening materials on estro-
gen metabolism can trigger pemphigus. Our result
showed that among outdoor workers, farming was the
outdoor job most frequently reported. One may specu-
late that beside sun exposure, environmental estrogens
may affect specific population with a susceptible genetic
background.
Traditionally, PV tends to appear between the ages of
40 and 60 years [9]. In the present study the mean age
was 43 years, close to findings from Thailand, Spain and
Korea [15,42,50], but lower when compared with data
given from countries like Romania, Germany and North
America [51-53] and higher than other countries like
Kuwait and Iran [14,54].
Educational achievement is connected with better em-
ployment and income, which in turn can affect health
behaviors and access to health facilities and thus treat-
ment in appropriate time [55]. That could partially ex-
plain the higher frequency of PV and the higher OLAS
mean values among the low educated group as well as
outdoor job workers in comparison to their counterpart.
In addition, outdoor workers are likely to be exposed to
sun light and UV radiation for a long time of the day.
The band of the UV radiation has been suggested to in-
duce pemphigus [56,57]. Also, heat might be necessary
to liberate a sufficient amount of PV antigen from epi-
thelium [58]. Moreover, mid latitude, subtropical and
tropical countries have been suspected to have higher
frequency of pemphigus than other countries. Thus,
higher incidence was found in Mediterranean countries
[20,59] compared to high latitude countries like Finland
and North America [18,19]. An epidemiological study
from Greece demonstrated that high temperatures and
extreme sun exposure raise the relapse frequency of PV[59]. Another study from South Africa observed exacerba-
tion of pemphigus during summer time [24]. In connec-
tion with that, Sudan is located between latitude 4 to 22
degrees north, characterized by an environment range
from tropical climate in the south, to savannah and desert
in the central and northern area where temperature nor-
mally exceeds 40°C, especially during summer [60,61].
Controversially, one study from Iran showed that higher
rate of disease onset was in winter [54]. Another study
from Tehran found that there was no significant differ-
ence of disease onset or recurrence among annual sea-
sons, indicating that genetic and racial variations might
play a more important role than climate differences in the
pathogenesis of PV [62].
PV was the predominant variant of pemphigus in the
present study (95.4%). This was in accordance with sev-
eral previous studies [11-15], but opposing data from
some African regions (Mali, South Africa, Tunisia and
Libya) where PF was the dominant variant [22-24,63].
The data from Mali and South Africa proposed that PV
is rarely seen in black African ethnicity. Sudan has two
ethnic groups; Afro-Arab tribes and non-Arab African
tribes, where Southern tribes belong to the latter one. In
the present result, PV was registered in only one patient
from Southern tribes of Sudan compared to 9 (47.4%)
from Western tribes (Afro-Arab and non-Arab African
tribes). Yet the disease was not registered in Sudanese
Eastern tribes (non-Arab African tribes) which lead to un-
explained results. Several heterogeneous factors have been
implicated of inducing or triggering pemphigus in different
ethnic populations including genetic factors, in particular
Human Leukocyte Antigen (HLA) class II loci. That has
been noted in Ashkenazi Jews, Iranian, Italian patients and
also in patients of South Asian and Mediterranean origin
[64,65]. In comparison, the disease seems to be rare in
Northern Europe and USA. However, genetic factors alone
is not enough to initiate the autoimmune reaction as dem-
onstrated by a report of PV in only one of two monozy-
gotic twins [66]. Our data showed an absence of PV in
first degree relationship. This is supported by the paucity
of familial PV reports in the literature as reviewed by
Tetsuya et al. [67]. It is conceivable that exogenous factors
might induce PV in genetically predisposed individuals.
Cigarette smoking has been a highly controversial topic
with respect to effect on certain autoimmune diseases. Al-
though it is considered one of the leading morbidity and
mortality risk factors [68], some clinical evidence has sup-
ported its beneficial and protective effect on patients with
pemphigus [69] and certain diseases such as ulcerative
colitis and recurrent aphthous ulcers [70,71]. Thus, smok-
ing history is an essential factor in pemphigus patients. A
case control study by Brenner et al. [37], reported that risk
for PV was lower in current and ex-smokers than for pa-
tients who had never smoked. It has been shown that
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cyte adhesion by increased motility, proliferation and lat-
eral migration. That would increase re-epithelialization
and rapid wound healing. On the other hand, opposite re-
sults were shown when patients were subjected to chronic
or long-term exposure to nicotine [72,73]. The effect of
chronic exposure to nicotine was shown to reduce cutane-
ous blood flow and inhibit and decrease fibroblast migra-
tion in wound healing and to induce wound infection
[74,75]. Moreover, immunosuppressive effects in terms of
reduction in immunoglobulins, helper/suppressor T-cell
ratios, lymphocyte transformation and natural killer cell
cytotoxicity could also delay the healing process. Never-
theless, varying outcomes are still recorded [76]. In as-
sociation with that, the present study showed that
smoking was exclusively reported by males and in only
21.1% (4/19) of the patients. Although non-smokers and
smokers registered similar OLAS means, the latter were
the less frequent.
In this study, patient’s medical history revealed some
medications that were taken before the disease eruption
such as penicillin, co-trimoxazole and anti-hypertensive
drugs, indicating a possible association, which has also
been suggested in other studies [5,77,78].
The present results showed that half of the patients
with oral lesions had experienced the first lesion in the
mouth followed by skin lesions. This is in accordance
with a study performed in India (53.5%) [79]. The 14.2%
(3/21) of patients with exclusively oral lesion found in
our study is comparable to 16.5% from Iran [80], but in
contrast to 86% found in Northern Greece [44]. Exclu-
sively oral lesions tend to be a marker for less virulent
disease and a better prognosis [81]. It is uncommon to
clinically identify vesicles or bullae in the oral mucosa
due to continuous mechanical forces that characterize
the normal activity of the mouth. Beside the thin and
fragile roof of the PV bullae, irregular erosions and ill-
defined ulcers were the principal clinical features of oral
PV. Our findings notified only one patient with bullae,
contradicting a Brazilian study that found a rate of 75%
of patients with clinically identifiable vesicles [82]. The
distribution of oral lesions in our PV patients followed
the international literature showing the most common
sites were palate, buccal mucosa, tongue and lower lip
[83]. Other studies found the gingiva to be the most com-
monly affected site [84,85]. Although gingival lesions are
uncommon at the onset, they usually manifest as severe
desquamative or erosive gingivitis in advanced stages of
PV [86].
Based on histology, we were able to confirm the diag-
nosis in 10 out of 11 specimens. The microscopic exam-
ination was found to be comparable with the classic
histology of PV as described in the literature. This result
reinforces previous suggestions, that oral lesions ofpemphigus preserve the histologic features of acantholy-
sis more than in skin lesions, and they are less prone to
bacterial infections than skin, where secondary infec-
tions may affect the definitive histologic pattern [87].
Oral ulcers were the main clinical characteristic features
of the patients in this study. Therefore, to demonstrate
the typical pathologic changes in PV, all specimens in
the present study were taken from intact oral mucosa
immediately adjacent to the lesions. Considering inflam-
matory infiltrates, the results showed that mononuclear
cells were the principal inflammatory cells in all speci-
mens, confirming the chronic nature of PV. Further-
more, evidences have shown that lymphocytes play a
critical role in immune surveillance and activation in
PV. Lymphocytes have been reported to produce specific
cytokines that may be critical for the launch and con-
tinuation of the production of Dsg3-specific autoanti-
bodies by B lymphocytes [88,89]. Our results showed
moderate variations in the numbers and means of in-
flammatory cells from one specimen to another, as well
as in the range of cells within one specimen. These re-
sults are in consistence with the literature [10].
Tzanck smear to detect acantholytic cells is used as a
screening procedure and rapid test for diagnosing oral
PV [90]. A recent report has shown that Candida smear
using methylene blue was useful in detecting acantholy-
tic cells in such cases [91]. Some studies found that the
efficacy of H&E staining alone in diagnosing PV is prob-
ably greater than 90% and could be considered satisfac-
tory [92,93]. However, ambiguous cases and treatment
planning remain challenging. Equivocal cases come from
a number of conditions that are expressed as oral vesi-
cles or bullae that rapidly rupture and result in erosions
or ulcers. Some are viral infections such as herpes sim-
plex infection, while others are immunologic diseases
like pemphigus, pemphigoid, lupus erythematosus and
lichen planus. In such cases, DIF and IIF are important
to discriminate between them, confirm diagnosis and
plan proper treatment. Limitations of these techniques
are the availability of blood serum or fresh frozen tissue
that requires specific facilities to perform, and they do
not always exist in all health services, especially in devel-
oping countries. It also is important to secure safe trans-
port to laboratories using correct media that prevent
autolysis of the tissue. In addition, it is costly and thus
not affordable for all patients. Thus, pathologists in
Sudan usually receive patients’ specimens that have been
fixed in formalin or normal saline [94]. To overcome
these limitations, a previous study applied DIF on
formalin-fixed, paraffin-embedded tissue [95]. Although
the technique was less sensitive than when using frozen
tissue, the possibility of misclassification was low. An-
other study using immunoperoxidase staining technique
on formalin-fixed, paraffin-embedded tissue from PV
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globulin in the absence of microscopic features of the
disease [96]. Our study demonstrates that IHC on
formalin-fixed, paraffin- embedded tissue is a reliable
method to confirm the diagnosis of PV. At the time of
the present study, and specifically in public hospitals in
Sudan, confirmation of the PV was based on clinical
examination, anamnesis and conventional histopath-
ology. Thus, IHC enhances the accuracy of diagnosing
PV and can be used when only formalin-fixed, paraffin-
embedded tissue is available for analysis.
Conclusion
PV was the predominating subtype of pemphigus in this
study. The majority of PV presented with oral lesions.
The results of this study are in agreement with the pre-
vious studies with respect to the age, gender, oral lesions
distribution and first presentation of PV. The aetiology
of PV is uncertain, but several heterogeneous factors
could implicate to its pathogenicity. IHC in formalin-
fixed, paraffin-embedded oral tissue biopsy confirmed
the diagnosis of PV. The current study shed light on the
higher prevalence of oral PV among the study popula-
tion, suggesting that great collaboration efforts between
dermatologists and dentists would provide better treatment
and avoid serious sequelae and death.
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